false 2020 Q3 Kearny Financial Corp. 0001617242 --06-30 Large Accelerated Filer Market valuation of underlying collateral Adjustments to reflect current conditions/selling costs Market valuation of underlying collateral Adjustments to reflect current conditions/selling costs Market valuation of underlying collateral Adjustments to reflect current conditions/selling costs Market valuation of underlying collateral Adjustments to reflect current conditions/selling costs 0.00 0.00 0.00 0.00 0.00 0.00 Market valuation of underlying collateral Adjustments to reflect current conditions/selling costs 0.06 Market valuation of underlying collateral Adjustments to reflect current conditions/selling costs 0.10 Market valuation of underlying collateral Adjustments to reflect current conditions/selling costs 0.09 0.08 0.11 0.10 0001617242 2019-07-01 2020-03-31 xbrli:shares 0001617242 2020-05-04 iso4217:USD 0001617242 2020-03-31 0001617242 2019-06-30 iso4217:USD xbrli:shares 0001617242 2020-01-01 2020-03-31 0001617242 2019-01-01 2019-03-31 0001617242 2018-07-01 2019-03-31 0001617242 us-gaap:FinancialServiceMember 2020-01-01 2020-03-31 0001617242 us-gaap:FinancialServiceMember 2019-01-01 2019-03-31 0001617242 us-gaap:FinancialServiceMember 2019-07-01 2020-03-31 0001617242 us-gaap:FinancialServiceMember 2018-07-01 2019-03-31 0001617242 us-gaap:CreditAndDebitCardMember 2020-01-01 2020-03-31 0001617242 us-gaap:CreditAndDebitCardMember 2019-01-01 2019-03-31 0001617242 us-gaap:CreditAndDebitCardMember 2019-07-01 2020-03-31 0001617242 us-gaap:CreditAndDebitCardMember 2018-07-01 2019-03-31 0001617242 us-gaap:CommonStockMember 2018-12-31 0001617242 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001617242 us-gaap:RetainedEarningsMember 2018-12-31 0001617242 krny:UnearnedEsopSharesMember 2018-12-31 0001617242 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001617242 2018-12-31 0001617242 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001617242 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0001617242 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001617242 krny:UnearnedEsopSharesMember 2019-01-01 2019-03-31 0001617242 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001617242 us-gaap:CommonStockMember 2019-03-31 0001617242 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001617242 us-gaap:RetainedEarningsMember 2019-03-31 0001617242 krny:UnearnedEsopSharesMember 2019-03-31 0001617242 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001617242 2019-03-31 0001617242 us-gaap:CommonStockMember 2018-06-30 0001617242 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001617242 us-gaap:RetainedEarningsMember 2018-06-30 0001617242 krny:UnearnedEsopSharesMember 2018-06-30 0001617242 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0001617242 2018-06-30 0001617242 us-gaap:RetainedEarningsMember 2018-07-01 2019-03-31 0001617242 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-07-01 2019-03-31 0001617242 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2019-03-31 0001617242 krny:UnearnedEsopSharesMember 2018-07-01 2019-03-31 0001617242 us-gaap:CommonStockMember 2018-07-01 2019-03-31 0001617242 us-gaap:CommonStockMember 2019-12-31 0001617242 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001617242 us-gaap:RetainedEarningsMember 2019-12-31 0001617242 krny:UnearnedEsopSharesMember 2019-12-31 0001617242 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001617242 2019-12-31 0001617242 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001617242 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001617242 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001617242 krny:UnearnedEsopSharesMember 2020-01-01 2020-03-31 0001617242 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001617242 us-gaap:CommonStockMember 2020-03-31 0001617242 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001617242 us-gaap:RetainedEarningsMember 2020-03-31 0001617242 krny:UnearnedEsopSharesMember 2020-03-31 0001617242 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001617242 us-gaap:CommonStockMember 2019-06-30 0001617242 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001617242 us-gaap:RetainedEarningsMember 2019-06-30 0001617242 krny:UnearnedEsopSharesMember 2019-06-30 0001617242 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001617242 us-gaap:RetainedEarningsMember 2019-07-01 2020-03-31 0001617242 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2020-03-31 0001617242 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2020-03-31 0001617242 krny:UnearnedEsopSharesMember 2019-07-01 2020-03-31 0001617242 us-gaap:CommonStockMember 2019-07-01 2020-03-31 0001617242 krny:AccountingStandardsUpdate201904Member 2019-07-01 2020-03-31 0001617242 us-gaap:AccountingStandardsUpdate201602Member 2019-07-01 2020-03-31 0001617242 krny:MSBFinancialCorporationMember 2019-07-01 2020-03-31 0001617242 us-gaap:AvailableforsaleSecuritiesMember 2019-07-01 2020-03-31 0001617242 us-gaap:HeldtomaturitySecuritiesMember 2019-07-01 2020-03-31 0001617242 krny:COVID19Member 2020-03-03 2020-03-03 0001617242 krny:COVID19Member 2019-07-01 2020-03-31 0001617242 us-gaap:EmployeeStockOptionMember 2019-07-01 2020-03-31 0001617242 us-gaap:EmployeeStockOptionMember 2018-07-01 2019-03-31 0001617242 krny:MSBFinancialCorporationMember 2019-12-18 2019-12-18 0001617242 krny:MSBFinancialCorporationMember 2019-12-18 xbrli:pure 0001617242 2019-12-18 0001617242 krny:MSBFinancialCorporationMember 2020-03-31 krny:Branch 0001617242 us-gaap:AccountingStandardsUpdate201613Member 2020-03-31 0001617242 us-gaap:AccountingStandardsUpdate201602Member 2019-07-01 0001617242 krny:AccountingStandardsUpdate201904Member 2019-07-01 2019-07-01 0001617242 us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:DebtSecuritiesMember 2020-03-31 0001617242 us-gaap:AssetBackedSecuritiesMember us-gaap:DebtSecuritiesMember 2020-03-31 0001617242 us-gaap:CollateralizedDebtObligationsMember us-gaap:DebtSecuritiesMember 2020-03-31 0001617242 us-gaap:CorporateDebtSecuritiesMember us-gaap:DebtSecuritiesMember 2020-03-31 0001617242 us-gaap:TrustPreferredSecuritiesSubjectToMandatoryRedemptionMember us-gaap:DebtSecuritiesMember 2020-03-31 0001617242 us-gaap:MortgageBackedSecuritiesMember krny:CollateralizedMortgageObligationsExcludingPassThroughSecuritiesMember 2020-03-31 0001617242 us-gaap:MortgageBackedSecuritiesMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-03-31 0001617242 us-gaap:MortgageBackedSecuritiesMember us-gaap:CommercialMortgageBackedSecuritiesMember 2020-03-31 0001617242 us-gaap:MortgageBackedSecuritiesMember 2020-03-31 0001617242 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:DebtSecuritiesMember 2019-06-30 0001617242 us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:DebtSecuritiesMember 2019-06-30 0001617242 us-gaap:AssetBackedSecuritiesMember us-gaap:DebtSecuritiesMember 2019-06-30 0001617242 us-gaap:CollateralizedDebtObligationsMember us-gaap:DebtSecuritiesMember 2019-06-30 0001617242 us-gaap:CorporateDebtSecuritiesMember us-gaap:DebtSecuritiesMember 2019-06-30 0001617242 us-gaap:TrustPreferredSecuritiesSubjectToMandatoryRedemptionMember us-gaap:DebtSecuritiesMember 2019-06-30 0001617242 us-gaap:DebtSecuritiesMember 2019-06-30 0001617242 us-gaap:MortgageBackedSecuritiesMember krny:CollateralizedMortgageObligationsExcludingPassThroughSecuritiesMember 2019-06-30 0001617242 us-gaap:MortgageBackedSecuritiesMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-06-30 0001617242 us-gaap:MortgageBackedSecuritiesMember us-gaap:CommercialMortgageBackedSecuritiesMember 2019-06-30 0001617242 us-gaap:MortgageBackedSecuritiesMember 2019-06-30 0001617242 us-gaap:AvailableforsaleSecuritiesMember srt:FederalHomeLoanBankOfNewYorkMember 2020-03-31 0001617242 us-gaap:AvailableforsaleSecuritiesMember srt:FederalHomeLoanBankOfNewYorkMember 2019-06-30 0001617242 us-gaap:AvailableforsaleSecuritiesMember krny:SecurePublicFundsOnDepositMember 2020-03-31 0001617242 us-gaap:AvailableforsaleSecuritiesMember krny:FederalReserveBankMember 2020-03-31 0001617242 us-gaap:AvailableforsaleSecuritiesMember krny:FederalReserveBankMember 2019-06-30 0001617242 us-gaap:AvailableforsaleSecuritiesMember krny:DepositorSweepAccountsMember 2020-03-31 0001617242 us-gaap:AvailableforsaleSecuritiesMember krny:DepositorSweepAccountsMember 2019-06-30 0001617242 us-gaap:AvailableforsaleSecuritiesMember 2020-03-31 0001617242 us-gaap:AvailableforsaleSecuritiesMember 2019-06-30 0001617242 us-gaap:DebtSecuritiesMember 2020-03-31 0001617242 us-gaap:CorporateBondSecuritiesMember 2019-06-30 0001617242 krny:CollateralizedMortgageObligationsExcludingPassThroughSecuritiesMember 2019-06-30 0001617242 us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-06-30 0001617242 us-gaap:CommercialMortgageBackedSecuritiesMember 2019-06-30 0001617242 krny:NonAgencySecuritiesMember 2019-06-30 0001617242 us-gaap:MortgageBackedSecuritiesMember 2019-06-30 0001617242 srt:FederalHomeLoanBankOfNewYorkMember us-gaap:HeldtomaturitySecuritiesMember 2019-06-30 0001617242 krny:SecurePublicFundsOnDepositMember us-gaap:HeldtomaturitySecuritiesMember 2019-06-30 0001617242 krny:FederalReserveBankMember us-gaap:HeldtomaturitySecuritiesMember 2020-03-31 0001617242 krny:FederalReserveBankMember us-gaap:HeldtomaturitySecuritiesMember 2019-06-30 0001617242 krny:DepositorSweepAccountsMember us-gaap:HeldtomaturitySecuritiesMember 2019-06-30 0001617242 us-gaap:HeldtomaturitySecuritiesMember 2020-03-31 0001617242 us-gaap:HeldtomaturitySecuritiesMember 2019-06-30 0001617242 us-gaap:CommercialMortgageBackedSecuritiesMember 2020-03-31 krny:Security 0001617242 krny:OneToFourFamilyResidentialMember 2020-03-31 0001617242 krny:OneToFourFamilyResidentialMember 2019-06-30 0001617242 srt:MultifamilyMember 2020-03-31 0001617242 srt:MultifamilyMember 2019-06-30 0001617242 krny:NonResidentialMember 2020-03-31 0001617242 krny:NonResidentialMember 2019-06-30 0001617242 us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-03-31 0001617242 us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-06-30 0001617242 krny:ConstructionReportablePortfolioSegmentMember 2020-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember 2019-06-30 0001617242 us-gaap:CommercialPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:CommercialPortfolioSegmentMember 2019-06-30 0001617242 krny:HomeEquityLoansAndLinesOfCreditMember 2020-03-31 0001617242 krny:HomeEquityLoansAndLinesOfCreditMember 2019-06-30 0001617242 krny:OtherConsumerLoansMember 2020-03-31 0001617242 krny:OtherConsumerLoansMember 2019-06-30 0001617242 krny:ConsumerSegmentMember 2020-03-31 0001617242 krny:ConsumerSegmentMember 2019-06-30 krny:Property 0001617242 us-gaap:ResidentialPortfolioSegmentMember srt:SingleFamilyMember us-gaap:RealEstateAcquiredInSatisfactionOfDebtMember 2020-03-31 krny:Loan 0001617242 us-gaap:ResidentialPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:ResidentialPortfolioSegmentMember srt:SingleFamilyMember us-gaap:RealEstateAcquiredInSatisfactionOfDebtMember 2019-06-30 0001617242 us-gaap:ResidentialPortfolioSegmentMember 2019-06-30 0001617242 us-gaap:ResidentialPortfolioSegmentMember srt:MinimumMember 2019-07-01 2020-03-31 0001617242 us-gaap:ResidentialPortfolioSegmentMember srt:MaximumMember 2019-07-01 2020-03-31 0001617242 krny:NonResidentialMortgageMember 2020-03-31 0001617242 us-gaap:HomeEquityLoanMember 2020-03-31 0001617242 us-gaap:ConsumerPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember us-gaap:ResidentialPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember us-gaap:CommercialPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember 2020-03-31 0001617242 krny:NonResidentialMortgageMember 2019-06-30 0001617242 us-gaap:HomeEquityLoanMember 2019-06-30 0001617242 us-gaap:ConsumerPortfolioSegmentMember 2019-06-30 0001617242 us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember us-gaap:ResidentialPortfolioSegmentMember 2019-06-30 0001617242 us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember us-gaap:CommercialPortfolioSegmentMember 2019-06-30 0001617242 us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember 2019-06-30 0001617242 us-gaap:ResidentialPortfolioSegmentMember 2019-12-31 0001617242 srt:MultifamilyMember 2019-12-31 0001617242 krny:NonResidentialMortgageMember 2019-12-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember 2019-12-31 0001617242 us-gaap:CommercialPortfolioSegmentMember 2019-12-31 0001617242 us-gaap:HomeEquityLoanMember 2019-12-31 0001617242 us-gaap:ConsumerPortfolioSegmentMember 2019-12-31 0001617242 us-gaap:ConsumerPortfolioSegmentMember 2020-01-01 2020-03-31 0001617242 us-gaap:ResidentialPortfolioSegmentMember 2020-01-01 2020-03-31 0001617242 srt:MultifamilyMember 2020-01-01 2020-03-31 0001617242 krny:NonResidentialMortgageMember 2020-01-01 2020-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember 2020-01-01 2020-03-31 0001617242 us-gaap:CommercialPortfolioSegmentMember 2020-01-01 2020-03-31 0001617242 us-gaap:HomeEquityLoanMember 2020-01-01 2020-03-31 0001617242 us-gaap:ConsumerPortfolioSegmentMember 2019-07-01 2020-03-31 0001617242 us-gaap:ResidentialPortfolioSegmentMember 2019-07-01 2020-03-31 0001617242 srt:MultifamilyMember 2019-07-01 2020-03-31 0001617242 krny:NonResidentialMortgageMember 2019-07-01 2020-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember 2019-07-01 2020-03-31 0001617242 us-gaap:CommercialPortfolioSegmentMember 2019-07-01 2020-03-31 0001617242 us-gaap:HomeEquityLoanMember 2019-07-01 2020-03-31 0001617242 us-gaap:ResidentialPortfolioSegmentMember 2018-12-31 0001617242 srt:MultifamilyMember 2018-12-31 0001617242 krny:NonResidentialMortgageMember 2018-12-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember 2018-12-31 0001617242 us-gaap:CommercialPortfolioSegmentMember 2018-12-31 0001617242 us-gaap:HomeEquityLoanMember 2018-12-31 0001617242 us-gaap:ConsumerPortfolioSegmentMember 2018-12-31 0001617242 us-gaap:CommercialPortfolioSegmentMember 2019-01-01 2019-03-31 0001617242 us-gaap:ConsumerPortfolioSegmentMember 2019-01-01 2019-03-31 0001617242 us-gaap:ResidentialPortfolioSegmentMember 2019-01-01 2019-03-31 0001617242 srt:MultifamilyMember 2019-01-01 2019-03-31 0001617242 krny:NonResidentialMortgageMember 2019-01-01 2019-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember 2019-01-01 2019-03-31 0001617242 us-gaap:HomeEquityLoanMember 2019-01-01 2019-03-31 0001617242 us-gaap:ResidentialPortfolioSegmentMember 2019-03-31 0001617242 srt:MultifamilyMember 2019-03-31 0001617242 krny:NonResidentialMortgageMember 2019-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember 2019-03-31 0001617242 us-gaap:CommercialPortfolioSegmentMember 2019-03-31 0001617242 us-gaap:HomeEquityLoanMember 2019-03-31 0001617242 us-gaap:ConsumerPortfolioSegmentMember 2019-03-31 0001617242 us-gaap:ResidentialPortfolioSegmentMember 2018-06-30 0001617242 srt:MultifamilyMember 2018-06-30 0001617242 krny:NonResidentialMortgageMember 2018-06-30 0001617242 krny:ConstructionReportablePortfolioSegmentMember 2018-06-30 0001617242 us-gaap:CommercialPortfolioSegmentMember 2018-06-30 0001617242 us-gaap:HomeEquityLoanMember 2018-06-30 0001617242 us-gaap:ConsumerPortfolioSegmentMember 2018-06-30 0001617242 us-gaap:ResidentialPortfolioSegmentMember 2018-07-01 2019-03-31 0001617242 krny:NonResidentialMortgageMember 2018-07-01 2019-03-31 0001617242 us-gaap:CommercialPortfolioSegmentMember 2018-07-01 2019-03-31 0001617242 us-gaap:ConsumerPortfolioSegmentMember 2018-07-01 2019-03-31 0001617242 srt:MultifamilyMember 2018-07-01 2019-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember 2018-07-01 2019-03-31 0001617242 us-gaap:HomeEquityLoanMember 2018-07-01 2019-03-31 0001617242 us-gaap:PassMember us-gaap:ResidentialPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:PassMember srt:MultifamilyMember 2020-03-31 0001617242 us-gaap:PassMember krny:NonResidentialMortgageMember 2020-03-31 0001617242 us-gaap:PassMember krny:ConstructionReportablePortfolioSegmentMember 2020-03-31 0001617242 us-gaap:PassMember us-gaap:CommercialPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:PassMember us-gaap:HomeEquityLoanMember 2020-03-31 0001617242 us-gaap:PassMember us-gaap:ConsumerPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:PassMember 2020-03-31 0001617242 us-gaap:SpecialMentionMember us-gaap:ResidentialPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:SpecialMentionMember srt:MultifamilyMember 2020-03-31 0001617242 us-gaap:SpecialMentionMember krny:NonResidentialMortgageMember 2020-03-31 0001617242 us-gaap:SpecialMentionMember us-gaap:CommercialPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:SpecialMentionMember us-gaap:HomeEquityLoanMember 2020-03-31 0001617242 us-gaap:SpecialMentionMember us-gaap:ConsumerPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:SpecialMentionMember 2020-03-31 0001617242 us-gaap:SubstandardMember us-gaap:ResidentialPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:SubstandardMember srt:MultifamilyMember 2020-03-31 0001617242 us-gaap:SubstandardMember krny:NonResidentialMortgageMember 2020-03-31 0001617242 us-gaap:SubstandardMember us-gaap:CommercialPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:SubstandardMember us-gaap:HomeEquityLoanMember 2020-03-31 0001617242 us-gaap:SubstandardMember us-gaap:ConsumerPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:SubstandardMember 2020-03-31 0001617242 us-gaap:DoubtfulMember us-gaap:ConsumerPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:DoubtfulMember 2020-03-31 0001617242 us-gaap:PassMember us-gaap:ResidentialPortfolioSegmentMember 2019-06-30 0001617242 us-gaap:PassMember srt:MultifamilyMember 2019-06-30 0001617242 us-gaap:PassMember krny:NonResidentialMortgageMember 2019-06-30 0001617242 us-gaap:PassMember krny:ConstructionReportablePortfolioSegmentMember 2019-06-30 0001617242 us-gaap:PassMember us-gaap:CommercialPortfolioSegmentMember 2019-06-30 0001617242 us-gaap:HomeEquityLoanMember us-gaap:PassMember 2019-06-30 0001617242 us-gaap:PassMember us-gaap:ConsumerPortfolioSegmentMember 2019-06-30 0001617242 us-gaap:PassMember 2019-06-30 0001617242 us-gaap:SpecialMentionMember us-gaap:ResidentialPortfolioSegmentMember 2019-06-30 0001617242 us-gaap:SpecialMentionMember srt:MultifamilyMember 2019-06-30 0001617242 us-gaap:SpecialMentionMember us-gaap:CommercialPortfolioSegmentMember 2019-06-30 0001617242 us-gaap:HomeEquityLoanMember us-gaap:SpecialMentionMember 2019-06-30 0001617242 us-gaap:SpecialMentionMember us-gaap:ConsumerPortfolioSegmentMember 2019-06-30 0001617242 us-gaap:SpecialMentionMember 2019-06-30 0001617242 us-gaap:SubstandardMember us-gaap:ResidentialPortfolioSegmentMember 2019-06-30 0001617242 us-gaap:SubstandardMember srt:MultifamilyMember 2019-06-30 0001617242 us-gaap:SubstandardMember krny:NonResidentialMortgageMember 2019-06-30 0001617242 us-gaap:SubstandardMember us-gaap:CommercialPortfolioSegmentMember 2019-06-30 0001617242 us-gaap:HomeEquityLoanMember us-gaap:SubstandardMember 2019-06-30 0001617242 us-gaap:SubstandardMember us-gaap:ConsumerPortfolioSegmentMember 2019-06-30 0001617242 us-gaap:SubstandardMember 2019-06-30 0001617242 us-gaap:DoubtfulMember us-gaap:ConsumerPortfolioSegmentMember 2019-06-30 0001617242 us-gaap:DoubtfulMember 2019-06-30 0001617242 us-gaap:FinancingReceivables30To59DaysPastDueMember us-gaap:ResidentialPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:FinancingReceivables30To59DaysPastDueMember krny:NonResidentialMortgageMember 2020-03-31 0001617242 us-gaap:FinancingReceivables30To59DaysPastDueMember us-gaap:CommercialPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:FinancingReceivables30To59DaysPastDueMember us-gaap:HomeEquityLoanMember 2020-03-31 0001617242 us-gaap:FinancingReceivables30To59DaysPastDueMember us-gaap:ConsumerPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:FinancingReceivables30To59DaysPastDueMember 2020-03-31 0001617242 us-gaap:FinancingReceivables60To89DaysPastDueMember us-gaap:ResidentialPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:FinancingReceivables60To89DaysPastDueMember krny:NonResidentialMortgageMember 2020-03-31 0001617242 us-gaap:FinancingReceivables60To89DaysPastDueMember 2020-03-31 0001617242 us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember us-gaap:ResidentialPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember krny:NonResidentialMortgageMember 2020-03-31 0001617242 us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember us-gaap:CommercialPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember us-gaap:HomeEquityLoanMember 2020-03-31 0001617242 us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember us-gaap:ConsumerPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2020-03-31 0001617242 us-gaap:ResidentialPortfolioSegmentMember us-gaap:FinancingReceivables30To59DaysPastDueMember 2019-06-30 0001617242 us-gaap:CommercialPortfolioSegmentMember us-gaap:FinancingReceivables30To59DaysPastDueMember 2019-06-30 0001617242 us-gaap:HomeEquityLoanMember us-gaap:FinancingReceivables30To59DaysPastDueMember 2019-06-30 0001617242 us-gaap:ConsumerPortfolioSegmentMember us-gaap:FinancingReceivables30To59DaysPastDueMember 2019-06-30 0001617242 us-gaap:FinancingReceivables30To59DaysPastDueMember 2019-06-30 0001617242 us-gaap:ResidentialPortfolioSegmentMember us-gaap:FinancingReceivables60To89DaysPastDueMember 2019-06-30 0001617242 us-gaap:HomeEquityLoanMember us-gaap:FinancingReceivables60To89DaysPastDueMember 2019-06-30 0001617242 us-gaap:ConsumerPortfolioSegmentMember us-gaap:FinancingReceivables60To89DaysPastDueMember 2019-06-30 0001617242 us-gaap:FinancingReceivables60To89DaysPastDueMember 2019-06-30 0001617242 us-gaap:ResidentialPortfolioSegmentMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2019-06-30 0001617242 krny:NonResidentialMortgageMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2019-06-30 0001617242 us-gaap:HomeEquityLoanMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2019-06-30 0001617242 us-gaap:ConsumerPortfolioSegmentMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2019-06-30 0001617242 us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2019-06-30 0001617242 us-gaap:PerformingFinancingReceivableMember us-gaap:ResidentialPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:PerformingFinancingReceivableMember srt:MultifamilyMember 2020-03-31 0001617242 us-gaap:PerformingFinancingReceivableMember krny:NonResidentialMortgageMember 2020-03-31 0001617242 us-gaap:PerformingFinancingReceivableMember krny:ConstructionReportablePortfolioSegmentMember 2020-03-31 0001617242 us-gaap:PerformingFinancingReceivableMember us-gaap:CommercialPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:PerformingFinancingReceivableMember us-gaap:HomeEquityLoanMember 2020-03-31 0001617242 us-gaap:PerformingFinancingReceivableMember us-gaap:ConsumerPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:PerformingFinancingReceivableMember 2020-03-31 0001617242 us-gaap:NonperformingFinancingReceivableMember us-gaap:ConsumerPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:NonperformingFinancingReceivableMember 2020-03-31 0001617242 us-gaap:NonperformingFinancingReceivableMember us-gaap:ResidentialPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:NonperformingFinancingReceivableMember srt:MultifamilyMember 2020-03-31 0001617242 us-gaap:NonperformingFinancingReceivableMember krny:NonResidentialMortgageMember 2020-03-31 0001617242 us-gaap:NonperformingFinancingReceivableMember us-gaap:CommercialPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:NonperformingFinancingReceivableMember us-gaap:HomeEquityLoanMember 2020-03-31 0001617242 us-gaap:PerformingFinancingReceivableMember us-gaap:ResidentialPortfolioSegmentMember 2019-06-30 0001617242 us-gaap:PerformingFinancingReceivableMember srt:MultifamilyMember 2019-06-30 0001617242 us-gaap:PerformingFinancingReceivableMember krny:NonResidentialMortgageMember 2019-06-30 0001617242 us-gaap:PerformingFinancingReceivableMember krny:ConstructionReportablePortfolioSegmentMember 2019-06-30 0001617242 us-gaap:PerformingFinancingReceivableMember us-gaap:CommercialPortfolioSegmentMember 2019-06-30 0001617242 us-gaap:HomeEquityLoanMember us-gaap:PerformingFinancingReceivableMember 2019-06-30 0001617242 us-gaap:PerformingFinancingReceivableMember us-gaap:ConsumerPortfolioSegmentMember 2019-06-30 0001617242 us-gaap:PerformingFinancingReceivableMember 2019-06-30 0001617242 us-gaap:NonperformingFinancingReceivableMember us-gaap:ConsumerPortfolioSegmentMember 2019-06-30 0001617242 us-gaap:NonperformingFinancingReceivableMember 2019-06-30 0001617242 us-gaap:NonperformingFinancingReceivableMember us-gaap:ResidentialPortfolioSegmentMember 2019-06-30 0001617242 us-gaap:NonperformingFinancingReceivableMember srt:MultifamilyMember 2019-06-30 0001617242 us-gaap:NonperformingFinancingReceivableMember krny:NonResidentialMortgageMember 2019-06-30 0001617242 us-gaap:NonperformingFinancingReceivableMember us-gaap:CommercialPortfolioSegmentMember 2019-06-30 0001617242 us-gaap:HomeEquityLoanMember us-gaap:NonperformingFinancingReceivableMember 2019-06-30 0001617242 srt:WeightedAverageMember 2020-03-31 0001617242 srt:WeightedAverageMember 2019-06-30 0001617242 us-gaap:InvestmentInFederalHomeLoanBankStockMember 2020-03-31 0001617242 us-gaap:InvestmentInFederalHomeLoanBankStockMember 2019-06-30 0001617242 us-gaap:MortgageBackedSecuritiesMember 2020-03-31 0001617242 krny:InterestRateSwapAndCapsMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherAssetsMember 2020-03-31 0001617242 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherAssetsMember 2020-03-31 0001617242 krny:InterestRateSwapAndCapsMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherLiabilitiesMember 2020-03-31 0001617242 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherLiabilitiesMember 2020-03-31 0001617242 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherAssetsMember 2019-06-30 0001617242 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherAssetsMember 2019-06-30 0001617242 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherLiabilitiesMember 2019-06-30 0001617242 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherLiabilitiesMember 2019-06-30 krny:Instrument 0001617242 us-gaap:CashFlowHedgingMember us-gaap:InterestRateSwapMember 2020-03-31 0001617242 us-gaap:CashFlowHedgingMember 2020-01-01 2020-03-31 0001617242 us-gaap:CashFlowHedgingMember 2019-07-01 2020-03-31 0001617242 us-gaap:InterestExpenseMember 2019-04-01 2020-03-31 0001617242 us-gaap:CashFlowHedgingMember us-gaap:InterestRateContractMember 2020-01-01 2020-03-31 0001617242 us-gaap:CashFlowHedgingMember us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember 2020-01-01 2020-03-31 0001617242 us-gaap:CashFlowHedgingMember us-gaap:InterestRateContractMember 2019-07-01 2020-03-31 0001617242 us-gaap:CashFlowHedgingMember us-gaap:InterestRateContractMember us-gaap:InterestExpenseMember 2019-07-01 2020-03-31 0001617242 us-gaap:CashFlowHedgingMember us-gaap:InterestRateContractMember 2019-01-01 2019-03-31 0001617242 us-gaap:CashFlowHedgingMember 2019-01-01 2019-03-31 0001617242 us-gaap:CashFlowHedgingMember us-gaap:InterestRateContractMember us-gaap:InterestExpenseMember 2019-01-01 2019-03-31 0001617242 us-gaap:CashFlowHedgingMember us-gaap:InterestRateContractMember 2018-07-01 2019-03-31 0001617242 us-gaap:CashFlowHedgingMember 2018-07-01 2019-03-31 0001617242 us-gaap:CashFlowHedgingMember us-gaap:InterestRateContractMember us-gaap:InterestExpenseMember 2018-07-01 2019-03-31 0001617242 us-gaap:InterestRateContractMember 2020-03-31 0001617242 us-gaap:InterestRateContractMember 2019-06-30 0001617242 krny:CounterPartyMember 2020-03-31 0001617242 us-gaap:LoanOriginationCommitmentsMember 2020-03-31 0001617242 us-gaap:LoanOriginationCommitmentsMember 2019-06-30 0001617242 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember krny:SalariesAndEmployeeBenefitsMember 2020-01-01 2020-03-31 0001617242 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember krny:SalariesAndEmployeeBenefitsMember 2019-01-01 2019-03-31 0001617242 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember krny:SalariesAndEmployeeBenefitsMember 2019-07-01 2020-03-31 0001617242 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember krny:SalariesAndEmployeeBenefitsMember 2018-07-01 2019-03-31 0001617242 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember krny:MiscellaneousNonInterestExpenseMember 2020-01-01 2020-03-31 0001617242 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember krny:MiscellaneousNonInterestExpenseMember 2019-01-01 2019-03-31 0001617242 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember krny:MiscellaneousNonInterestExpenseMember 2019-07-01 2020-03-31 0001617242 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember krny:MiscellaneousNonInterestExpenseMember 2018-07-01 2019-03-31 0001617242 us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:FairValueInputsLevel2Member us-gaap:DebtSecuritiesMember 2020-03-31 0001617242 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:DebtSecuritiesMember 2020-03-31 0001617242 us-gaap:CollateralizedDebtObligationsMember us-gaap:FairValueInputsLevel2Member us-gaap:DebtSecuritiesMember 2020-03-31 0001617242 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:DebtSecuritiesMember 2020-03-31 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:DebtSecuritiesMember us-gaap:TrustPreferredSecuritiesSubjectToMandatoryRedemptionMember 2020-03-31 0001617242 us-gaap:FairValueInputsLevel2Member 2020-03-31 0001617242 us-gaap:FairValueInputsLevel2Member krny:CollateralizedMortgageObligationsExcludingPassThroughSecuritiesMember 2020-03-31 0001617242 krny:CollateralizedMortgageObligationsExcludingPassThroughSecuritiesMember 2020-03-31 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-03-31 0001617242 us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-03-31 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:CommercialMortgageBackedSecuritiesMember 2020-03-31 0001617242 us-gaap:FairValueInputsLevel2Member krny:InterestRateSwapsAndCapsMember 2020-03-31 0001617242 krny:InterestRateSwapsAndCapsMember 2020-03-31 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:InterestRateSwapMember 2020-03-31 0001617242 us-gaap:InterestRateSwapMember 2020-03-31 0001617242 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:DebtSecuritiesMember 2019-06-30 0001617242 us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:FairValueInputsLevel2Member us-gaap:DebtSecuritiesMember 2019-06-30 0001617242 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:DebtSecuritiesMember 2019-06-30 0001617242 us-gaap:CollateralizedDebtObligationsMember us-gaap:FairValueInputsLevel2Member us-gaap:DebtSecuritiesMember 2019-06-30 0001617242 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:DebtSecuritiesMember 2019-06-30 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:DebtSecuritiesMember us-gaap:TrustPreferredSecuritiesSubjectToMandatoryRedemptionMember 2019-06-30 0001617242 us-gaap:FairValueInputsLevel3Member us-gaap:DebtSecuritiesMember us-gaap:TrustPreferredSecuritiesSubjectToMandatoryRedemptionMember 2019-06-30 0001617242 us-gaap:FairValueInputsLevel2Member 2019-06-30 0001617242 us-gaap:FairValueInputsLevel3Member 2019-06-30 0001617242 us-gaap:FairValueInputsLevel2Member krny:CollateralizedMortgageObligationsExcludingPassThroughSecuritiesMember 2019-06-30 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-06-30 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:CommercialMortgageBackedSecuritiesMember 2019-06-30 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:InterestRateSwapMember 2019-06-30 0001617242 us-gaap:InterestRateSwapMember 2019-06-30 0001617242 krny:ImpairedLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-03-31 0001617242 krny:ImpairedLoansMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-03-31 0001617242 krny:ImpairedLoansMember us-gaap:FairValueInputsLevel3Member krny:NonResidentialMortgageMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-03-31 0001617242 krny:ImpairedLoansMember krny:NonResidentialMortgageMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-03-31 0001617242 krny:ImpairedLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:CommercialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-03-31 0001617242 krny:ImpairedLoansMember us-gaap:CommercialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-03-31 0001617242 krny:ImpairedLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2020-03-31 0001617242 krny:ImpairedLoansMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-03-31 0001617242 krny:OtherRealEstateOwnedMember us-gaap:FairValueInputsLevel3Member us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-03-31 0001617242 krny:OtherRealEstateOwnedMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-03-31 0001617242 krny:OtherRealEstateOwnedMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2020-03-31 0001617242 krny:OtherRealEstateOwnedMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-03-31 0001617242 us-gaap:FairValueInputsLevel3Member krny:ImpairedLoansMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2019-06-30 0001617242 krny:ImpairedLoansMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2019-06-30 0001617242 us-gaap:FairValueInputsLevel3Member krny:ImpairedLoansMember krny:NonResidentialMortgageMember us-gaap:FairValueMeasurementsNonrecurringMember 2019-06-30 0001617242 krny:ImpairedLoansMember krny:NonResidentialMortgageMember us-gaap:FairValueMeasurementsNonrecurringMember 2019-06-30 0001617242 us-gaap:FairValueInputsLevel3Member krny:ImpairedLoansMember us-gaap:CommercialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2019-06-30 0001617242 krny:ImpairedLoansMember us-gaap:CommercialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2019-06-30 0001617242 us-gaap:FairValueInputsLevel3Member krny:ImpairedLoansMember us-gaap:FairValueMeasurementsNonrecurringMember 2019-06-30 0001617242 krny:ImpairedLoansMember us-gaap:FairValueMeasurementsNonrecurringMember 2019-06-30 0001617242 krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-03-31 0001617242 krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember krny:NonResidentialMortgageMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-03-31 0001617242 krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember us-gaap:CommercialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-03-31 0001617242 krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-03-31 0001617242 krny:OtherRealEstateOwnedMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-03-31 0001617242 krny:OtherRealEstateOwnedMember us-gaap:MarketApproachValuationTechniqueMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-03-31 0001617242 krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-01-01 2020-03-31 0001617242 krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember krny:NonResidentialMortgageMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-01-01 2020-03-31 0001617242 krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember us-gaap:CommercialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-01-01 2020-03-31 0001617242 krny:OtherRealEstateOwnedMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-01-01 2020-03-31 0001617242 srt:MinimumMember krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-01-01 2020-03-31 0001617242 srt:MinimumMember krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember krny:NonResidentialMortgageMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-01-01 2020-03-31 0001617242 srt:MinimumMember krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember us-gaap:CommercialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-01-01 2020-03-31 0001617242 srt:MaximumMember krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-01-01 2020-03-31 0001617242 srt:MaximumMember krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember krny:NonResidentialMortgageMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-01-01 2020-03-31 0001617242 srt:MaximumMember krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember us-gaap:CommercialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-01-01 2020-03-31 0001617242 krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2019-06-30 0001617242 krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember krny:NonResidentialMortgageMember us-gaap:FairValueMeasurementsNonrecurringMember 2019-06-30 0001617242 krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember us-gaap:CommercialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2019-06-30 0001617242 krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember us-gaap:FairValueMeasurementsNonrecurringMember 2019-06-30 0001617242 krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2018-07-01 2019-06-30 0001617242 krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember krny:NonResidentialMortgageMember us-gaap:FairValueMeasurementsNonrecurringMember 2018-07-01 2019-06-30 0001617242 krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember us-gaap:CommercialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2018-07-01 2019-06-30 0001617242 srt:MinimumMember krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2018-07-01 2019-06-30 0001617242 srt:MinimumMember krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember krny:NonResidentialMortgageMember us-gaap:FairValueMeasurementsNonrecurringMember 2018-07-01 2019-06-30 0001617242 srt:MinimumMember krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember us-gaap:CommercialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2018-07-01 2019-06-30 0001617242 srt:MaximumMember krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2018-07-01 2019-06-30 0001617242 srt:MaximumMember krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember krny:NonResidentialMortgageMember us-gaap:FairValueMeasurementsNonrecurringMember 2018-07-01 2019-06-30 0001617242 srt:MaximumMember krny:ImpairedLoansMember us-gaap:MarketApproachValuationTechniqueMember krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember us-gaap:CommercialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2018-07-01 2019-06-30 0001617242 us-gaap:FairValueInputsLevel3Member krny:ImpairedLoansMember 2020-03-31 0001617242 us-gaap:FairValueInputsLevel3Member krny:ImpairedLoansMember 2019-06-30 0001617242 us-gaap:FairValueInputsLevel3Member krny:OtherRealEstateOwnedMember us-gaap:FairValueMeasurementsNonrecurringMember 2019-06-30 0001617242 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-03-31 0001617242 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-03-31 0001617242 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-03-31 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-03-31 0001617242 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-03-31 0001617242 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-06-30 0001617242 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-06-30 0001617242 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-06-30 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-06-30 0001617242 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-06-30 0001617242 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-03-31 0001617242 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-06-30 0001617242 krny:AccumulatedNetUnrealizedGainLossOnSecuritiesTransferredFromAvailableForSaleToHeldToMaturityMember 2019-06-30 0001617242 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-03-31 0001617242 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-06-30 0001617242 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-03-31 0001617242 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-06-30 0001617242 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001617242 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0001617242 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-07-01 2020-03-31 0001617242 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2018-07-01 2019-03-31 0001617242 krny:DepositRelatedFeesAndChargesMember 2020-01-01 2020-03-31 0001617242 krny:DepositRelatedFeesAndChargesMember 2019-01-01 2019-03-31 0001617242 krny:DepositRelatedFeesAndChargesMember 2019-07-01 2020-03-31 0001617242 krny:DepositRelatedFeesAndChargesMember 2018-07-01 2019-03-31 0001617242 krny:ElectronicBankingFeesAndChargesInterchangeIncomeMember 2020-01-01 2020-03-31 0001617242 krny:ElectronicBankingFeesAndChargesInterchangeIncomeMember 2019-01-01 2019-03-31 0001617242 krny:ElectronicBankingFeesAndChargesInterchangeIncomeMember 2019-07-01 2020-03-31 0001617242 krny:ElectronicBankingFeesAndChargesInterchangeIncomeMember 2018-07-01 2019-03-31

 

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2020

OR

 

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to             

Commission File Number 001-37399

 

KEARNY FINANCIAL CORP.

(Exact name of registrant as specified in its charter)

 

 

Maryland

  

30-0870244

(State or other jurisdiction of
incorporation or organization)

  

(I.R.S. Employer
Identification Number)

 

 

 

120 Passaic Ave., Fairfield, New Jersey

  

07004

(Address of principal executive offices)

  

(Zip Code)

Registrant’s telephone number, including area code

973-244-4500

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock, $0.01 par value

 

KRNY

 

The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes ☒    No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes ☒    No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filers,” “accelerated filers,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

☒

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

 

 

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes ☐    No ☒

The number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: May 4, 2020.

$0.01 par value common stock — 83,663,192 shares outstanding

 

 

 

KEARNY FINANCIAL CORP. AND SUBSIDIARIES

INDEX

 

 

 

 

 

Page

Number

PART I—FINANCIAL INFORMATION

 

 

 

 

 

 

 

Item 1:

 

Financial Statements

 

 

 

 

 

 

 

 

 

Consolidated Statements of Financial Condition at March 31, 2020 (Unaudited) and June 30, 2019

 

1

 

 

 

 

 

 

 

Consolidated Statements of Income for the Three and Nine Months Ended March 31, 2020 and March 31, 2019 (Unaudited)

 

2

 

 

 

 

 

 

 

Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended March 31, 2020 and March 31, 2019 (Unaudited)

 

4

 

 

 

 

 

 

 

Consolidated Statements of Changes in Stockholders’ Equity for the Three and Nine Months Ended March 31, 2020 and March 31, 2019 (Unaudited)

 

5

 

 

 

 

 

 

 

Consolidated Statements of Cash Flows for the Nine Months Ended March 31, 2020 and March 31, 2019 (Unaudited)

 

7

 

 

 

 

 

 

 

Notes to Consolidated Financial Statements (Unaudited)

 

9

 

 

 

 

 

Item 2:

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

50

 

 

 

 

 

Item 3:

 

Quantitative and Qualitative Disclosure About Market Risk

 

68

 

 

 

 

 

Item 4:

 

Controls and Procedures

 

71

 

 

 

 

 

PART II—OTHER INFORMATION

 

 

 

 

 

 

 

Item 1:

 

Legal Proceedings

 

72

 

 

 

 

 

Item 1A:

 

Risk Factors

 

72

 

 

 

 

 

Item 2:

 

Unregistered Sales of Equity Securities and Use of Proceeds

 

73

 

 

 

 

 

Item 3:

 

Defaults Upon Senior Securities

 

73

 

 

 

 

 

Item 4:

 

Mine Safety Disclosures

 

73

 

 

 

 

 

Item 5:

 

Other Information

 

73

 

 

 

 

 

Item 6:

 

Exhibits

 

74

 

 

 

 

 

SIGNATURES

 

75

 

 

 

 

KEARNY FINANCIAL CORP. AND SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION

(In Thousands, Except Share and Per Share Data)

 

 

March 31,

 

 

June 30,

 

 

2020

 

 

2019

 

 

(Unaudited)

 

 

 

 

 

Assets

 

 

 

 

 

 

 

Cash and amounts due from depository institutions

$

20,200

 

 

$

19,032

 

Interest-bearing deposits in other banks

 

39,252

 

 

 

19,903

 

Cash and cash equivalents

 

59,452

 

 

 

38,935

 

Investment securities available for sale, at fair value

 

1,476,344

 

 

 

714,263

 

Investment securities held to maturity (fair value $35,433 and $584,678, respectively)

 

34,618

 

 

 

576,652

 

Loans held-for-sale

 

11,245

 

 

 

12,267

 

Loans receivable, including unaccreted yield adjustments of $(42,461) and $(52,025),

respectively

 

4,562,512

 

 

 

4,678,928

 

Less: allowance for loan losses

 

(37,191

)

 

 

(33,274

)

Net loans receivable

 

4,525,321

 

 

 

4,645,654

 

Premises and equipment

 

58,985

 

 

 

56,854

 

Federal Home Loan Bank ("FHLB") of New York stock

 

59,324

 

 

 

64,190

 

Accrued interest receivable

 

19,036

 

 

 

19,360

 

Goodwill

 

210,895

 

 

 

210,895

 

Core deposit intangibles

 

4,242

 

 

 

5,160

 

Bank owned life insurance

 

260,843

 

 

 

256,155

 

Deferred income tax assets, net

 

27,150

 

 

 

25,367

 

Other real estate owned

 

178

 

 

 

-

 

Other assets

 

26,200

 

 

 

9,077

 

Total Assets

$

6,773,833

 

 

$

6,634,829

 

 

 

 

 

 

 

 

 

Liabilities and Stockholders' Equity

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

Deposits:

 

 

 

 

 

 

 

Non-interest-bearing

$

321,824

 

 

$

309,063

 

Interest-bearing

 

3,931,430

 

 

 

3,838,547

 

Total deposits

 

4,253,254

 

 

 

4,147,610

 

Borrowings

 

1,384,025

 

 

 

1,321,982

 

Advance payments by borrowers for taxes

 

16,492

 

 

 

16,887

 

Other liabilities

 

50,390

 

 

 

21,191

 

Total Liabilities

 

5,704,161

 

 

 

5,507,670

 

 

 

 

 

 

 

 

 

Stockholders' Equity

 

 

 

 

 

 

 

Preferred stock, $0.01 par value, 100,000,000 shares authorized;

  none issued and outstanding

 

-

 

 

 

-

 

Common stock, $0.01 par value; 800,000,000 shares authorized;

  83,664,427 shares and 89,125,655 shares issued and outstanding, respectively

 

837

 

 

 

891

 

Paid-in capital

 

721,474

 

 

 

787,394

 

Retained earnings

 

380,671

 

 

 

366,679

 

Unearned employee stock ownership plan shares;

  3,010,464 shares and 3,160,987 shares, respectively

 

(29,185

)

 

 

(30,644

)

Accumulated other comprehensive (loss) income

 

(4,125

)

 

 

2,839

 

Total Stockholders' Equity

 

1,069,672

 

 

 

1,127,159

 

Total Liabilities and Stockholders' Equity

$

6,773,833

 

 

$

6,634,829

 

 

See notes to unaudited consolidated financial statements.

 

- 1 -

KEARNY FINANCIAL CORP. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(In Thousands, Except Per Share Data)

(Unaudited)

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

March 31,

 

 

March 31,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Interest Income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loans

 

$

46,603

 

 

$

48,116

 

 

$

140,811

 

 

$

144,568

 

Taxable investment securities

 

 

10,526

 

 

 

9,511

 

 

 

29,552

 

 

 

27,441

 

Tax-exempt investment securities

 

 

547

 

 

 

710

 

 

 

1,906

 

 

 

2,139

 

Other interest-earning assets

 

 

1,100

 

 

 

1,320

 

 

 

3,588

 

 

 

3,737

 

Total Interest Income

 

 

58,776

 

 

 

59,657

 

 

 

175,857

 

 

 

177,885

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest Expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deposits

 

 

14,768

 

 

 

14,114

 

 

 

46,413

 

 

 

37,380

 

Borrowings

 

 

6,398

 

 

 

6,905

 

 

 

20,540

 

 

 

22,338

 

Total Interest Expense

 

 

21,166

 

 

 

21,019

 

 

 

66,953

 

 

 

59,718

 

Net Interest Income

 

 

37,610

 

 

 

38,638

 

 

 

108,904

 

 

 

118,167

 

Provision for (reversal of) loan losses

 

 

6,270

 

 

 

(179

)

 

 

4,023

 

 

 

2,892

 

Net Interest Income after Provision for (Reversal of)

Loan Losses

 

 

31,340

 

 

 

38,817

 

 

 

104,881

 

 

 

115,275

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-Interest Income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fees and service charges

 

 

1,338

 

 

 

1,674

 

 

 

4,951

 

 

 

4,105

 

Gain (loss) on sale and call of securities

 

 

2,234

 

 

 

(182

)

 

 

2,231

 

 

 

(182

)

Gain on sale of loans

 

 

565

 

 

 

151

 

 

 

1,838

 

 

 

384

 

Loss on sale and write down of other real estate

owned

 

 

-

 

 

 

(6

)

 

 

(28

)

 

 

(20

)

Income from bank owned life insurance

 

 

1,532

 

 

 

1,560

 

 

 

4,688

 

 

 

4,753

 

Electronic banking fees and charges

 

 

309

 

 

 

253

 

 

 

920

 

 

 

780

 

Miscellaneous

 

 

223

 

 

 

226

 

 

 

117

 

 

 

347

 

Total Non-Interest Income

 

 

6,201

 

 

 

3,676

 

 

 

14,717

 

 

 

10,167

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-Interest Expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Salaries and employee benefits

 

 

15,537

 

 

 

15,350

 

 

 

46,488

 

 

 

46,691

 

Net occupancy expense of premises

 

 

2,685

 

 

 

2,979

 

 

 

8,736

 

 

 

8,476

 

Equipment and systems

 

 

2,672

 

 

 

3,053

 

 

 

8,807

 

 

 

9,356

 

Advertising and marketing

 

 

612

 

 

 

739

 

 

 

2,037

 

 

 

2,103

 

Federal deposit insurance premium

 

 

-

 

 

 

455

 

 

 

-

 

 

 

1,341

 

Directors' compensation

 

 

771

 

 

 

770

 

 

 

2,310

 

 

 

2,274

 

Merger-related expenses

 

 

285

 

 

 

-

 

 

 

504

 

 

 

-

 

Debt extinguishment expenses

 

 

2,156

 

 

 

-

 

 

 

2,156

 

 

 

-

 

Miscellaneous

 

 

3,344

 

 

 

3,425

 

 

 

9,695

 

 

 

10,257

 

Total Non-Interest Expense

 

 

28,062

 

 

 

26,771

 

 

 

80,733

 

 

 

80,498

 

Income before Income Taxes

 

 

9,479

 

 

 

15,722

 

 

 

38,865

 

 

 

44,944

 

Income tax expense

 

 

225

 

 

 

4,305

 

 

 

7,589

 

 

 

11,613

 

Net Income

 

$

9,254

 

 

$

11,417

 

 

$

31,276

 

 

$

33,331

 

 

See notes to unaudited consolidated financial statements.

 

- 2 -

KEARNY FINANCIAL CORP. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME (Continued)

(In Thousands, Except Per Share Data)

(Unaudited)

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

March 31,

 

 

March 31,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Net Income per Common Share (EPS)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.11

 

 

$

0.13

 

 

$

0.38

 

 

$

0.36

 

Diluted

 

$

0.11

 

 

$

0.13

 

 

$

0.38

 

 

$

0.36

 

Weighted Average Number of Common Shares

Outstanding

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

81,339

 

 

 

89,488

 

 

 

82,981

 

 

 

92,370

 

Diluted

 

 

81,358

 

 

 

89,532

 

 

 

83,016

 

 

 

92,419

 

 

See notes to unaudited consolidated financial statements.

 

 

 

- 3 -

KEARNY FINANCIAL CORP. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

(In Thousands, Unaudited)

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

March 31,

 

 

March 31,

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Net Income

$

9,254

 

 

$

11,417

 

 

$

31,276

 

 

$

33,331

 

Other Comprehensive Loss, net of tax:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net unrealized gain on securities available

for sale

 

2,705

 

 

 

3,637

 

 

 

7,968

 

 

 

1,121

 

Amortization of net unrealized loss on securities

available for sale transferred to held to maturity

 

-

 

 

 

38

 

 

 

421

 

 

 

168

 

Net realized (gain) loss on sale and call of

securities available for sale

 

(1,575

)

 

 

128

 

 

 

(1,574

)

 

 

128

 

Fair value adjustments on derivatives

 

(13,213

)

 

 

(5,034

)

 

 

(14,120

)

 

 

(12,366

)

Benefit plan adjustments

 

3

 

 

 

8

 

 

 

341

 

 

 

(7

)

Total Other Comprehensive Loss

 

(12,080

)

 

 

(1,223

)

 

 

(6,964

)

 

 

(10,956

)

Total Comprehensive (Loss) Income

$

(2,826

)

 

$

10,194

 

 

$

24,312

 

 

$

22,375

 

 

See notes to unaudited consolidated financial statements.

 

 

 

- 4 -

KEARNY FINANCIAL CORP. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

Three and Nine Months Ended March 31, 2019

(In Thousands, Unaudited)

 

 

Common Stock

 

 

Paid-In

 

 

Retained

 

 

Unearned

ESOP

 

 

Accumulated

Other

Comprehensive

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Earnings

 

 

Shares

 

 

Income

 

 

Total

 

Balance - December 31, 2018

 

93,772

 

 

$

938

 

 

$

848,145

 

 

$

356,993

 

 

$

(31,617

)

 

$

8,802

 

 

$

1,183,261

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

-

 

 

 

-

 

 

 

-

 

 

 

11,417

 

 

 

-

 

 

 

-

 

 

 

11,417

 

Other comprehensive loss, net

  of income tax expense

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,223

)

 

 

(1,223

)

ESOP shares committed to be

  released (50 shares)

 

-

 

 

 

-

 

 

 

161

 

 

 

-

 

 

 

487

 

 

 

-

 

 

 

648

 

Stock option exercise

 

21

 

 

 

-

 

 

 

152

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

152

 

Stock option expense

 

-

 

 

 

-

 

 

 

538

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

538

 

Share repurchases

 

(2,446

)

 

 

(24

)

 

 

(32,364

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(32,388

)

Issuance of shares for stock benefit

  plans

 

148

 

 

 

1

 

 

 

(1

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Restricted stock plan shares

  earned (71 shares)

 

-

 

 

 

-

 

 

 

1,044

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,044

 

Cash dividends declared

  ($0.06 per common share)

 

-

 

 

 

-

 

 

 

-

 

 

 

(5,338

)

 

 

-

 

 

 

-

 

 

 

(5,338

)

Balance - March 31, 2019

 

91,495

 

 

$

915

 

 

$

817,675

 

 

$

363,072

 

 

$

(31,130

)

 

$

7,579

 

 

$

1,158,111

 

 

 

Common Stock

 

 

Paid-In

 

 

Retained

 

 

Unearned

ESOP

 

 

Accumulated

Other

Comprehensive

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Earnings

 

 

Shares

 

 

Income

 

 

Total

 

Balance - June 30, 2018

 

99,626

 

 

$

996

 

 

$

922,711

 

 

$

359,096

 

 

$

(32,590

)

 

$

18,535

 

 

$

1,268,748

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cumulative effect of change in

accounting principle for the

adoption of ASU 2017-08

 

-

 

 

 

-

 

 

 

-

 

 

 

(531

)

 

 

-

 

 

 

-

 

 

 

(531

)

Balance - July 1, 2018, as adjusted

for change in accounting principle

 

99,626

 

 

 

996

 

 

 

922,711

 

 

 

358,565

 

 

 

(32,590

)

 

 

18,535

 

 

 

1,268,217

 

Net income

 

-

 

 

 

-

 

 

 

-

 

 

 

33,331

 

 

 

-

 

 

 

-

 

 

 

33,331

 

Other comprehensive loss, net

  of income tax expense

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(10,956

)

 

 

(10,956

)

ESOP shares committed to be

  released (150 shares)

 

-

 

 

 

-

 

 

 

527

 

 

 

-

 

 

 

1,460

 

 

 

-

 

 

 

1,987

 

Stock option exercise

 

21

 

 

 

-

 

 

 

152

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

152

 

Stock option expense

 

-

 

 

 

-

 

 

 

1,533

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,533

 

Share repurchases

 

(8,231

)

 

 

(81

)

 

 

(109,416

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(109,497

)

Issuance of shares under stock

benefit plans

 

233

 

 

 

2

 

 

 

(2

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Restricted stock plan shares

  earned (213 shares)

 

-

 

 

 

-

 

 

 

3,112

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,112

 

Cancellation of shares issued for

  restricted stock awards

 

(154

)

 

 

(2

)

 

 

(942

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(944

)

Cash dividends declared

  ($0.31 per common share)

 

-

 

 

 

-

 

 

 

-

 

 

 

(28,824

)

 

 

-

 

 

 

-

 

 

 

(28,824

)

Balance - March 31, 2019

 

91,495

 

 

$

915

 

 

$

817,675

 

 

$

363,072

 

 

$

(31,130

)

 

$

7,579

 

 

$

1,158,111

 

 

See notes to unaudited consolidated financial statements.

- 5 -

KEARNY FINANCIAL CORP. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

Three and Nine Months Ended March 31, 2020

(In Thousands, Unaudited)

 

 

Common Stock

 

 

Paid-In

 

 

Retained

 

 

Unearned

ESOP

 

 

Accumulated

Other

Comprehensive

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Earnings

 

 

Shares

 

 

Loss

 

 

Total

 

Balance - December 31, 2019

 

85,150

 

 

$

851

 

 

$

737,539

 

 

$

377,896

 

 

$

(29,671

)

 

$

7,955

 

 

$

1,094,570

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

-

 

 

 

-

 

 

 

-

 

 

 

9,254

 

 

 

-

 

 

 

-

 

 

 

9,254

 

Other comprehensive loss, net

  of income tax

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(12,080

)

 

 

(12,080

)

ESOP shares committed to be

  released (50 shares)

 

-

 

 

 

-

 

 

 

95

 

 

 

-

 

 

 

486

 

 

 

-

 

 

 

581

 

Stock option expense

 

-

 

 

 

-

 

 

 

465

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

465

 

Share repurchases

 

(1,476

)

 

 

(14

)

 

 

(17,514

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(17,528

)

Restricted stock plan shares

  earned (70 shares)

 

-

 

 

 

-

 

 

 

1,025

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,025

 

Cancellation of shares issued for

  restricted stock awards

 

(10

)

 

 

-

 

 

 

(136

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(136

)

Cash dividends declared

  ($0.08 per common share)

 

-

 

 

 

-

 

 

 

-

 

 

 

(6,479

)

 

 

-

 

 

 

-

 

 

 

(6,479

)

Balance - March 31, 2020

 

83,664

 

 

$

837

 

 

$

721,474

 

 

$

380,671

 

 

$

(29,185

)

 

$

(4,125

)

 

$

1,069,672

 

 

 

 

Common Stock

 

 

Paid-In

 

 

Retained

 

 

Unearned

ESOP

 

 

Accumulated

Other

Comprehensive

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Earnings

 

 

Shares

 

 

Loss

 

 

Total

 

Balance - June 30, 2019

 

89,126

 

 

$

891

 

 

$

787,394

 

 

$

366,679

 

 

$

(30,644

)

 

$

2,839

 

 

 

1,127,159

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

-

 

 

 

-

 

 

 

-

 

 

 

31,276

 

 

 

-

 

 

 

-

 

 

 

31,276

 

Other comprehensive loss, net

  of income tax benefit

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(6,964

)

 

 

(6,964

)

ESOP shares committed to be

  released (150 shares)

 

-

 

 

 

-

 

 

 

475

 

 

 

-

 

 

 

1,459

 

 

 

-

 

 

 

1,934

 

Stock option expense

 

-

 

 

 

-

 

 

 

1,382

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,382

 

Share repurchases

 

(5,376

)

 

 

(53

)

 

 

(69,729

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(69,782

)

Restricted stock plan shares

  earned (208 shares)

 

-

 

 

 

-

 

 

 

3,024

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,024

 

Cancellation of shares issued for

  restricted stock awards

 

(86

)

 

 

(1

)

 

 

(1,072

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,073

)

Cash dividends declared

  ($0.21 per common share)

 

-

 

 

 

-

 

 

 

-

 

 

 

(17,284

)

 

 

-

 

 

 

-

 

 

 

(17,284

)

Balance - March 31, 2020

 

83,664

 

 

$

837

 

 

$

721,474

 

 

$

380,671

 

 

$

(29,185

)

 

$

(4,125

)

 

$

1,069,672

 

 

See notes to unaudited consolidated financial statements.

 

 

- 6 -

 

KEARNY FINANCIAL CORP. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Thousands, Unaudited)

 

 

Nine Months Ended

 

 

March 31,

 

 

2020

 

 

2019

 

Cash Flows from Operating Activities:

 

 

 

 

 

 

 

Net income

$

31,276

 

 

$

33,331

 

Adjustment to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

Depreciation and amortization of premises and equipment

 

3,404

 

 

 

3,190

 

Net accretion of premiums, discounts and loan fees and costs

 

(6,716

)

 

 

(8,479

)

Deferred income taxes and valuation allowance

 

1,145

 

 

 

3,698

 

Amortization of intangible assets

 

918

 

 

 

825

 

Amortization (accretion) of benefit plans’ unrecognized net gain

 

485

 

 

 

(25

)

Provision for loan losses

 

4,023

 

 

 

2,892

 

Loss on write-down and sales of other real estate owned

 

28

 

 

 

20

 

Loans originated for sale

 

(173,436

)

 

 

(33,716

)

Proceeds from sale of mortgage loans held-for-sale

 

176,269

 

 

 

33,911

 

Gain on sale of mortgage loans held-for-sale, net

 

(1,811

)

 

 

(328

)

Realized (gain) loss on sale and call of investment securities available for sale

 

(2,231

)

 

 

182

 

Proceeds from sale of SBA loans

 

497

 

 

 

922

 

Realized gain on sale of SBA loans

 

(27

)

 

 

(56

)

Realized loss on disposition of premises and equipment

 

342

 

 

 

17

 

Increase in cash surrender value of bank owned life insurance

 

(4,688

)

 

 

(4,753

)

ESOP, stock option plan and restricted stock plan expenses

 

6,340

 

 

 

6,632

 

Decrease (increase) in interest receivable

 

324

 

 

 

(1,816

)

(Increase) decrease in other assets

 

(20,444

)

 

 

3,134

 

(Decrease) increase in interest payable

 

(3,237

)

 

 

3,574

 

Increase (decrease) in other liabilities

 

17,652

 

 

 

(4,132

)

Net Cash Provided by Operating Activities

 

30,113

 

 

 

39,023

 

 

 

 

 

 

 

 

 

Cash Flows from Investing Activities:

 

 

 

 

 

 

 

Purchases of:

 

 

 

 

 

 

 

Investment securities available for sale

 

(487,898

)

 

 

(113,686

)

Investment securities held to maturity

 

-

 

 

 

(55,247

)

Proceeds from:

 

 

 

 

 

 

 

Repayments/calls/maturities of investment securities available for sale

 

111,194

 

 

 

60,377

 

Repayments/calls/maturities of investment securities held to maturity

 

4,155

 

 

 

52,286

 

Sales of investment securities available for sale

 

164,299

 

 

 

51,989

 

Purchase of loans

 

(41,816

)

 

 

(63,305

)

Net decrease (increase) in loans receivable

 

165,642

 

 

 

(87,023

)

Proceeds from the sale of other real estate owned

 

-

 

 

 

496

 

Purchase of interest rate caps

 

(1,476

)

 

 

-

 

Additions to premises and equipment

 

(6,272

)

 

 

(5,349

)

Proceeds from cash settlement of premises and equipment

 

395

 

 

 

108

 

Purchase of FHLB stock

 

(2,250

)

 

 

(10,215

)

Redemption of FHLB stock

 

7,116

 

 

 

4,931

 

Net Cash Used in Investing Activities

$

(86,911

)

 

$

(164,638

)

 

See notes to unaudited consolidated financial statements.

- 7 -

KEARNY FINANCIAL CORP. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)

(In Thousands, Unaudited)

 

 

Nine Months Ended

 

 

March 31,

 

 

2020

 

 

2019

 

Cash Flows from Financing Activities:

 

 

 

 

 

 

 

Net increase in deposits

 

106,500

 

 

 

65,640

 

Repayment of term FHLB advances

 

(2,633,146

)

 

 

(2,309,586

)

Proceeds from term FHLB advances

 

2,525,000

 

 

 

2,427,000

 

Net increase in other short-term borrowings

 

167,935

 

 

 

8,430

 

Net decrease in advance payments by borrowers for taxes

 

(395

)

 

 

(880

)

Repurchase and cancellation of common stock of Kearny Financial Corp.

 

(69,782

)

 

 

(109,497

)

Cancellation of shares repurchased on vesting to pay taxes

 

(1,073

)

 

 

(944

)

Exercise of stock options

 

-

 

 

 

152

 

Dividends paid

 

(17,724

)

 

 

(29,404

)

Net Cash Provided by Financing Activities

 

77,315

 

 

 

50,911

 

Net Increase (Decrease) in Cash and Cash Equivalents

 

20,517

 

 

 

(74,704

)

Cash and Cash Equivalents - Beginning

 

38,935

 

 

 

128,864

 

Cash and Cash Equivalents - Ending

$

59,452

 

 

$

54,160

 

 

 

 

 

 

 

 

 

Supplemental Disclosures of Cash Flows Information:

 

 

 

 

 

 

 

Cash paid during the period for:

 

 

 

 

 

 

 

Income taxes, net of refunds

$

8,029

 

 

$

4,633

 

Interest

$

70,189

 

 

$

56,144

 

 

 

 

 

 

 

 

 

Non-cash investing and financing activities:

 

 

 

 

 

 

 

Acquisition of real estate owned in settlement of loans

$

206

 

 

$

-

 

 

 

 

 

 

 

 

 

In conjunction with the adoption of ASU 2019-04, as detailed in Note 6 to the unaudited

consolidated financial statements, the following qualifying held to maturity securities were

transferred to available for sale:

 

 

 

 

 

 

 

Debt securities transferred from held to maturity to available for sale

$

537,732

 

 

$

-

 

 

 

 

 

 

 

 

 

In conjunction with the adoption of ASU 2016-02, as detailed in Note 6 to the unaudited

consolidated financial statements, the following assets and liabilities were recognized:

 

 

 

 

 

 

 

Operating lease right-of-use assets

$

17,243

 

 

$

-

 

Operating lease liabilities

$

17,758

 

 

$

-

 

 

See notes to unaudited consolidated financial statements.

 

 

 

- 8 -

KEARNY FINANCIAL CORP. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

 

1.     SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation

The unaudited consolidated financial statements include the accounts of Kearny Financial Corp. (the “Company”), its wholly-owned subsidiary, Kearny Bank (the “Bank”) and the Bank’s wholly-owned subsidiaries, CJB Investment Corp. and KFS Insurance Services, Inc. The Company conducts its business principally through the Bank. Management prepared the unaudited consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”), including the elimination of all significant inter-company accounts and transactions during consolidation.

Basis of Presentation

The accompanying unaudited consolidated financial statements were prepared in accordance with instructions for Form 10-Q and Regulation S-X and do not include information or footnotes necessary for a complete presentation of financial condition, income, comprehensive (loss) income, changes in stockholders’ equity and cash flows in conformity with GAAP. However, in the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation of the unaudited consolidated financial statements have been included. The results of operations for the three-month and nine-month periods ended March 31, 2020 are not necessarily indicative of the results that may be expected for the entire fiscal year or any other period.

The data in the consolidated statement of financial condition for June 30, 2019 was derived from the Company’s 2019 Annual Report on Form 10-K. That data, along with the interim unaudited financial information presented in the consolidated statements of financial condition, income, comprehensive (loss) income, changes in stockholders’ equity and cash flows should be read in conjunction with the audited consolidated financial statements, including the notes thereto, included in the Company’s 2019 Annual Report on Form 10-K.

Risks and Uncertainties

On March 11, 2020, the World Health Organization declared the outbreak of COVID-19 a global pandemic. The COVID-19 pandemic has adversely affected, and may continue to adversely affect local, national and global economic activity. Actions taken to help mitigate the spread of COVID-19 include restrictions on travel, localized quarantines, and government-mandated closures of certain businesses. The spread of the outbreak has caused significant disruptions to the U.S. economy and has disrupted banking and other financial activity in the areas in which the Company operates.

On March 3, 2020, the Federal Open Market Committee reduced the targeted federal funds interest rate range by 50 basis points to 1.00 percent to 1.25 percent. This range was further reduced to 0 percent to 0.25 percent on March 16, 2020. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was enacted to, among other provisions, provide emergency assistance for individuals, families and businesses affected by the COVID-19 pandemic. These reductions in interest rates and other effects of the COVID-19 pandemic may materially and adversely affect the Company's financial condition and results of operations in future periods. It is unknown how long the adverse conditions associated with the COVID-19 pandemic will last and what the complete financial effect will be to the Company.  It is possible that estimates made in the financial statements could be materially and adversely impacted as a result of these conditions, including estimates regarding expected credit losses on loans receivable, other-than-temporary impairment of investment securities and impairment of goodwill.

Goodwill

Goodwill represents the excess cost over fair value of the net assets of institutions acquired in purchase transactions. Goodwill is evaluated annually or during interim periods when a triggering event occurs which indicates that the fair value of the reporting unit may be below its carrying amount.  At March 31, 2020, due to the impact of COVID-19, including the deterioration of economic conditions and the decline in the market price of many publicly traded securities, including the common stock of the Company, management determined that a triggering event had occurred. This triggering event necessitated the qualitative evaluation of goodwill impairment.  Upon completion of that evaluation the Company determined that, as of March 31, 2020 it was more likely than not that the fair value of the Company’s single reporting unit exceed its carrying amount and therefore goodwill was not impaired.

If an impairment loss is determined to exist in the future, such loss will be reflected as an expense in the consolidated statements of income in the period in which the impairment loss is determined.

 

- 9 -

2.     NET INCOME PER COMMON SHARE (“EPS”)

Basic EPS is based on the weighted average number of common shares actually outstanding, including both vested and unvested restricted stock awards, adjusted for Employee Stock Ownership Plan (“ESOP”) shares not yet committed to be released. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock, such as outstanding stock options, were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the Company. Diluted EPS is calculated by adjusting the weighted average number of shares of common stock outstanding to include the effect of contracts or securities exercisable or which could be converted into common stock, if dilutive, using the treasury stock method. Shares issued and reacquired during any period are weighted for the portion of the period they were outstanding.

The following is a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations:

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

March 31, 2020

 

 

March 31, 2020

 

 

 

Income

(Numerator)

 

 

Shares

(Denominator)

 

 

Per

Share

Amount

 

 

Income

(Numerator)

 

 

Shares

(Denominator)

 

 

Per

Share

Amount

 

 

 

(In Thousands, Except Per Share Data)

 

 

(In Thousands, Except Per Share Data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

9,254

 

 

 

 

 

 

 

 

 

 

$

31,276

 

 

 

 

 

 

 

 

 

Basic earnings per share, income

  available to common stockholders

 

$

9,254

 

 

 

81,339

 

 

$

0.11

 

 

$

31,276

 

 

 

82,981

 

 

$

0.38

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock options

 

 

 

 

 

 

19

 

 

 

 

 

 

 

 

 

 

 

35

 

 

 

 

 

 

 

$

9,254

 

 

 

81,358

 

 

$

0.11

 

 

$

31,276

 

 

 

83,016

 

 

$

0.38

 

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

March 31, 2019

 

 

March 31, 2019

 

 

 

Income

(Numerator)

 

 

Shares

(Denominator)

 

 

Per

Share

Amount

 

 

Income

(Numerator)

 

 

Shares

(Denominator)

 

 

Per

Share

Amount

 

 

 

(In Thousands, Except Per Share Data)

 

 

(In Thousands, Except Per Share Data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

11,417

 

 

 

 

 

 

 

 

 

 

$

33,331

 

 

 

 

 

 

 

 

 

Basic earnings per share, income

  available to common stockholders

 

$

11,417

 

 

 

89,488

 

 

$

0.13

 

 

$

33,331

 

 

 

92,370

 

 

$

0.36

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock options

 

 

 

 

 

 

44

 

 

 

 

 

 

 

 

 

 

 

49

 

 

 

 

 

 

 

$

11,417

 

 

 

89,532

 

 

$

0.13

 

 

$

33,331

 

 

 

92,419

 

 

$

0.36

 

 

Stock options for 3,115,000 and 3,299,000 shares of common stock were not considered in computing diluted earnings per share at March 31, 2020 and March 31, 2019, respectively, because they were considered anti-dilutive.

 

 

3.     SUBSEQUENT EVENTS

The Company has evaluated events and transactions occurring subsequent to the statement of financial condition date of March 31, 2020, for items that should potentially be recognized or disclosed in these consolidated financial statements.  The evaluation was conducted through the date this document was filed.

 

 

4.    PROPOSED ACQUISITION OF MSB FINANCIAL CORP.

On December 18, 2019, the Company and MSB Financial Corp. (“MSBF”), the holding company for Millington Bank announced that the companies had entered into a definitive agreement pursuant to which the Company will acquire MSBF.  Consideration will be paid to MSBF stockholders in a combination of stock and cash.  Under the terms of merger agreement MSBF will merge with and into the Company and each outstanding share of MSBF common stock will be exchanged for 1.3 shares of the Company’s common stock or $18.00 in cash.  

- 10 -

MSBF stockholders may elect cash or stock, or a combination thereof, subject to proration to ensure that, in the aggregate, 10% of MSBF shares will be converted into cash and 90% of MSBF shares will be converted into the Company’s common stock.  Upon closing, the Company’s stockholders holders will own approximately 94% of the combined company and MSBF stockholders will own approximately 6% of the combined company.

As of March 31, 2020, MSBF had approximately $600.4 million of assets, gross loans of $528.9 million and deposits of $447.4 million and operated four New Jersey branches located in Somerset and Morris counties.  The required approvals to complete this transaction include MSBF shareholder approval, regulatory approval, and the continued effectiveness of the registration statement filed by the Company with respect to the common stock to be issued in the transaction.  The merger is expected to close late in the quarter ended June 30, 2020 or early in the quarter ended September 30, 2020.  A special meeting of MSBF stockholders has been scheduled for May 28, 2020.

 

 

5.    MERGER RELATED EXPENSES

Merger-related expenses are recorded in the Consolidated Statements of Income as a component of non-interest expense and include costs relating to the Company’s proposed acquisition of MSBF, as described above.  These charges represent one-time costs associated with acquisition activities and do not represent ongoing costs of the fully integrated combined organization.  Accounting guidance requires that acquisition-related transactional and restructuring costs incurred by the Company be charged to expense as incurred.

 

 

6.     RECENT ACCOUNTING PRONOUNCEMENTS

In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.  The ASU requires credit losses on most financial assets measured at amortized cost and certain other instruments to be measured using an expected credit loss model, referred to as the current expected credit loss (“CECL”) model. Under this model, entities will estimate credit losses over the entire contractual term of the instrument (considering estimated prepayments, but not expected extensions or modifications unless reasonable expectation of a troubled debt restructuring exists) from the date of initial recognition of that instrument. An allowance will be established for loans that have been acquired in a business combination that currently do not have an allowance.  As of March 31, 2020, approximately $972.4 million of acquired loans do not have an allowance.

The ASU also replaces the current accounting model for purchased credit impaired loans and debt securities. The allowance for credit losses for purchased financial assets with a more-than insignificant amount of credit deterioration since origination (“PCD assets”), should be determined in a similar manner to other financial assets measured on an amortized cost basis. However, upon initial recognition, the allowance for credit losses is added to the purchase price (“gross up approach”) to determine the initial amortized cost basis. The subsequent accounting for PCD financial assets is the same expected loss model described above.

Further, the ASU made certain targeted amendments to the existing impairment model for available-for-sale (“AFS”) debt securities. For an AFS debt security for which there is neither the intent nor a more-likely-than-not requirement to sell, an entity will record credit losses as an allowance rather than a write-down of the amortized cost basis.  For public business entities that are SEC filers and not smaller reporting companies, the amendments are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years.  The Company will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of July 1, 2020 (i.e. modified retrospective approach).  The Company has selected a third party firm to assist in the development of a CECL program, and has selected a software model to assist in the calculation of the allowance for loan losses in preparation for the change to the expected loss model. The Company is continuing its evaluation of this ASU including the potential impact on its consolidated financial statements.  The extent of change is indeterminable at this time as it will be dependent upon portfolio composition and credit quality at the adoption date, as well as economic conditions and forecasts at that time.  Upon adoption, any impact to the allowance for credit losses, currently allowance for loan and lease losses, will have an offsetting impact on retained earnings, and be net of tax.  The CARES Act offers insured depository institutions, as defined in Section 3 of the Federal Deposit Insurance Act, optional temporary relief from applying CECL.  These depository institutions are not required to comply with CECL during the period beginning on the date of enactment of the CARES Act and ending on the earlier of the termination of the national emergency declared under the National Emergencies Act, related to the outbreak of COVID-19, and December 31, 2020. The Company is currently evaluating the impact of electing this temporary relief.

- 11 -

In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. This ASU simplifies subsequent measurement of goodwill by eliminating Step 2 of the impairment test while retaining the option to perform the qualitative assessment for a reporting unit to determine whether the quantitative impairment test is necessary. The ASU also eliminates the requirements for any reporting unit with a zero or negative carrying amount to perform a qualitative assessment and, if it fails that qualitative test, to perform Step 2 of the goodwill impairment test. Therefore, the same impairment assessment applies to all reporting units. For public entities, ASU 2017-04 is effective for fiscal years beginning after December 15, 2019 with early adoption permitted for interim or annual goodwill impairment testing dates beginning after January 1, 2017. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements.

In May 2019, the FASB issued ASU 2019-05, “Financial Instruments - Credit Losses (Topic 326); Targeted Transition Relief”.  ASU 2019-05 provides transition relief by providing entities with an alternative to irrevocably elect the fair value option for eligible financial assets measured at amortized cost upon adoption of the credit losses standard. To be eligible for the transition election, the existing financial asset must otherwise be both within the scope of the new credit losses standard and eligible for the applying the fair value option in ASC 825-10.3.  The election must be applied on an instrument-by-instrument basis and is not available for either available for sale or held to maturity debt securities. For entities that have adopted ASU 2016-13, ASU 2019-05 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted once ASU 2016-13 has been adopted. For entities that elect the fair value option, the difference between the carrying amount and the fair value of the financial asset would be recognized through a cumulative-effect adjustment to opening retained earnings net of tax, as of the date an entity adopted ASU 2016-13. Changes in fair value of that financial asset would subsequently be reported in current earnings.  The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements.

In November 2019, the FASB issued ASU 2019-11, “Codification Improvements to Topic 326, Financial Instruments-Credit Losses”.  ASU 2019-11 clarifies the accounting treatment on the following issues: (i) negative allowances; (ii) troubled debt restructuring (TDR) transition; (iii) accrued interest disclosures; and (iv) collateral maintenance practical expedient.  ASU 2019-11 will permit an entity to record negative allowances on write-offs or expected write-offs of the amortized cost basis of purchased financial assets with credit deterioration (PCD) within ASC 326-20’s scope.  Regarding TDRs, the FASB tentatively approved a clarification to allow entities to calculate a prepayment-adjusted effective interest rate for TDRs existing as of the adoption date of ASC 326 based on the prepayment assumptions as of the adoption date rather than the restructuring date.  In the previously issued ASU 2019-04, FASB allowed an entity to elect a practical expedient to disclose separately the total amount of accrued interest included in the amortized cost basis as a single balance to meet certain disclosure requirements. ASU 2019-11 extends this relief to all relevant disclosures involving amortized cost basis.  A collateral maintenance practical expedient regarding collateral-dependent financial assets, will permit an allowance to be estimated as the difference between the value of the collateral net of costs to sell and the amortized cost basis of the loans.  For entities that have not yet adopted ASU 2016-13, the effective dates and transition requirements for these amendments are the same as ASU 2016-13.  The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements.

In December 2019, the FASB issued ASU 2019-12, “Income taxes (Topic 740); Simplifying the Accounting for Income Taxes”. ASU 2019-12 provides amendments intended to reduce the cost and complexity in accounting for income taxes while maintaining or improving the usefulness of the information provided to users of financial statements.  ASU 2019-12 removes the following exceptions from ASC 740, Income Taxes: (i) exceptions to the incremental approach for intraperiod tax allocation; (ii) exceptions to accounting for basis differences when a foreign subsidiary becomes an equity method investment or a foreign equity method investment become a subsidiary; and (iii) exception in interim period income tax accounting for year-to-date losses that exceed anticipated losses. ASU 2019-12 provides the following amendments that simplify and improve guidance with Topic 740: (i) franchise taxes that are based partially on income; (ii) transactions that result in a step up in the tax basis of goodwill; (iii) separate financial statements of legal entities that are not subject to tax; (iv) enacted changes in tax laws in interim periods; and (v) employee stock ownership plans and investments in qualified affordable housing projects accounted for using the equity method. For public business entities, the amendments in the ASU 2019-12 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements.  

- 12 -

Adoption of New Accounting Standards

Effective July 1, 2019, the Company implemented ASU No. 2016-02, “Leases (Topic 842)” (modified by ASU 2018-01 – Leases (Topic 842): Land Easement Practical Expedient for Transition to Topic 842) and ASU 2018-20 – Leases (Topic 842) Narrow – Scope Improvements for Lessors).  ASU 2016-02 requires the recognition of a right of use asset and related lease liability by lessees for leases classified as operating leases under current GAAP.  Topic 842, which replaces the current guidance under Topic 840, retains a distinction between finance leases and operating leases. The recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee also will not significantly change from current GAAP.  For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize right of use assets and lease liabilities.  The Company has made this accounting policy election. Effective with the adoption on July 1, 2019, the Company recognized a “right-of-use-asset” and a “lease liability” for its operating leases and has elected to apply practical expedients pertaining to the ASU. The Company applied the following three practical expediencies, which must be elected as a package and applied consistently to all of our leases: (i) the Company did not have to reassess whether any expired leases or existing contracts are, or contain, a lease; (ii) the Company did not have to reassess the lease classifications for any expired or existing leases.  Accordingly, Topic 840 operating leases became Topic 842 operating leases; and (iii) the Company did not have to reassess initial; direct costs for any existing leases. The Company applied a modified retrospective transition approach for the applicable leases.  ASU 2016-02 provides for a modified retrospective transition approach requiring lessees to recognize and measure leases on the balance sheet at the beginning of either the earliest period presented or as of the beginning of the period of adoption. The Company elected to account for lease and non-lease components separately because such amounts are readily determinable under our lease contracts rather than elect the practical expedient to account for the components as a single lease component.  The Company elected to apply ASU 2016-02 as of the beginning of the period of adoption (July 1, 2019) and will not restate comparative periods. Upon adoption of ASU 2016-02, the Company recorded a right-of-use asset of approximately $17.2 million and a lease liability of approximately $17.8 million.

In October 2018, the FASB issued ASU 2018-16, Derivatives and Hedging (Topic 815), Inclusion of the Secured Overnight Financing Rate (“SOFR”) Overnight Index Swap (“OIS”) Rate as a Benchmark Interest Rate for Hedge Accounting Purposes. This ASU permits the use of the OIS Rate based on SOFR as a benchmark interest rate for purposes of applying hedge accounting under Topic 815. This is the fifth U.S. benchmark interest rate eligible for use in hedge accounting in addition to interest rates on direct Treasury obligations of the U.S. Government, the London Interbank Offered Rate swap rate, and the OIS Rate based on the Fed Funds Effective Rate and the Securities Industry and Financial Markets Association Municipal Swap Rate.  The amendments in this ASU are required to be adopted concurrently with the amendments in ASU 2017-12, Derivatives and Hedging: Targeted Improvements to Accounting for Hedging Activities, for entities that have not adopted that guidance.  For public entities that have previously adopted ASU 2017-12, the amendments are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted in any interim period if an entity already has adopted ASU 2017-12.  The Company early adopted ASU 2017-12 on July 1, 2017.  The amendments in ASU 2018-16 should be applied on a prospective basis for qualifying new or re-designated hedging relationships entered into on or after the date of adoption.  The Company adopted ASU 2018-16 on July 1, 2019, and its adoption did not have a significant impact on the Company’s audited consolidated financial statements.

In April 2019, the FASB issued ASU 2019-04 Codification Improvements to Topic 326, Financial Instruments Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments. ASU 2019-04 amends certain aspects of accounting for credit losses, hedging activities, and financial instruments addressed by ASUs 2016-13, 2016-01, and 2017-12, respectively. Significant amendments to ASU 2016-13 relate to the measurement of accrued interest, transfers between classifications or categories for loans and debt securities and including recoveries when estimating the allowance for credit losses. For Topic 825, the codification improvements to ASU 2016-01 provide scope clarification for Subtopics 320-10, Investments-Debt and Equity Securities-Overall, and 321-10, Investments-Equity Securities-Overall, held to maturity debt securities fair value disclosures, and re-measurement of equity securities at historical exchange rates.  Significant amendments to ASU 2017-12 amends the guidance related to partial-term fair value hedges of interest rate risk, disclosure of fair value hedge basis adjustments, and scope for not-for-profit entities. ASU 2019-04 clarifies that an entity that reclassifies debt securities from the held to maturity category to available for sale as part of its transition would not (1) call in to question its held to maturity assertion for other securities held at the entity’s most recent reporting date, (2) be required to actually designate any reclassified security in a last-of-layer hedge, or (3) be restricted from selling any reclassified security.  The Company adopted ASU 2019-04 on July 1, 2019. As part of the adoption, the Company reclassified $537.7 million of investment securities held to maturity to investment securities available for sale. The Company did not reclassify investment securities from held to maturity to available for sale upon the original adoption of the amendments in ASU 2017-12. Entities electing to reclassify investment securities upon adoption of the amendments in this update are required to reflect the reclassification as of the beginning of the first annual period beginning after the issuance of ASU 2019-04 (July 1, 2019).

 

 

- 13 -

7.     SECURITIES AVAILABLE FOR SALE

The amortized cost, gross unrealized gains and losses and fair values of debt and mortgage-backed securities available for sale at March 31, 2020 and June 30, 2019 and stratification by contractual maturity of debt securities available for sale at March 31, 2020 are presented below as of the dates indicated.  As of July 1, 2019, the Company adopted ASU 2019-04 and reclassified $537.7 million of securities held to maturity to securities available for sale.  See Note 6, Recent Accounting Pronouncements, for further details regarding the adoption of ASU 2019-04.

 

 

March 31, 2020

 

 

Amortized

Cost

 

 

Gross

Unrealized

Gains

 

 

Gross

Unrealized

Losses

 

 

Fair

Value

 

 

(In Thousands)

 

Investment securities available for sale:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Obligations of state and political subdivisions

$

57,360

 

 

$

791

 

 

$

-

 

 

$

58,151

 

Asset-backed securities

 

178,379

 

 

 

-

 

 

 

9,277

 

 

 

169,102

 

Collateralized loan obligations

 

199,342

 

 

 

-

 

 

 

9,777

 

 

 

189,565

 

Corporate bonds

 

162,962

 

 

 

1,208

 

 

 

455

 

 

 

163,715

 

Trust preferred securities

 

2,967

 

 

 

-

 

 

 

115

 

 

 

2,852

 

Total debt securities

 

601,010

 

 

 

1,999

 

 

 

19,624

 

 

 

583,385

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mortgage-backed securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Collateralized mortgage obligations (1)

 

33,718

 

 

 

953

 

 

 

-

 

 

 

34,671

 

Residential pass-through securities (1)

 

588,241

 

 

 

18,872

 

 

 

-

 

 

 

607,113

 

Commercial pass-through securities (1)

 

242,345

 

 

 

8,885

 

 

 

55

 

 

 

251,175

 

Total mortgage-backed securities

 

864,304

 

 

 

28,710

 

 

 

55

 

 

 

892,959

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total securities available for sale

$

1,465,314

 

 

$

30,709

 

 

$

19,679

 

 

$

1,476,344

 

 

(1)

Government-sponsored enterprises.

 

 

March 31, 2020

 

 

Amortized

Cost

 

 

Fair

Value

 

 

(In Thousands)

 

Debt securities available for sale:

 

 

 

 

 

 

 

Due in one year or less

$

25,258

 

 

$

25,232

 

Due after one year through five years

 

83,405

 

 

 

83,237

 

Due after five years through ten years

 

193,869

 

 

 

191,781

 

Due after ten years

 

298,478

 

 

 

283,135

 

Total

$

601,010

 

 

$

583,385

 

 

 

 

 

 

 

 

 

- 14 -

 

 

June 30, 2019

 

 

Amortized

Cost

 

 

Gross

Unrealized

Gains

 

 

Gross

Unrealized

Losses

 

 

Fair

Value

 

 

(In Thousands)

 

Securities available for sale:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. agency securities

$

3,642

 

 

$

40

 

 

$

4

 

 

$

3,678

 

Obligations of state and political subdivisions

 

26,628

 

 

 

323

 

 

 

-

 

 

 

26,951

 

Asset-backed securities

 

178,168

 

 

 

1,465

 

 

 

320

 

 

 

179,313

 

Collateralized loan obligations

 

209,453

 

 

 

254

 

 

 

1,096

 

 

 

208,611

 

Corporate bonds

 

122,929

 

 

 

121

 

 

 

1,026

 

 

 

122,024

 

Trust preferred securities

 

3,967

 

 

 

-

 

 

 

211

 

 

 

3,756

 

Total debt securities

 

544,787

 

 

 

2,203

 

 

 

2,657

 

 

 

544,333

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mortgage-backed securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Collateralized mortgage obligations (1)

 

21,469

 

 

 

70

 

 

 

149

 

 

 

21,390

 

Residential pass-through securities (1)

 

44,611

 

 

 

156

 

 

 

464

 

 

 

44,303

 

Commercial pass-through securities (1)

 

101,421

 

 

 

2,816

 

 

 

-

 

 

 

104,237

 

Total mortgage-backed securities

 

167,501

 

 

 

3,042

 

 

 

613

 

 

 

169,930

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total securities available for sale

$

712,288

 

 

$

5,245

 

 

$

3,270

 

 

$

714,263

 

 

(1)

Government-sponsored enterprises.

Sales of securities available for sale were as follows for the periods presented below:

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

March 31,

 

 

March 31,

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

(In Thousands)

 

 

(In Thousands)

 

Available for sale securities sold:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from sales of securities

$

160,653

 

 

$

51,989

 

 

$

164,299

 

 

$

51,989

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross realized gains

$

2,350

 

 

$

190

 

 

$

2,363

 

 

$

190

 

Gross realized losses

 

(116

)

 

 

(372

)

 

 

(145

)

 

 

(372

)

Net gain (loss) on sales of securities

$

2,234

 

 

$

(182

)

 

$

2,218

 

 

$

(182

)

 

Calls of securities available for sale resulted in gross gains of $13,000 during the nine months ended March 31, 2020.  During the three months ended March 31, 2020 and for the three and nine months ended March 31, 2019 there were no gains or losses recognized on the calls of securities available for sale.

 

Securities available for sale pledged for borrowings at the FHLB and other institutions, and securities pledged for public funds and other purposes, were as follows as of the dates presented below:

 

 

 

 

 

 

March 31,

 

 

June 30,

 

 

 

 

 

 

2020

 

 

2019

 

 

 

 

 

 

(In Thousands)

 

Available for sale securities pledged:

 

 

 

 

 

 

 

 

 

 

 

Pledged for borrowings at the FHLB of New York

 

 

 

 

$

159,200

 

 

$

24,099

 

Pledged to secure public funds on deposit

 

 

 

 

 

9,852

 

 

 

-

 

Pledged for potential borrowings at the Federal

Reserve Bank of New York

 

 

 

 

 

387,296

 

 

 

43,623

 

Pledged as collateral for depositor sweep accounts

 

 

 

 

 

7,849

 

 

 

1,322

 

Total available for sale securities pledged

 

 

 

 

$

564,197

 

 

$

69,044

 

 

- 15 -

 

8.     SECURITIES HELD TO MATURITY

The amortized cost, gross unrecognized gains and losses and fair values of debt and mortgage-backed securities held to maturity at March 31, 2020 and June 30, 2019 and stratification by contractual maturity of debt securities held to maturity at March 31, 2020 are presented below:

 

 

March 31, 2020

 

 

Amortized

Cost

 

 

Gross

Unrecognized

Gains

 

 

Gross

Unrecognized

Losses

 

 

Fair

Value

 

 

(In Thousands)

 

Investment securities held to maturity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Obligations of state and political subdivisions

$

34,618

 

 

$

817

 

 

$

2

 

 

$

35,433

 

Total debt securities

 

34,618

 

 

 

817

 

 

 

2

 

 

 

35,433

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total securities held to maturity

$

34,618

 

 

$

817

 

 

$

2

 

 

$

35,433

 

 

 

 

 

March 31, 2020

 

 

Amortized

Cost

 

 

Fair

Value

 

 

(In Thousands)

 

Debt securities held to maturity:

 

 

 

 

 

 

 

Due in one year or less

$

7,331

 

 

$

7,342

 

Due after one year through five years

 

18,469

 

 

 

18,811

 

Due after five years through ten years

 

8,818

 

 

 

9,280

 

Total

$

34,618

 

 

$

35,433

 

 

- 16 -

 

 

June 30, 2019

 

 

Amortized

Cost

 

 

Gross

Unrecognized

Gains

 

 

Gross

Unrecognized

Losses

 

 

Fair

Value

 

 

(In Thousands)

 

Securities held to maturity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Obligations of state and political subdivisions

$

104,086

 

 

$

1,787

 

 

$

16

 

 

$

105,857

 

Corporate bonds

 

63,086

 

 

 

914

 

 

 

-

 

 

 

64,000

 

Total debt securities

 

167,172

 

 

 

2,701

 

 

 

16

 

 

 

169,857

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mortgage-backed securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Collateralized mortgage obligations (1)

 

46,370

 

 

 

568

 

 

 

168

 

 

 

46,770

 

Residential pass-through securities (1)

 

166,283

 

 

 

1,961

 

 

 

518

 

 

 

167,726

 

Commercial pass-through securities (1)

 

196,816

 

 

 

3,504

 

 

 

6

 

 

 

200,314

 

Non-agency securities

 

11

 

 

 

-

 

 

 

-

 

 

 

11

 

Total mortgage-backed securities

 

409,480

 

 

 

6,033

 

 

 

692

 

 

 

414,821

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total securities held to maturity

$

576,652

 

 

$

8,734

 

 

$

708

 

 

$

584,678

 

 

(1)

Government-sponsored enterprises.

 

There were no sales or calls of securities held to maturity during the three and nine months ended March 31, 2020 and March 31, 2019.

Securities held to maturity pledged for borrowings at the FHLB and other institutions, and securities pledged for public funds and other purposes, were as follows as of the dates presented below:

 

 

 

 

 

 

March 31,

 

 

June 30,

 

 

 

 

 

 

2020

 

 

2019

 

 

 

 

 

 

(In Thousands)

 

Held to maturity securities pledged:

 

 

 

 

 

 

 

 

 

 

 

Pledged for borrowings at the FHLB of New York

 

 

 

 

$

-

 

 

$

136,696

 

Pledged to secure public funds on deposit

 

 

 

 

 

-

 

 

 

7,023

 

Pledged for potential borrowings at the Federal

Reserve Bank of New York

 

 

 

 

 

34,338

 

 

 

103,419

 

Pledged as collateral for depositor sweep accounts

 

 

 

 

 

-

 

 

 

12,884

 

Total held to maturity securities pledged

 

 

 

 

$

34,338

 

 

$

260,022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

- 17 -

9.     IMPAIRMENT OF SECURITIES

The following two tables summarize the fair values, gross unrealized and unrecognized losses and the number of securities impaired within the available for sale and held to maturity portfolios at March 31, 2020 and June 30, 2019. The gross unrealized losses, presented by security type, represent temporary impairments of value within each portfolio as of the dates presented. Temporary impairments within the available for sale portfolio have been recognized through other comprehensive loss as reductions in stockholders’ equity on a tax-effected basis.

The tables are followed by a discussion that summarizes the Company’s rationale for recognizing impairments, where applicable, as temporary versus those identified as other-than-temporary. Such rationale is presented by investment type and generally applies consistently to both the available for sale and held to maturity portfolios, except where specifically noted.

 

 

March 31, 2020

 

 

Less than 12 Months

 

 

12 Months or More

 

 

Total

 

 

Fair

Value

 

 

Unrealized

Losses

 

 

Fair

Value

 

 

Unrealized

Losses

 

 

Number of Securities

 

 

Fair

Value

 

 

Unrealized

Losses

 

 

(Dollars in Thousands)

 

Securities Available for Sale:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asset-backed securities

$

150,005

 

 

$

8,376

 

 

$

19,097

 

 

$

901

 

 

$

16

 

 

$

169,102

 

 

$

9,277

 

Collateralized loan obligations

 

69,236

 

 

 

3,409

 

 

 

120,329

 

 

 

6,368

 

 

 

19

 

 

 

189,565

 

 

 

9,777

 

Corporate bonds

 

34,922

 

 

 

86

 

 

 

44,615

 

 

 

369

 

 

 

8

 

 

 

79,537

 

 

 

455

 

Trust preferred securities

 

-

 

 

 

-

 

 

 

2,852

 

 

 

115

 

 

 

2

 

 

 

2,852

 

 

 

115

 

Commercial pass-through

securities

 

11,976

 

 

 

55

 

 

 

-

 

 

 

-

 

 

 

1

 

 

 

11,976

 

 

 

55

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

$

266,139

 

 

$

11,926

 

 

$

186,893

 

 

$

7,753

 

 

 

46

 

 

$

453,032

 

 

$

19,679

 

 

 

 

June 30, 2019

 

 

Less than 12 Months

 

 

12 Months or More

 

 

Total

 

 

Fair

Value

 

 

Unrealized

Losses

 

 

Fair

Value

 

 

Unrealized

Losses

 

 

Number of Securities

 

 

Fair

Value

 

 

Unrealized

Losses

 

 

(Dollars in Thousands)

 

Securities Available for Sale:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. agency securities

$

-

 

 

$

-

 

 

$

1,122

 

 

$

4

 

 

 

5

 

 

$

1,122

 

 

$

4

 

Asset-backed securities

 

40,211

 

 

 

262

 

 

 

4,934

 

 

 

58

 

 

 

4

 

 

 

45,145

 

 

 

320

 

Collateralized loan obligations

 

44,061

 

 

 

75

 

 

 

115,914

 

 

 

1,021

 

 

 

15

 

 

 

159,975

 

 

 

1,096

 

Corporate bonds

 

47,486

 

 

 

509

 

 

 

44,462

 

 

 

517

 

 

 

11

 

 

 

91,948

 

 

 

1,026

 

Trust preferred securities

 

-

 

 

 

-

 

 

 

2,756

 

 

 

211

 

 

 

2

 

 

 

2,756

 

 

 

211

 

Collateralized mortgage

obligations

 

-

 

 

 

-

 

 

 

16,369

 

 

 

149

 

 

 

4

 

 

 

16,369

 

 

 

149

 

Residential pass-through

securities

 

-

 

 

 

-

 

 

 

33,519

 

 

 

464

 

 

 

6

 

 

 

33,519

 

 

 

464

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

$

131,758

 

 

$

846

 

 

$

219,076

 

 

$

2,424

 

 

 

47

 

 

$

350,834

 

 

$

3,270

 

 

- 18 -

 

 

March 31, 2020

 

 

Less than 12 Months

 

 

12 Months or More

 

 

Total

 

 

Fair

Value

 

 

Unrecognized Losses

 

 

Fair

Value

 

 

Unrecognized Losses

 

 

Number of Securities

 

 

Fair

Value

 

 

Unrecognized

Losses

 

 

(Dollars in Thousands)

 

Securities Held to Maturity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Obligations of state and political

  subdivisions

$

1,279

 

 

$

2

 

 

$

-

 

 

$

-

 

 

 

3

 

 

$

1,279

 

 

$

2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

$

1,279

 

 

$

2

 

 

$

-

 

 

$

-

 

 

 

3

 

 

$

1,279

 

 

$

2

 

 

 

 

June 30, 2019

 

 

Less than 12 Months

 

 

12 Months or More

 

 

Total

 

 

Fair

Value

 

 

Unrecognized Losses

 

 

Fair

Value

 

 

Unrecognized Losses

 

 

Number of Securities

 

 

Fair

Value

 

 

Unrecognized

Losses

 

 

(Dollars in Thousands)

 

Securities Held to Maturity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Obligations of state and political

  subdivisions

$

274

 

 

$

1

 

 

$

7,149

 

 

$

15

 

 

 

19

 

 

$

7,423

 

 

$

16

 

Collateralized mortgage

obligations

 

-

 

 

 

-

 

 

 

9,347

 

 

 

168

 

 

 

5

 

 

 

9,347

 

 

 

168

 

Residential pass-through

securities

 

438

 

 

 

1

 

 

 

76,848

 

 

 

517

 

 

 

70

 

 

 

77,286

 

 

 

518

 

Commercial pass-through

securities

 

-

 

 

 

-

 

 

 

1,852

 

 

 

6

 

 

 

2

 

 

 

1,852

 

 

 

6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

$

712

 

 

$

2

 

 

$

95,196

 

 

$

706

 

 

 

96

 

 

$

95,908

 

 

$

708

 

 

In general, if the fair value of a debt security is less than its amortized cost basis at the time of evaluation, the security is impaired and the impairment is to be evaluated to determine if it is other than temporary.  The Company evaluates the impaired securities in its portfolio for possible other-than-temporary impairment (“OTTI”) on at least a quarterly basis.  The following represents the circumstances under which an impaired security is determined to be other-than-temporarily impaired: (i) when the Company intends to sell the impaired debt security; (ii) when the Company more likely than not will be required to sell the impaired debt security before recovery of its amortized cost; or (iii) when an impaired debt security does not meet either of the two conditions above, but the Company does not expect to recover the entire amortized cost of the security.

In the first two circumstances noted above, the amount of OTTI to be recognized in earnings is the entire difference between the security’s amortized cost basis and its fair value at the balance sheet date.  In the third circumstance, however, the OTTI is to be separated into the amount representing the credit loss from the amount related to all other factors.  The credit loss component is to be recognized in earnings while the non-credit loss component is to be recognized in other comprehensive income.  In these cases, OTTI is generally predicated on an adverse change in cash flows versus those expected at the time of purchase.  The absence of an adverse change in expected cash flows generally indicates that a security’s impairment is related to other non-credit loss factors and is thereby generally not recognized as OTTI.

The Company considers a variety of factors when determining whether a credit loss exists for an impaired security including, but not limited to (i) the length of time and the extent to which the fair value has been less than the amortized cost basis; (ii) adverse conditions specifically related to the security, an industry, or a geographic area; (iii) the historical and implied volatility of the fair value of the security; (iv) the payment structure of the debt security; (v) actual or expected failure of the issuer of the security to make scheduled interest or principal payments; (vi) changes to the rating of the security by external rating agencies; and (vii) recoveries or additional declines in fair value subsequent to the balance sheet date.  The Company regularly monitors the historical cash flows and financial strength of all issuers and/or guarantors to confirm that security impairment, where applicable, is not due to an actual or expected adverse change in security cash flows that would result in the recognition of credit-related OTTI.

- 19 -

The unrealized losses on the Company’s securities are due to the combined effects of several market-related factors including changes in market interest rates and changes in market credit spreads.  Those market conditions may fluctuate over time resulting in certain securities being impaired for periods in excess of 12 months.  However, the longevity of such impairment is not necessarily reflective of an expectation for an adverse change in cash flows signifying a credit loss. Unrealized losses within the asset-backed securities and collateralized loan obligation categories are reflective of such changes in market credit spreads however are not necessarily indicative of OTTI. No issuers within these investment categories have defaulted on their interest payments, the Company has the stated ability and intent to hold until forecasted recovery those securities so designated and does not intend to sell the temporarily impaired available for sale securities prior to the recovery of their fair value to a level equal to or greater than the Company’s amortized cost.  Furthermore, the Company has concluded that the possibility of being required to sell the securities prior to their anticipated recovery is unlikely.  

In light of the factors noted above, the Company does not consider its balance of securities with unrealized losses at March 31, 2020 and June 30, 2019, to be other-than-temporarily impaired as of those dates.

 

 

10.     LOANS RECEIVABLE

 

The following table sets forth the composition of the Company’s loan portfolio at March 31, 2020 and June 30, 2019:

 

 

March 31,

 

 

June 30,

 

 

2020

 

 

2019

 

 

(In Thousands)

 

One- to four-family residential mortgage

$

1,338,099

 

 

$

1,344,044

 

 

 

 

 

 

 

 

 

Commercial mortgage:

 

 

 

 

 

 

 

Multi-family

 

1,879,907

 

 

 

1,946,391

 

Nonresidential

 

1,202,652

 

 

 

1,258,869

 

Total commercial mortgage

 

3,082,559

 

 

 

3,205,260

 

 

 

 

 

 

 

 

 

Construction

 

17,880

 

 

 

13,907

 

 

 

 

 

 

 

 

 

Commercial business

 

73,922

 

 

 

65,763

 

 

 

 

 

 

 

 

 

Consumer:

 

 

 

 

 

 

 

Home equity loans and lines of credit

 

87,909

 

 

 

96,165

 

Other consumer loans

 

4,604

 

 

 

5,814

 

Total consumer

 

92,513

 

 

 

101,979

 

 

 

 

 

 

 

 

 

Total loans

 

4,604,973

 

 

 

4,730,953

 

 

 

 

 

 

 

 

 

Unaccreted yield adjustments including net premiums and discounts

on purchased and acquired loans and net deferred  fees and costs on

loans originated

 

(42,461

)

 

 

(52,025

)

 

 

 

 

 

 

 

 

Total loans receivable, net of yield adjustments

$

4,562,512

 

 

$

4,678,928

 

 

 

- 20 -

11.     LOAN QUALITY AND ALLOWANCE FOR LOAN LOSSES

Residential Mortgage Loans in Foreclosure. We may obtain physical possession of one- to four-family real estate collateralizing a residential mortgage loan via foreclosure or through an in-substance repossession.  As of March 31, 2020, we held one single-family property in other real estate owned, with a carrying value of $178,000 that was acquired through foreclosure on a residential mortgage loan.  As of that same date, we held nine residential mortgage loans with aggregate carrying values totaling $1.9 million which were in the process of foreclosure.  Residential mortgage loans in the process of foreclosure at March 31, 2020, were secured by residential properties in the State of New Jersey and New York.

As of June 30, 2019, we held no single-family properties that were acquired through foreclosures on residential mortgage loans.  As of that same date, we held 11 residential mortgage loans with aggregate carrying values totaling $2.1 million which were in the process of foreclosure.

The states of  New Jersey and New York have issued executive orders which declared moratoriums on removing individuals from a residential property as a result of an eviction or foreclosure proceeding. The orders issued will be in effect for at least 60 to 90 days, as applicable.  In response to these orders, on March 28, 2020, the Company temporarily suspended residential property foreclosure sales and evictions.

 

Loan Quality. The following tables present the balance of the allowance for loan losses at March 31, 2020 and June 30, 2019 based upon the calculation methodology as described in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2019. The tables identify the valuation allowances attributable to specifically identified impairments on individually evaluated loans, including those acquired with deteriorated credit quality, as well as valuation allowances for impairments on loans evaluated collectively. The tables include the underlying balance of loans receivable applicable to each category as of those dates as well as the activity in the allowance for loan losses for the three and nine months ended March 31, 2020 and March 31, 2019. Unless otherwise noted, the balance of loans reported in the tables below excludes yield adjustments and the allowance for loan loss.

 

Allowance for Loan Losses

 

At March 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential

Mortgage

 

 

Multi-Family Mortgage

 

 

Non-

Residential

Mortgage

 

 

Construction

 

 

Commercial

Business

 

 

Home

Equity

Loans

 

 

Other

Consumer

 

 

Total

 

 

(In Thousands)

 

Balance of allowance for loan losses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loans acquired with deteriorated

  credit quality

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

Loans individually

  evaluated for impairment

 

8

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

8

 

 

 

-

 

 

 

-

 

 

 

16

 

Loans collectively

  evaluated for impairment

 

4,747

 

 

 

18,891

 

 

 

10,710

 

 

 

184

 

 

 

1,994

 

 

 

564

 

 

 

85

 

 

 

37,175

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total allowance for loan losses

$

4,755

 

 

$

18,891

 

 

$

10,710

 

 

$

184

 

 

$

2,002

 

 

$

564

 

 

$

85

 

 

$

37,191

 

 

 

- 21 -

Balance of Loans Receivable

 

At March 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential

Mortgage

 

 

Multi-Family Mortgage

 

 

Non-

Residential

Mortgage

 

 

Construction

 

 

Commercial

Business

 

 

Home

Equity

Loans

 

 

Other

Consumer

 

 

Total

 

 

(In Thousands)

 

Balance of loans receivable:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loans acquired with deteriorated

  credit quality

$

78

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

223

 

 

$

-

 

 

$

-

 

 

$

301

 

Loans individually

  evaluated for impairment

 

9,512

 

 

 

2,995

 

 

 

23,680

 

 

 

-

 

 

 

5,785

 

 

 

1,614

 

 

 

-

 

 

 

43,586

 

Loans collectively

  evaluated for impairment

 

1,328,509

 

 

 

1,876,912

 

 

 

1,178,972

 

 

 

17,880

 

 

 

67,914

 

 

 

86,295

 

 

 

4,604

 

 

 

4,561,086

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total loans

$

1,338,099

 

 

$

1,879,907

 

 

$

1,202,652

 

 

$

17,880

 

 

$

73,922

 

 

$

87,909

 

 

$

4,604

 

 

$

4,604,973

 

Unaccreted yield

  adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(42,461

)

Loans receivable, net of

   yield adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

4,562,512

 

 

 

 

Allowance for Loan Losses

 

At June 30, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential

Mortgage

 

 

Multi-Family Mortgage

 

 

Non-

Residential

Mortgage

 

 

Construction

 

 

Commercial

Business

 

 

Home

Equity

Loans

 

 

Other

Consumer

 

 

Total

 

 

(In Thousands)

 

Balance of allowance for loan losses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loans acquired with deteriorated

  credit quality

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

Loans individually

  evaluated for impairment

 

31

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

31

 

Loans collectively

  evaluated for impairment

 

3,346

 

 

 

16,959

 

 

 

9,672

 

 

 

136

 

 

 

2,467

 

 

 

491

 

 

 

172

 

 

 

33,243

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total allowance for loan losses

$

3,377

 

 

$

16,959

 

 

$

9,672

 

 

$

136

 

 

$

2,467

 

 

$

491

 

 

$

172

 

 

$

33,274

 

 

 

- 22 -

Balance of Loans Receivable

 

At June 30, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential

Mortgage

 

 

Multi-Family Mortgage

 

 

Non-

Residential

Mortgage

 

 

Construction

 

 

Commercial

Business

 

 

Home

Equity

Loans

 

 

Other

Consumer

 

 

Total

 

 

(In Thousands)

 

Balance of loans receivable:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loans acquired with deteriorated

  credit quality

$

84

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

242

 

 

$

-

 

 

$

-

 

 

 

326

 

Loans individually

  evaluated for impairment

 

12,545

 

 

 

70

 

 

 

8,900

 

 

 

-

 

 

 

1,213

 

 

 

1,531

 

 

 

-

 

 

 

24,259

 

Loans collectively

  evaluated for impairment

 

1,331,415

 

 

 

1,946,321

 

 

 

1,249,969

 

 

 

13,907

 

 

 

64,308

 

 

 

94,634

 

 

 

5,814

 

 

 

4,706,368

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total loans

$

1,344,044

 

 

$

1,946,391

 

 

$

1,258,869

 

 

$

13,907

 

 

$

65,763

 

 

$

96,165

 

 

$

5,814

 

 

$

4,730,953

 

Unaccreted yield

  adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(52,025

)

Loans receivable, net of

   yield adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

4,678,928

 

 

- 23 -

 

 

 

Allowance for Loan Losses

 

Three Months Ended March 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential

Mortgage

 

 

Multi-Family Mortgage

 

 

Non-

Residential

Mortgage

 

 

Construction

 

 

Commercial

Business

 

 

Home

Equity

Loans

 

 

Other

Consumer

 

 

Total

 

 

(In Thousands)

 

Changes in the allowance for loan

  losses for the three months ended

  March 31, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

At December 31, 2019:

$

3,478

 

 

$

16,060

 

 

$

8,684

 

 

$

142

 

 

$

2,008

 

 

$

456

 

 

$

109

 

 

$

30,937

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total charge offs

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(26

)

 

 

(26

)

Total recoveries

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

10

 

 

 

10

 

Total provisions

 

1,277

 

 

 

2,831

 

 

 

2,026

 

 

 

42

 

 

 

(6

)

 

 

108

 

 

 

(8

)

 

 

6,270

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total allowance for loan losses

$

4,755

 

 

$

18,891

 

 

$

10,710

 

 

$

184

 

 

$

2,002

 

 

$

564

 

 

$

85

 

 

$

37,191

 

 

 

Allowance for Loan Losses

 

Nine Months Ended March 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential

Mortgage

 

 

Multi-Family Mortgage

 

 

Non-

Residential

Mortgage

 

 

Construction

 

 

Commercial

Business

 

 

Home

Equity

Loans

 

 

Other

Consumer

 

 

Total

 

 

(In Thousands)

 

Changes in the allowance for loan

  losses for the nine months ended

  March 31, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

At June 30, 2019:

$

3,377

 

 

$

16,959

 

 

$

9,672

 

 

$

136

 

 

$

2,467

 

 

$

491

 

 

$

172

 

 

$

33,274

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total charge offs

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(134

)

 

 

(134

)

Total recoveries

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

28

 

 

 

28

 

Total provisions

 

1,378

 

 

 

1,932

 

 

 

1,038

 

 

 

48

 

 

 

(465

)

 

 

73

 

 

 

19

 

 

 

4,023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total allowance for loan losses

$

4,755

 

 

$

18,891

 

 

$

10,710

 

 

$

184

 

 

$

2,002

 

 

$

564

 

 

$

85

 

 

$

37,191

 

 

- 24 -

 

Allowance for Loan Losses

 

Three Months Ended March 31, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential

Mortgage

 

 

Multi-Family Mortgage

 

 

Non-

Residential

Mortgage

 

 

Construction

 

 

Commercial

Business

 

 

Home

Equity

Loans

 

 

Other

Consumer

 

 

Total

 

 

(In Thousands)

 

Changes in the allowance for loan

  losses for the three months ended

  March 31, 2019:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

At December 31, 2018:

$

2,977

 

 

$

17,095

 

 

$

9,918

 

 

$

305

 

 

$

2,514

 

 

$

464

 

 

$

253

 

 

$

33,526

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total charge offs

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(184

)

 

 

-

 

 

 

(76

)

 

 

(260

)

Total recoveries

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

18

 

 

 

18

 

Total provisions

 

138

 

 

 

(83

)

 

 

(343

)

 

 

(156

)

 

 

234

 

 

 

25

 

 

 

6

 

 

 

(179

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total allowance for loan losses

$

3,115

 

 

$

17,012

 

 

$

9,575

 

 

$

149

 

 

$

2,564

 

 

$

489

 

 

$

201

 

 

$

33,105

 

 

 

Allowance for Loan Losses

 

Nine Months Ended March 31, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential

Mortgage

 

 

Multi-Family Mortgage

 

 

Non-

Residential

Mortgage

 

 

Construction

 

 

Commercial

Business

 

 

Home

Equity

Loans

 

 

Other

Consumer

 

 

Total

 

 

(In Thousands)

 

Changes in the allowance for loan

  losses for the nine months ended

  March 31, 2019:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

At June 30, 2018:

$

2,479

 

 

$

14,946

 

 

$

9,787

 

 

$

258

 

 

$

2,552

 

 

$

430

 

 

$

413

 

 

$

30,865

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total charge offs

 

(83

)

 

 

-

 

 

 

(54

)

 

 

-

 

 

 

(369

)

 

 

-

 

 

 

(215

)

 

 

(721

)

Total recoveries

 

-

 

 

 

-

 

 

 

2

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

67

 

 

 

69

 

Total provisions

 

719

 

 

 

2,066

 

 

 

(160

)

 

 

(109

)

 

 

381

 

 

 

59

 

 

 

(64

)

 

 

2,892

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total allowance for loan losses

$

3,115

 

 

$

17,012

 

 

$

9,575

 

 

$

149

 

 

$

2,564

 

 

$

489

 

 

$

201

 

 

$

33,105

 

 

- 25 -

The following tables present key indicators of credit quality regarding the Company’s loan portfolio based upon loan classification and contractual payment status at March 31, 2020 and June 30, 2019 based upon the methodology for identifying and reporting such loans as described in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2019.

 

Credit-Rating Classification of Loans Receivable

 

At March 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential

Mortgage

 

 

Multi-Family Mortgage

 

 

Non-

Residential

Mortgage

 

 

Construction

 

 

Commercial

Business

 

 

Home

Equity

Loans

 

 

Other

Consumer

 

 

Total

 

 

(In Thousands)

 

Pass

$

1,325,449

 

 

$

1,875,819

 

 

$

1,172,834

 

 

$

17,880

 

 

$

67,722

 

 

$

86,061

 

 

$

4,587

 

 

$

4,550,352

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Special Mention

 

281

 

 

 

1,093

 

 

 

5,905

 

 

 

-

 

 

 

2,660

 

 

 

158

 

 

 

1

 

 

 

10,098

 

Substandard

 

12,369

 

 

 

2,995

 

 

 

23,913

 

 

 

-

 

 

 

3,540

 

 

 

1,690

 

 

 

14

 

 

 

44,521

 

Doubtful

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2

 

 

 

2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total loans

$

1,338,099

 

 

$

1,879,907

 

 

$

1,202,652

 

 

$

17,880

 

 

$

73,922

 

 

$

87,909

 

 

$

4,604

 

 

$

4,604,973

 

 

 

 

Credit-Rating Classification of Loans Receivable

 

At June 30, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential

Mortgage

 

 

Multi-Family Mortgage

 

 

Non-

Residential

Mortgage

 

 

Construction

 

 

Commercial

Business

 

 

Home

Equity

Loans

 

 

Other

Consumer

 

 

Total

 

 

(In Thousands)

 

Pass

$

1,328,811

 

 

$

1,945,205

 

 

$

1,249,438

 

 

$

13,907

 

 

$

59,768

 

 

$

94,544

 

 

$

5,776

 

 

$

4,697,449

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Special Mention

 

629

 

 

 

1,116

 

 

 

-

 

 

 

-

 

 

 

3,894

 

 

 

28

 

 

 

14

 

 

 

5,681

 

Substandard

 

14,604

 

 

 

70

 

 

 

9,431

 

 

 

-

 

 

 

2,101

 

 

 

1,593

 

 

 

23

 

 

 

27,822

 

Doubtful

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1

 

 

 

1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total loans

$

1,344,044

 

 

$

1,946,391

 

 

$

1,258,869

 

 

$

13,907

 

 

$

65,763

 

 

$

96,165

 

 

$

5,814

 

 

$

4,730,953

 

 

 

- 26 -

 

Contractual Payment Status of Loans Receivable

 

At March 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential

Mortgage

 

 

Multi-Family Mortgage

 

 

Non-

Residential

Mortgage

 

 

Construction

 

 

Commercial

Business

 

 

Home

Equity

Loans

 

 

Other

Consumer

 

 

Total

 

 

(In Thousands)

 

Current

$

1,331,827

 

 

$

1,879,907

 

 

$

1,182,448

 

 

$

17,880

 

 

$

73,431

 

 

$

87,507

 

 

$

4,589

 

 

$

4,577,589

 

Past due:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

30-59 days

 

2,457

 

 

 

-

 

 

 

15,796

 

 

 

-

 

 

 

296

 

 

 

20

 

 

 

3

 

 

 

18,572

 

60-89 days

 

661

 

 

 

-

 

 

 

139

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

800

 

90 days and over

 

3,154

 

 

 

-

 

 

 

4,269

 

 

 

-

 

 

 

195

 

 

 

382

 

 

 

12

 

 

 

8,012

 

Total past due

 

6,272

 

 

 

-

 

 

 

20,204

 

 

 

-

 

 

 

491

 

 

 

402

 

 

 

15

 

 

 

27,384

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total loans

$

1,338,099

 

 

$

1,879,907

 

 

$

1,202,652

 

 

$

17,880

 

 

$

73,922

 

 

$

87,909

 

 

$

4,604

 

 

$

4,604,973

 

 

 

Contractual Payment Status of Loans Receivable

 

At June 30, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential

Mortgage

 

 

Multi-Family Mortgage

 

 

Non-

Residential

Mortgage

 

 

Construction

 

 

Commercial

Business

 

 

Home

Equity

Loans

 

 

Other

Consumer

 

 

Total

 

 

(In Thousands)

 

Current

$

1,338,347

 

 

$

1,946,391

 

 

$

1,256,892

 

 

$

13,907

 

 

$

65,668

 

 

$

95,793

 

 

$

5,754

 

 

$

4,722,752

 

Past due:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

30-59 days

 

1,680

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

95

 

 

 

197

 

 

 

25

 

 

 

1,997

 

60-89 days

 

473

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

36

 

 

 

13

 

 

 

522

 

90 days and over

 

3,544

 

 

 

-

 

 

 

1,977

 

 

 

-

 

 

 

-

 

 

 

139

 

 

 

22

 

 

 

5,682

 

Total past due

 

5,697

 

 

 

-

 

 

 

1,977

 

 

 

-

 

 

 

95

 

 

 

372

 

 

 

60

 

 

 

8,201

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total loans

$

1,344,044

 

 

$

1,946,391

 

 

$

1,258,869

 

 

$

13,907

 

 

$

65,763

 

 

$

96,165

 

 

$

5,814

 

 

$

4,730,953

 

 

- 27 -

The following tables present information relating to the Company’s nonperforming and impaired loans at March 31, 2020 and June 30, 2019 based upon the methodology for identifying and reporting such loans as described in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2019. Loans reported as 90 days and over past due accruing in the table immediately below are also reported in the preceding contractual payment status table under the heading 90 days and over past due.

 

Performance Status of Loans Receivable

 

At March 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential

Mortgage

 

 

Multi-Family Mortgage

 

 

Non-

Residential

Mortgage

 

 

Construction

 

 

Commercial

Business

 

 

Home

Equity

Loans

 

 

Other

Consumer

 

 

Total

 

 

(In Thousands)

 

Performing

$

1,331,069

 

 

$

1,876,912

 

 

$

1,178,972

 

 

$

17,880

 

 

$

73,194

 

 

$

86,958

 

 

$

4,592

 

 

$

4,569,577

 

Nonperforming:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

90 days and over past due accruing

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

12

 

 

 

12

 

Nonaccrual

 

7,030

 

 

 

2,995

 

 

 

23,680

 

 

 

-

 

 

 

728

 

 

 

951

 

 

 

-

 

 

 

35,384

 

Total nonperforming

 

7,030

 

 

 

2,995

 

 

 

23,680

 

 

 

-

 

 

 

728

 

 

 

951

 

 

 

12

 

 

 

35,396

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total loans

$

1,338,099

 

 

$

1,879,907

 

 

$

1,202,652

 

 

$

17,880

 

 

$

73,922

 

 

$

87,909

 

 

$

4,604

 

 

$

4,604,973

 

 

 

Performance Status of Loans Receivable

 

At June 30, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential

Mortgage

 

 

Multi-Family Mortgage

 

 

Non-

Residential

Mortgage

 

 

Construction

 

 

Commercial

Business

 

 

Home

Equity

Loans

 

 

Other

Consumer

 

 

Total

 

 

(In Thousands)

 

Performing

$

1,334,101

 

 

$

1,946,321

 

 

$

1,249,969

 

 

$

13,907

 

 

$

65,294

 

 

$

95,299

 

 

$

5,792

 

 

$

4,710,683

 

Nonperforming:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

90 days and over past due accruing

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

22

 

 

 

22

 

Nonaccrual

 

9,943

 

 

 

70

 

 

 

8,900

 

 

 

-

 

 

 

469

 

 

 

866

 

 

 

-

 

 

 

20,248

 

Total nonperforming

 

9,943

 

 

 

70

 

 

 

8,900

 

 

 

-

 

 

 

469

 

 

 

866

 

 

 

22

 

 

 

20,270

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total loans

$

1,344,044

 

 

$

1,946,391

 

 

$

1,258,869

 

 

$

13,907

 

 

$

65,763

 

 

$

96,165

 

 

$

5,814

 

 

$

4,730,953

 

 

 

 

- 28 -

Impairment Status of Loans Receivable

 

At March 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential

Mortgage

 

 

Multi-Family Mortgage

 

 

Non-

Residential

Mortgage

 

 

Construction

 

 

Commercial

Business

 

 

Home

Equity

Loans

 

 

Other

Consumer

 

 

Total

 

 

(In Thousands)

 

Carrying value of impaired loans:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-impaired loans

$

1,328,509

 

 

$

1,876,912

 

 

$

1,178,972

 

 

$

17,880

 

 

$

67,914

 

 

$

86,295

 

 

$

4,604

 

 

$

4,561,086

 

Impaired loans:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Impaired loans with no allowance

  for impairment

 

9,495

 

 

 

2,995

 

 

 

23,680

 

 

 

 

 

 

 

5,919

 

 

 

1,614

 

 

 

-

 

 

 

43,703

 

Impaired loans with allowance

  for impairment:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Recorded investment

 

95

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

89

 

 

 

-

 

 

 

-

 

 

 

184

 

Allowance for impairment

 

(8

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(8

)

 

 

-

 

 

 

-

 

 

 

(16

)

Balance of impaired loans net

  of allowance for impairment

 

87

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

81

 

 

 

-

 

 

 

-

 

 

 

168

 

Total impaired loans, excluding

  allowance for impairment:

 

9,590

 

 

 

2,995

 

 

 

23,680

 

 

 

-

 

 

 

6,008

 

 

 

1,614

 

 

 

-

 

 

 

43,887

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total loans

$

1,338,099

 

 

$

1,879,907

 

 

$

1,202,652

 

 

$

17,880

 

 

$

73,922

 

 

$

87,909

 

 

$

4,604

 

 

$

4,604,973

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unpaid principal balance

  of impaired loans:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total impaired loans

$

11,761

 

 

$

3,544

 

 

$

25,236

 

 

$

73

 

 

$

8,978

 

 

$

2,004

 

 

$

-

 

 

$

51,596

 

 

 

Impairment Status of Loans Receivable

 

At June 30, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential

Mortgage

 

 

Multi-Family Mortgage

 

 

Non-

Residential

Mortgage

 

 

Construction

 

 

Commercial

Business

 

 

Home

Equity

Loans

 

 

Other

Consumer

 

 

Total

 

 

(In Thousands)

 

Carrying value of impaired loans:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-impaired loans

$

1,331,415

 

 

$

1,946,321

 

 

$

1,249,969

 

 

$

13,907

 

 

$

64,308

 

 

$

94,634

 

 

$

5,814

 

 

$

4,706,368

 

Impaired loans:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Impaired loans with no allowance

  for impairment

 

12,266

 

 

 

70

 

 

 

8,900

 

 

 

-

 

 

 

1,455

 

 

 

1,531

 

 

 

-

 

 

 

24,222

 

Impaired loans with allowance

  for impairment:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Recorded investment

 

363

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

363

 

Allowance for impairment

 

(31

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(31

)

Balance of impaired loans net

  of allowance for impairment

 

332

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

332

 

Total impaired loans, excluding

  allowance for impairment:

 

12,629

 

 

 

70

 

 

 

8,900

 

 

 

-

 

 

 

1,455

 

 

 

1,531

 

 

 

-

 

 

 

24,585

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total loans

$

1,344,044

 

 

$

1,946,391

 

 

$

1,258,869

 

 

$

13,907

 

 

$

65,763

 

 

$

96,165

 

 

$

5,814

 

 

$

4,730,953

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unpaid principal balance

  of impaired loans:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total impaired loans

$

14,985

 

 

$

779

 

 

$

10,200

 

 

$

73

 

 

$

3,987

 

 

$

1,924

 

 

$

-

 

 

$

31,948

 

 

- 29 -

 

Impairment Status of Loans Receivable

 

Three and Nine Months Ended March 31, 2020 and 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential

Mortgage

 

 

Multi-Family Mortgage

 

 

Non-

Residential

Mortgage

 

 

Construction

 

 

Commercial

Business

 

 

Home

Equity

Loans

 

 

Other

Consumer

 

 

Total

 

 

(In Thousands)

 

For the three months ended

  March 31, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average balance of impaired loans

$

10,191

 

 

$

3,028

 

 

$

12,404

 

 

$

-

 

 

$

4,702

 

 

$

1,649

 

 

$

-

 

 

$

31,974

 

Interest earned on impaired loans

$

29

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

89

 

 

$

9

 

 

$

-

 

 

$

127

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the nine months ended

  March 31, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average balance of impaired loans

$

10,964

 

 

$

2,144

 

 

$

10,227

 

 

$

-

 

 

$

3,341

 

 

$

1,566

 

 

$

-

 

 

$

28,242

 

Interest earned on impaired loans

$

90

 

 

$

28

 

 

$

-

 

 

$

-

 

 

$

188

 

 

$

25

 

 

$

-

 

 

$

331

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the three months ended

  March 31, 2019:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average balance of impaired loans

$

13,766

 

 

$

86

 

 

$

8,750

 

 

$

-

 

 

$

2,143

 

 

$

1,540

 

 

$

-

 

 

$

26,285

 

Interest earned on impaired loans

$

32

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

19

 

 

$

9

 

 

$

-

 

 

$

60

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the nine months ended

  March 31, 2019:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average balance of impaired loans

$

13,014

 

 

$

97

 

 

$

8,039

 

 

$

-

 

 

$

2,352

 

 

$

1,556

 

 

$

-

 

 

$

25,058

 

Interest earned on impaired loans

$

97

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

48

 

 

$

26

 

 

$

-

 

 

$

171

 

- 30 -

The following table presents information regarding the restructuring of the Company’s troubled debts during the nine months ended March 31, 2020 and March 31, 2019, and any defaults during those periods of troubled debt restructurings (“TDRs”) that were restructured within 12 months of the date of default.  

  

Troubled Debt Restructurings of Loans Receivable

 

Nine Months Ended March 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential

Mortgage

 

 

Multi-Family Mortgage

 

 

Non-

Residential

Mortgage

 

 

Construction

 

 

Commercial

Business

 

 

Home

Equity

Loans

 

 

Other

Consumer

 

 

Total

 

 

(Dollars in Thousands)

 

Troubled debt restructuring activity

  for the nine months ended

  March 31, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of loans

 

3

 

 

 

1

 

 

 

1

 

 

 

-

 

 

 

5

 

 

 

1

 

 

 

-

 

 

 

11

 

Pre-modification outstanding

  recorded investment

$

1,046

 

 

$

3,062

 

 

$

521

 

 

$

-

 

 

$

4,349

 

 

$

82

 

 

$

-

 

 

$

9,060

 

Post-modification outstanding

  recorded investment

 

982

 

 

 

2,996

 

 

 

517

 

 

 

-

 

 

 

4,415

 

 

 

81

 

 

 

-

 

 

 

8,991

 

Reserves included in and charge offs

against the allowance for loan loss

recognized at modification

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

15

 

 

 

-

 

 

 

-

 

 

 

15

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Troubled debt restructuring defaults

  for the nine months ended

  March 31, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of loans

 

-

 

 

 

-

 

 

 

1

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1

 

Outstanding recorded investment

$

-

 

 

$

-

 

 

$

517

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

517

 

 

 

Troubled Debt Restructurings of Loans Receivable

 

Nine Months Ended March 31, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential

Mortgage

 

 

Multi-Family Mortgage

 

 

Non-

Residential

Mortgage

 

 

Construction

 

 

Commercial

Business

 

 

Home

Equity

Loans

 

 

Other

Consumer

 

 

Total

 

 

(Dollars in Thousands)

 

Troubled debt restructuring activity

  for the nine months ended

  March 31, 2019:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of loans

 

5

 

 

 

-

 

 

 

1

 

 

 

-

 

 

 

6

 

 

 

-

 

 

 

-

 

 

 

12

 

Pre-modification outstanding

  recorded investment

$

1,267

 

 

$

-

 

 

$

2,957

 

 

$

-

 

 

$

1,468

 

 

$

-

 

 

$

-

 

 

$

5,692

 

Post-modification outstanding

  recorded investment

 

1,309

 

 

 

-

 

 

 

2,955

 

 

 

-

 

 

 

1,488

 

 

 

-

 

 

 

-

 

 

 

5,752

 

Reserves included in and charge offs

against the allowance for loan loss

recognized at modification

 

2

 

 

 

-

 

 

 

2

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Troubled debt restructuring defaults

  for the nine months ended

  March 31, 2019:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of loans

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Outstanding recorded investment

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

- 31 -

The manner in which the terms of a loan are modified through a troubled debt restructuring generally includes one or more of the following changes to the loan’s repayment terms:

 

•

Interest Rate Reduction: Temporary or permanent reduction of the interest rate charged against the outstanding balance of the loan.

 

•

Capitalization of Prior Past Dues: Capitalization of prior amounts due to the outstanding balance of the loan.

 

•

Extension of Maturity or Balloon Date: Extending the term of the loan past its original balloon or maturity date.

 

•

Deferral of Principal Payments: Temporary deferral of the principal portion of a loan payment.

 

•

Payment Recalculation and Re-amortization: Recalculation of the recurring payment obligation and resulting loan amortization/repayment schedule based on the loan’s modified terms.

 

 

12.     LEASES

The Company adopted ASU 2016-02, “Leases (Topic 842)” and all subsequent ASUs that modified Topic 842 on July 1, 2019. Topic 842 requires lessees to recognize a lease liability and a right-of-use asset, measured at the present value of the future minimum lease payments, at the lease commencement date. At the time of adoption, operating lease right-of-use assets of approximately $17.2 million and operating lease liabilities of approximately $17.8 million were recorded in other assets and other liabilities, respectively, on our Consolidated Statements of Financial Condition. The calculated amount of the right-of-use asset and lease liabilities are impacted by the length of the lease term and the discount rate used to calculate the present value of the minimum lease payments. The discount rate used in determining the lease liability for each individual lease was the Company’s incremental borrowing rate at the time of adoption of ASU 2016-02, on a collateralized basis, over a similar term.

As of March 31, 2020, the weighted average remaining lease term for operating leases was 8.59 years and the weighted average discount rate used in the measurement of operating lease liabilities was 2.51%.  

The Company has elected to account for lease and non-lease components separately since such amounts are readily determinable under the Company’s lease contracts.  Total operating lease costs for the three and nine months ended March 31, 2020 was $832,000 and $3.1 million, respectively. Net rent expense for the three and nine months ended March 31, 2019, prior to the adoption of ASU 2016-02 was $794,000 and $2.3 million, respectively.

There were no sale and leaseback transactions, leveraged leases or lease transactions with related parties during the three and nine months ended March 31, 2020.  At March 31, 2020, the Company had no leases that had not yet commenced.

 

A maturity analysis of operating lease liabilities and reconciliation of the undiscounted cash flows to the total operating lease liability at March 31, 2020 is as follows:

 

 

 

 

 

 

March 31,

 

 

 

 

 

 

2020

 

 

 

 

 

 

(In Thousands)

 

Less than one year

 

 

 

 

$

3,183

 

After one year but within two years

 

 

 

 

 

2,947

 

After two years but within three years

 

 

 

 

 

2,536

 

After three years but within four years

 

 

 

 

 

1,788

 

After four years but within five years

 

 

 

 

 

1,448

 

Greater than five years

 

 

 

 

 

7,739

 

Total undiscounted cash flows

 

 

 

 

 

19,641

 

Less: discount on cash flows

 

 

 

 

 

(2,210

)

Total lease liability

 

 

 

 

$

17,431

 

 

- 32 -

13.     DEPOSITS

Deposits are summarized as follows:

 

 

March 31,

 

 

June 30,

 

 

2020

 

 

 

2019

 

 

(In Thousands)

 

Non-interest-bearing demand

$

321,824

 

 

$

309,063

 

Interest-bearing demand

 

1,134,420

 

 

 

843,432

 

Savings

 

848,950

 

 

 

790,658

 

Certificates of deposits

 

1,948,060

 

 

 

2,204,457

 

Total deposits

$

4,253,254

 

 

$

4,147,610

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

14.     BORROWINGS

Fixed rate advances from the FHLB of New York mature as follows:

 

 

March 31, 2020

 

 

June 30, 2019

 

 

 

Balance

 

 

Weighted

Average

Interest Rate

 

 

Balance

 

 

Weighted

Average

Interest Rate

 

 

 

(Dollars in Thousands)

By remaining period to maturity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Less than one year

$

875,000

 

 

 

1.23

 

%

$

873,400

 

 

 

2.49

 

%

One to two years

 

27,000

 

 

 

2.85

 

 

 

64,046

 

 

 

1.87

 

 

Two to three years

 

-

 

 

 

0.00

 

 

 

62,700

 

 

 

2.46

 

 

Three to four years

 

145,000

 

 

 

3.04

 

 

 

155,000

 

 

 

3.00

 

 

Four to five years

 

103,500

 

 

 

2.65

 

 

 

22,500

 

 

 

2.63

 

 

Greater than five years

 

29,000

 

 

 

2.77

 

 

 

110,000

 

 

 

2.69

 

 

Total advances

 

1,179,500

 

 

 

1.65

 

%

 

1,287,646

 

 

 

2.54

 

%

Unamortized fair value adjustments

 

(2,181

)

 

 

 

 

 

 

(4,435

)

 

 

 

 

 

Total advances, net of

  fair value adjustments

$

1,177,319

 

 

 

 

 

 

$

1,283,211

 

 

 

 

 

 

 

At March 31, 2020, FHLB advances were collateralized by the FHLB capital stock owned by the Bank and mortgage loans and securities with carrying values totaling approximately $3.28 billion and $159.2 million, respectively. At June 30, 2019, FHLB advances were collateralized by the FHLB capital stock owned by the Bank and mortgage loans and securities with carrying values totaling approximately $3.04 billion and $160.8 million, respectively.

Borrowings at March 31, 2020 and June 30, 2019 also included overnight borrowings in the form of depositor sweep accounts totaling $6.7 million and $8.8 million, respectively. Borrowings at March 31, 2020 and June 30, 2019 also included other overnight borrowings totaling $200.0 million and $30.0 million, respectively.

 

- 33 -

15.     DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

Risk Management Objective of Using Derivatives

The Company uses various financial instruments, including derivatives, to manage its exposure to interest rate risk. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to specific wholesale funding positions.

 

Fair Values of Derivative Instruments on the Statement of Financial Condition

The tables below present the fair value of the Company’s derivative financial instruments as well as their classification on the Statement of Financial Condition as of March 31, 2020 and June 30, 2019:

 

 

March 31, 2020

 

 

Asset Derivatives

 

 

Liability Derivatives

 

 

Location

 

Fair Value

 

 

Location

 

Fair Value

 

 

(In Thousands)

 

Derivatives designated as hedging

   instruments:

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps and caps

Other assets

 

$

535

 

 

Other liabilities

 

$

15,372

 

Total

 

 

$

535

 

 

 

 

$

15,372

 

 

 

June 30, 2019

 

 

Asset Derivatives

 

 

Liability Derivatives

 

 

Location

 

Fair Value

 

 

Location

 

Fair Value

 

 

(In Thousands)

 

Derivatives designated as hedging

   instruments:

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps

Other assets

 

$

3,856

 

 

Other liabilities

 

$

140

 

Total

 

 

$

3,856

 

 

 

 

$

140

 

 

Cash Flow Hedges of Interest Rate Risk

The Company’s objectives in using derivatives are primarily to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company has entered into interest rate swaps and caps as part of its interest rate risk management strategy.  These interest rate products are designated as cash flow hedges.  As of March 31, 2020, the Company had a total of 16 interest rate swaps and caps with a total notional amount of $1.18 billion hedging specific wholesale funding positions.

For derivatives designated as cash flow hedges, the gain or loss on the derivative is recorded in other comprehensive income, net of tax, and subsequently reclassified into interest expense in the same period during which the hedged transaction affects earnings.

Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable rate wholesale funding positions.  During the three and nine months ended March 31, 2020, the Company had $417,000 and $2.6 million, respectively, of reclassifications to interest expense.  During the next twelve months, the Company estimates that $6.5 million will be reclassified as an increase in interest expense.

- 34 -

The tables below present the pre-tax effects of the Company’s derivative instruments on the Consolidated Statements of Income and Comprehensive Income for the three and nine months ended March 31, 2020 and 2019:

 

 

Three Months Ended March 31, 2020

 

 

Amount of Gain

(Loss) Recognized

in OCI on

Derivatives

 

 

Location of Gain

(Loss) Reclassified

from Accumulated

OCI into Income

 

Amount of Gain

(Loss) Reclassified

from Accumulated

OCI into Income

 

 

(In Thousands)

 

Derivatives in cash flow

   hedging relationships:

 

 

 

 

 

 

 

 

 

Interest rate contracts

$

(18,324

)

 

Interest expense

 

$

417

 

Total

$

(18,324

)

 

 

 

$

417

 

 

 

Nine Months Ended March 31, 2020

 

 

Amount of Gain

(Loss) Recognized

in OCI on

Derivatives

 

 

Location of Gain

(Loss) Reclassified

from Accumulated

OCI into Income

 

Amount of Gain

(Loss) Reclassified

from Accumulated

OCI into Income

 

 

(In Thousands)

 

Derivatives in cash flow

   hedging relationships:

 

 

 

 

 

 

 

 

 

Interest rate contracts

$

(17,405

)

 

Interest expense

 

$

2,623

 

Total

$

(17,405

)

 

 

 

$

2,623

 

 

 

Three Months Ended March 31, 2019

 

 

Amount of Gain

(Loss) Recognized

in OCI on

Derivatives

 

 

Location of Gain

(Loss) Reclassified

from Accumulated

OCI into Income

 

Amount of Gain

(Loss) Reclassified

from Accumulated

OCI into Income

 

 

(In Thousands)

 

Derivatives in cash flow

   hedging relationships:

 

 

 

 

 

 

 

 

 

Interest rate contracts

$

(4,982

)

 

Interest expense

 

$

2,159

 

Total

$

(4,982

)

 

 

 

$

2,159

 

 

 

Nine Months Ended March 31, 2019

 

 

Amount of Gain

(Loss) Recognized

in OCI on

Derivatives

 

 

Location of Gain

(Loss) Reclassified

from Accumulated

OCI into Income

 

Amount of Gain

(Loss) Reclassified

from Accumulated

OCI into Income

 

 

(In Thousands)

 

Derivatives in cash flow

   hedging relationships:

 

 

 

 

 

 

 

 

 

Interest rate contracts

$

(12,058

)

 

Interest expense

 

$

4,855

 

Total

$

(12,058

)

 

 

 

$

4,855

 

 

 

- 35 -

Offsetting Derivatives

 

The tables below present a gross presentation, the effects of offsetting, and a net presentation of the Company’s derivatives in the Consolidated Statements of Financial Condition as of March 31, 2020 and June 30, 2019, respectively. The net amounts presented for derivative assets or liabilities can be reconciled to the tabular disclosure of fair value. The tabular disclosure of fair value provides the location that derivative assets and liabilities are presented on the Consolidated Statements of Financial Condition.

 

 

March 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Amounts Not Offset

 

 

 

 

 

 

Gross Amount Recognized

 

 

Gross Amounts Offset

 

 

Net Amounts Presented

 

 

Financial Instruments

 

 

Cash Collateral Received

 

 

Net Amount

 

 

(In Thousands)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate contracts

$

1,267

 

 

$

(732

)

 

$

535

 

 

$

-

 

 

$

-

 

 

$

535

 

Total

$

1,267

 

 

$

(732

)

 

$

535

 

 

$

-

 

 

$

-

 

 

$

535

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Amounts Not Offset

 

 

 

 

 

 

Gross Amount Recognized

 

 

Gross Amounts Offset

 

 

Net Amounts Presented

 

 

Financial Instruments

 

 

Cash Collateral Posted

 

 

Net Amount

 

 

(In Thousands)

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate contracts

$

16,104

 

 

$

(732

)

 

$

15,372

 

 

$

-

 

 

$

(14,940

)

 

$

432

 

Total

$

16,104

 

 

$

(732

)

 

$

15,372

 

 

$

-

 

 

$

(14,940

)

 

$

432

 

 

 

 

June 30, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Amounts Not Offset

 

 

 

 

 

 

Gross Amount Recognized

 

 

Gross Amounts Offset

 

 

Net Amounts Presented

 

 

Financial Instruments

 

 

Cash Collateral Received

 

 

Net Amount

 

 

(In Thousands)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate contracts

$

5,334

 

 

$

(1,478

)

 

$

3,856

 

 

$

-

 

 

$

-

 

 

$

3,856

 

Total

$

5,334

 

 

$

(1,478

)

 

$

3,856

 

 

$

-

 

 

$

-

 

 

$

3,856

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Amounts Not Offset

 

 

 

 

 

 

Gross Amount Recognized

 

 

Gross Amounts Offset

 

 

Net Amounts Presented

 

 

Financial Instruments

 

 

Cash Collateral Posted

 

 

Net Amount

 

 

(In Thousands)

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate contracts

$

1,618

 

 

$

(1,478

)

 

$

140

 

 

$

-

 

 

$

-

 

 

$

140

 

Total

$

1,618

 

 

$

(1,478

)

 

$

140

 

 

$

-

 

 

$

-

 

 

$

140

 

 

- 36 -

Credit-risk-related Contingent Features

The Company has agreements with each of its derivative counterparties that contain a provision where if the Company defaults on any of its indebtedness, then the Company could also be declared in default on its derivative obligations and could be required to terminate its derivative positions with the counterparty.  The Company also has agreements with its derivative counterparties that contain a provision where if the Company fails to maintain its status as a well-capitalized institution, then the Company could be required to terminate its derivative positions with the counterparty.  As of March 31, 2020, the termination value of derivatives in a net liability position, which includes accrued interest but excludes any adjustment for nonperformance risk, related to those agreements was $15.0 million.  

As required under the enforceable master netting arrangement with its derivatives counterparties, at March 31, 2020, the Company posted financial collateral of $14.9 million that was not included as offsetting amount.

In addition to the derivative instruments noted above, the Company’s pipeline of loans held for sale at March 31, 2020 and June 30, 2019, included $114.5 million and $46.2 million, respectively, of in process loans whose terms included interest rate locks to borrowers, which are considered free-standing derivative instruments whose fair values are not material to our financial condition or results of operations.

 

16.     BENEFIT PLANS

Components of Net Periodic Expense

The following table sets forth the aggregate net periodic benefit expense for the Bank’s Benefit Equalization Plan, Postretirement Welfare Plan, Directors’ Consultation and Retirement Plan and Atlas Bank Retirement Income Plan:

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

Affected Line Item in the Consolidated

 

March 31,

 

 

March 31,

 

 

Statements of Income

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

 

 

 

(In Thousands)

 

 

(In Thousands)

 

 

 

 

 

Service cost

$

20

 

 

$

13

 

 

$

59

 

 

$

41

 

 

Salaries and employee benefits

Interest cost

 

81

 

 

 

95

 

 

 

244

 

 

 

283

 

 

Miscellaneous non-interest  expense

Amortization of unrecognized loss

 

4

 

 

 

11

 

 

 

14

 

 

 

33

 

 

Miscellaneous non-interest  expense

Expected return on assets

 

(28

)

 

 

(28

)

 

 

(84

)

 

 

(84

)

 

Miscellaneous non-interest  expense

Net periodic benefit cost

$

77

 

 

$

91

 

 

$

233

 

 

$

273

 

 

 

 

 

 

- 37 -

 

17.     INCOME TAXES

The following table presents a reconciliation between the reported income taxes for the periods presented and the income taxes which would be computed by applying the federal income tax rate of 21% to income for the three and nine months ended March 31, 2020 and March 31, 2019.

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

March 31,

 

 

March 31,

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

(Dollars in Thousands)

 

 

(Dollars in Thousands)

 

Income before income taxes

$

9,479

 

 

$

15,722

 

 

$

38,865

 

 

$

44,944

 

Statutory federal tax rate

 

21

%

 

 

21

%

 

 

21

%

 

 

21

%

Federal income tax expense at statutory rate

$

1,991

 

 

$

3,302

 

 

$

8,162

 

 

$

9,438

 

(Reduction) increases in income taxes resulting from:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tax exempt interest

 

(114

)

 

 

(147

)

 

 

(396

)

 

 

(444

)

State tax, net of federal tax effect

 

554

 

 

 

1,540

 

 

 

2,604

 

 

 

3,661

 

Incentive stock option compensation expense

 

21

 

 

 

12

 

 

 

58

 

 

 

68

 

Income from bank-owned life insurance

 

(324

)

 

 

(421

)

 

 

(990

)

 

 

(1,000

)

Non-deductible merger-related expenses

 

49

 

 

 

-

 

 

 

69

 

 

 

-

 

Impact of CARES Act

 

(1,624

)

 

 

-

 

 

 

(1,624

)

 

 

-

 

Reversal of capital loss carryforward valuation allowance

 

(425

)

 

 

-

 

 

 

(425

)

 

 

-

 

Impact of deferred tax rate adjustment

 

-

 

 

 

-

 

 

 

-

 

 

 

(820

)

Other items, net

 

97

 

 

 

19

 

 

 

131

 

 

 

710

 

Total income tax expense

$

225

 

 

$

4,305

 

 

$

7,589

 

 

$

11,613

 

Effective income tax rate

 

2.37

%

 

 

27.38

%

 

 

19.53

%

 

 

25.84

%

 

- 38 -

The tax effects of existing temporary differences that give rise to deferred income tax assets and liabilities are as follows:

 

 

 

 

 

 

March 31,

 

 

June 30,

 

 

 

 

 

 

2020

 

 

 

2019

 

 

 

 

 

 

(Unaudited)

 

 

 

 

 

 

 

 

 

 

(In Thousands)

 

Deferred income tax assets:

 

 

 

 

 

 

 

 

 

 

 

Purchase accounting

 

 

 

 

$

12,539

 

 

$

15,137

 

Accumulated other comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

Defined benefit plans

 

 

 

 

 

175

 

 

 

319

 

Derivatives

 

 

 

 

 

4,814

 

 

 

-

 

Unrealized loss on securities available for sale

  transferred to held to maturity

 

 

 

 

 

-

 

 

 

175

 

Allowance for loan losses

 

 

 

 

 

11,007

 

 

 

9,831

 

Benefit plans

 

 

 

 

 

2,384

 

 

 

2,280

 

Compensation

 

 

 

 

 

938

 

 

 

1,246

 

Stock-based compensation

 

 

 

 

 

2,072

 

 

 

1,973

 

Uncollected interest

 

 

 

 

 

1,261

 

 

 

1,070

 

Depreciation

 

 

 

 

 

553

 

 

 

-

 

Charitable contribution carryover

 

 

 

 

 

-

 

 

 

186

 

Net operating loss carryover

 

 

 

 

 

33

 

 

 

919

 

Capital loss carryforward

 

 

 

 

 

318

 

 

 

814

 

Other items

 

 

 

 

 

868

 

 

 

587

 

 

 

 

 

 

 

36,962

 

 

 

34,537

 

Valuation allowance

 

 

 

 

 

(540

)

 

 

(1,258

)

 

 

 

 

 

 

36,422

 

 

 

33,279

 

Deferred income tax liabilities:

 

 

 

 

 

 

 

 

 

 

 

Deferred loan fees and costs

 

 

 

 

 

568

 

 

 

1,584

 

Accumulated other comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

Derivatives

 

 

 

 

 

-

 

 

 

1,094

 

Unrealized gain on securities available for sale

 

 

 

 

 

3,234

 

 

 

573

 

Goodwill

 

 

 

 

 

4,654

 

 

 

4,608

 

Other items

 

 

 

 

 

816

 

 

 

53

 

 

 

 

 

 

 

9,272

 

 

 

7,912

 

Net deferred income tax asset

 

 

 

 

$

27,150

 

 

$

25,367

 

 

- 39 -

18.     FAIR VALUE OF FINANCIAL INSTRUMENTS

In January 2016, the FASB issued ASU 2016-01, “Financial Instruments”. This guidance amends existing guidance to improve accounting standards for financial instruments including clarification and simplification of accounting and disclosure requirements and the requirement for public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes. The Company adopted the guidance effective July 1, 2018.  Upon adoption, the fair value of the Company’s loan portfolio is now presented using an exit price method.

 

Fair value is the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. There are three levels of inputs that may be used to measure fair values: 

 

 

Level 1:

  

Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date.

 

 

Level 2:

  

Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability or inputs that are derived principally from, or corroborated by, market data by correlation or other means.

 

 

Level 3:

  

Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation.

 

 

Assets Measured on a Recurring Basis:

The following methods and significant assumptions were used to estimate the fair values of the Company’s assets measured at fair value on a recurring basis at March 31, 2020 and June 30, 2019:

Investment Securities Available for Sale

The Company’s available for sale investment securities are reported at fair value utilizing Level 2 inputs. For these securities, the Company obtains fair value measurements from an independent pricing service. The fair value measurements consider observable data that may include dealer quotes, market spreads, cash flows, the U.S. Treasury yield curve, live trading levels, trade execution data, market consensus prepayment speeds, credit information and the securities’ terms and conditions, among other things.  From time to time, the Company validates prices supplied by the independent pricing service by comparison to prices obtained from third-party sources or derived using internal models.

Derivatives

The Company has contracted with a third party vendor to provide periodic valuations for its interest rate derivatives to determine the fair value of its interest rate caps and swaps. The vendor utilizes standard valuation methodologies applicable to interest rate derivatives such as discounted cash flow analysis and extensions of the Black-Scholes model. Such valuations are based upon readily observable market data and are therefore considered Level 2 valuations by the Company.  

- 40 -

 

Those assets measured at fair value on a recurring basis are summarized below:

 

 

March 31, 2020

 

 

Quoted

Prices

in Active

Markets for

Identical

Assets

(Level 1)

 

 

Significant

Other

Observable

Inputs

(Level 2)

 

 

Significant

Unobservable

Inputs

(Level 3)

 

 

Total

 

 

(In Thousands)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt securities available for sale:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Obligations of state and political subdivisions

 

-

 

 

 

58,151

 

 

 

-

 

 

 

58,151

 

Asset-backed securities

 

-

 

 

 

169,102

 

 

 

-

 

 

 

169,102

 

Collateralized loan obligations

 

-

 

 

 

189,565

 

 

 

-

 

 

 

189,565

 

Corporate bonds

 

-

 

 

 

163,715

 

 

 

-

 

 

 

163,715

 

Trust preferred securities

 

-

 

 

 

2,852

 

 

 

-

 

 

 

2,852

 

Total debt securities

 

-

 

 

 

583,385

 

 

 

-

 

 

 

583,385

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mortgage-backed securities available for sale:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Collateralized mortgage obligations

 

-

 

 

 

34,671

 

 

 

-

 

 

 

34,671

 

Residential pass-through securities

 

-

 

 

 

607,113

 

 

 

-

 

 

 

607,113

 

Commercial pass-through securities

 

-

 

 

 

251,175

 

 

 

-

 

 

 

251,175

 

Total mortgage-backed securities

 

-

 

 

 

892,959

 

 

 

-

 

 

 

892,959

 

Total securities available for sale

$

-

 

 

$

1,476,344

 

 

$

-

 

 

$

1,476,344

 

Interest rate swaps and caps

 

-

 

 

 

535

 

 

 

-

 

 

 

535

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets

$

-

 

 

$

1,476,879

 

 

$

-

 

 

$

1,476,879

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps

$

-

 

 

$

15,372

 

 

$

-

 

 

$

15,372

 

Total liabilities

$

-

 

 

$

15,372

 

 

$

-

 

 

$

15,372

 

 

 

- 41 -

 

June 30, 2019

 

 

Quoted Prices

in Active

Markets for

Identical

Assets

(Level 1)

 

 

Significant

Other

Observable

Inputs

(Level 2)

 

 

Significant

Unobservable

Inputs

(Level 3)

 

 

Total

 

 

(In Thousands)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt securities available for sale:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. agency securities

$

-

 

 

$

3,678

 

 

$

-

 

 

$

3,678

 

Obligations of state and political subdivisions

 

-

 

 

 

26,951

 

 

 

-

 

 

 

26,951

 

Asset-backed securities

 

-

 

 

 

179,313

 

 

 

-

 

 

 

179,313

 

Collateralized loan obligations

 

-

 

 

 

208,611

 

 

 

-

 

 

 

208,611

 

Corporate bonds

 

-

 

 

 

122,024

 

 

 

-

 

 

 

122,024

 

Trust preferred securities

 

-

 

 

 

2,756

 

 

 

1,000

 

 

 

3,756

 

Total debt securities

 

-

 

 

 

543,333

 

 

 

1,000

 

 

 

544,333

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mortgage-backed securities available for sale:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Collateralized mortgage obligations

 

-

 

 

 

21,390

 

 

 

-

 

 

 

21,390

 

Residential pass-through securities

 

-

 

 

 

44,303

 

 

 

-

 

 

 

44,303

 

Commercial pass-through securities

 

-

 

 

 

104,237

 

 

 

-

 

 

 

104,237

 

Total mortgage-backed securities

 

-

 

 

 

169,930

 

 

 

-

 

 

 

169,930

 

Total securities available for sale

 

-

 

 

 

713,263

 

 

 

1,000

 

 

 

714,263

 

Interest rate swaps

 

-

 

 

 

3,856

 

 

 

-

 

 

 

3,856

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets

$

-

 

 

$

717,119

 

 

$

1,000

 

 

$

718,119

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps

$

-

 

 

$

140

 

 

$

-

 

 

$

140

 

Total liabilities

$

-

 

 

$

140

 

 

$

-

 

 

$

140

 

 

Assets Measured on a Non-Recurring Basis:

The following methods and assumptions were used to estimate the fair values of the Company’s assets measured at fair value on a non-recurring basis at March 31, 2020 and June 30, 2019:

Impaired Loans

An impaired loan is evaluated and valued at the time the loan is identified as impaired at the lower of cost or fair value. Loans for which it is probable that payment of interest and principal will not be made in accordance with the contractual terms of the loan agreement are considered impaired. Fair value is measured based on the value of the collateral securing the loan and is classified at a Level 3 in the fair value hierarchy. Once a loan is identified as individually impaired, management measures impairment in accordance with the FASB’s guidance on accounting by creditors for impairment of a loan with the fair value estimated using the fair value of the collateral reduced by estimated disposal costs.  Those impaired loans not requiring an allowance represent loans for which the fair value of the expected repayments or collateral exceeds the recorded investments in such loans. Impaired loans are reviewed and evaluated on at least a quarterly basis for additional impairment and adjusted accordingly.

 

- 42 -

Other Real Estate Owned  

Other real estate owned (“OREO”) is recorded at estimated fair value, less estimated selling costs when acquired, thus establishing a new cost basis. Fair value is generally based on independent appraisals. These appraisals include adjustments to comparable assets based on the appraisers’ market knowledge and experience.  When an asset is acquired, the excess of the loan balance over fair value, less estimated selling costs, is charged to the allowance for loan losses. If further declines in the estimated fair value of the asset occur, a write-down is recorded through expense. The valuation of foreclosed assets is subjective in nature and may be adjusted in the future because of changes in economic conditions.

 

Those assets measured at fair value on a non-recurring basis are summarized below:

 

 

March 31, 2020

 

 

Quoted Prices

in Active

Markets for

Identical

Assets

(Level 1)

 

 

Significant

Other

Observable

Inputs

(Level 2)

 

 

Significant

Unobservable

Inputs

(Level 3)

 

 

Total

 

 

(In Thousands)

 

Impaired loans:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential mortgage

$

-

 

 

$

-

 

 

$

2,371

 

 

$

2,371

 

Non-residential mortgage

 

-

 

 

 

-

 

 

 

791

 

 

 

791

 

Commercial business

 

-

 

 

 

-

 

 

 

92

 

 

 

92

 

Total

$

-

 

 

$

-

 

 

$

3,254

 

 

$

3,254

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other real estate owned, net:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential mortgage

$

-

 

 

$

-

 

 

$

178

 

 

$

178

 

Total

$

-

 

 

$

-

 

 

$

178

 

 

$

178

 

 

 

June 30, 2019

 

 

Quoted Prices

in Active

Markets for

Identical

Assets

(Level 1)

 

 

Significant

Other

Observable

Inputs

(Level 2)

 

 

Significant

Unobservable

Inputs

(Level 3)

 

 

Total

 

 

(In Thousands)

 

Impaired loans:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential mortgage

$

-

 

 

$

-

 

 

$

3,071

 

 

$

3,071

 

Non-residential mortgage

 

-

 

 

 

-

 

 

 

791

 

 

 

791

 

Commercial business

 

-

 

 

 

-

 

 

 

16

 

 

 

16

 

Total

$

-

 

 

$

-

 

 

$

3,878

 

 

$

3,878

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

- 43 -

The following table presents additional quantitative information about assets measured at fair value on a non-recurring basis and for which the Company has utilized adjusted Level 3 inputs to determine fair value:

 

 

March 31, 2020

 

 

Fair

Value

 

 

Valuation

Techniques

 

Unobservable

Input

 

Range

 

 

Weighted

Average

 

 

(In Thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

Impaired loans:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential mortgage

$

2,371

 

 

Market valuation of

underlying collateral

(1)

Adjustments to reflect current

conditions/selling costs

(2)

6% - 8 %

 

 

 

7.40

%

Non-residential mortgage

 

791

 

 

Market valuation of

underlying collateral

(1)

Adjustments to reflect current

conditions/selling costs

(2)

10% - 11%

 

 

 

10.98

%

Commercial business

 

92

 

 

Market valuation of

underlying collateral

(1)

Adjustments to reflect current

conditions/selling costs

(2)

9% - 10%

 

 

 

9.35

%

Total

$

3,254

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other real estate owned, net:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential mortgage

$

178

 

 

Market valuation of

underlying collateral

(3)

Adjustments to reflect current

conditions/selling costs

(2)

6.00%

 

 

 

6.00

%

Total

$

178

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

June 30, 2019

 

 

Fair

Value

 

 

Valuation

Techniques

 

Unobservable

Input

 

Range

 

Weighted

Average

 

 

(In Thousands)

 

 

 

 

 

 

 

 

 

 

 

Impaired loans:

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential mortgage

$

3,071

 

 

Market valuation of

underlying collateral

(1)

Adjustments to reflect current

conditions/selling costs

(2)

6% - 8%

 

 

7.03

%

Non-residential mortgage

 

791

 

 

Market valuation of

underlying collateral

(1)

Adjustments to reflect current

conditions/selling costs

(2)

10% - 11%

 

 

10.08

%

Commercial business

 

16

 

 

Market valuation of

underlying collateral

(1)

Adjustments to reflect current

conditions/selling costs

(2)

9% - 10%

 

 

9.36

%

Total

$

3,878

 

 

 

 

 

 

 

 

 

 

 

 

(1)

The fair value of impaired loans is generally determined based on an independent appraisal of the fair value of a loan’s underlying collateral.

(2)

The fair value basis of impaired loans and other real estate owned is adjusted to reflect management’s estimates of selling costs including, but not necessarily limited to, real estate brokerage commissions and title transfer fees.

(3)

The fair value basis of other real estate owned is generally determined based upon the lower of an independent appraisal of the property’s fair value or the applicable listing price or contracted sales price.

 

At March 31, 2020, impaired loans valued using Level 3 inputs comprised loans with principal balances totaling $3.3 million and valuation allowances of $16,000 reflecting fair values of $3.3 million. By comparison, at June 30, 2019, impaired loans valued using Level 3 inputs comprised loans with principal balances totaling $3.9 million and valuation allowances of $31,000 reflecting fair values of $3.9 million.

Once a loan is foreclosed, the fair value of the other real estate owned continues to be evaluated based upon the fair value of the repossessed real estate originally securing the loan.  At March 31, 2020, the Company held other real estate owned totaling $178,000 whose carrying value was written down utilizing Level 3 inputs.  At June 30, 2019, the Company held no other real estate owned whose carrying value was written down utilizing Level 3 inputs.

 

- 44 -

The following presents the carrying amount, fair value, and placement in the fair value hierarchy of the Company’s financial instruments as of March 31, 2020 and June 30, 2019:

 

 

March 31, 2020

 

 

Carrying

Amount

 

 

Fair

Value

 

 

Quoted

Prices

in Active

Markets for

Identical

Assets

(Level 1)

 

 

Significant

Other

Observable

Inputs

(Level 2)

 

 

Significant

Unobservable

Inputs

(Level 3)

 

 

(In Thousands)

 

Financial assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

$

59,452

 

 

$

59,452

 

 

$

59,452

 

 

$

-

 

 

$

-

 

Investment securities available for sale

 

1,476,344

 

 

 

1,476,344

 

 

 

-

 

 

 

1,476,344

 

 

 

-

 

Investment securities held to maturity

 

34,618

 

 

 

35,433

 

 

 

-

 

 

 

35,433

 

 

 

-

 

Loans held-for-sale

 

11,245

 

 

 

11,318

 

 

 

-

 

 

 

11,318

 

 

 

-

 

Net loans receivable

 

4,525,321

 

 

 

4,512,519

 

 

 

-

 

 

 

-

 

 

 

4,512,519

 

FHLB Stock

 

59,324

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Interest receivable

 

19,036

 

 

 

19,036

 

 

 

-

 

 

 

5,413

 

 

 

13,623

 

Interest rate swaps and caps

 

535

 

 

 

535

 

 

 

-

 

 

 

535

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deposits

 

4,253,254

 

 

 

4,277,611

 

 

 

2,305,194

 

 

 

-

 

 

 

1,972,417

 

Borrowings

 

1,384,025

 

 

 

1,421,194

 

 

 

-

 

 

 

-

 

 

 

1,421,194

 

Interest payable on deposits

 

749

 

 

 

749

 

 

 

415

 

 

 

-

 

 

 

334

 

Interest payable on borrowings

 

3,019

 

 

 

3,019

 

 

 

-

 

 

 

-

 

 

 

3,019

 

Interest rate swaps

 

15,372

 

 

 

15,372

 

 

 

-

 

 

 

15,372

 

 

 

-

 

 

 

 

June 30, 2019

 

 

Carrying

Amount

 

 

Fair

Value

 

 

Quoted

Prices

in Active

Markets for

Identical

Assets

(Level 1)

 

 

Significant

Other

Observable

Inputs

(Level 2)

 

 

Significant

Unobservable

Inputs

(Level 3)

 

 

(In Thousands)

 

Financial assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

$

38,935

 

 

$

38,935

 

 

$

38,935

 

 

$

-

 

 

$

-

 

Investment securities available for sale

 

714,263

 

 

 

714,263

 

 

 

-

 

 

 

713,263

 

 

 

1,000

 

Investment securities held to maturity

 

576,652

 

 

 

584,678

 

 

 

-

 

 

 

584,678

 

 

 

-

 

Loans held-for-sale

 

12,267

 

 

 

12,501

 

 

 

-

 

 

 

12,501

 

 

 

-

 

Net loans receivable

 

4,645,654

 

 

 

4,630,853

 

 

 

-

 

 

 

-

 

 

 

4,630,853

 

FHLB Stock

 

64,190

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Interest receivable

 

19,360

 

 

 

19,360

 

 

 

11

 

 

 

5,278

 

 

 

14,071

 

Interest rate swaps

 

3,856

 

 

 

3,856

 

 

 

-

 

 

 

3,856

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deposits

 

4,147,610

 

 

 

4,152,558

 

 

 

1,943,154

 

 

 

-

 

 

 

2,209,404

 

Borrowings

 

1,321,982

 

 

 

1,337,560

 

 

 

-

 

 

 

-

 

 

 

1,337,560

 

Interest payable on deposits

 

3,106

 

 

 

3,106

 

 

 

367

 

 

 

-

 

 

 

2,739

 

Interest payable on borrowings

 

3,899

 

 

 

3,899

 

 

 

-

 

 

 

-

 

 

 

3,899

 

Interest rate swaps

 

140

 

 

 

140

 

 

 

-

 

 

 

140

 

 

 

-

 

 

- 45 -

Commitments. The fair value of commitments to fund credit lines and originate or participate in loans held in portfolio or loans held for sale is estimated using fees currently charged to enter into similar agreements taking into account the remaining terms of the agreements and the present creditworthiness of the counterparties. For fixed rate loan commitments, including those relating to loans held for sale that are considered derivative instruments for financial statement reporting purposes, the fair value also considers the difference between current levels of interest and the committed rates. The carrying value, represented by the net deferred fee arising from the unrecognized commitment, and the fair value, determined by discounting the remaining contractual fee over the term of the commitment using fees currently charged to enter into similar agreements with similar credit risk, is not considered material for disclosure.

Limitations. Fair value estimates are made at a specific point in time based on relevant market information and information about the financial instruments. These estimates do not reflect any premium or discount that could result from offering for sale at one time the entire holdings of a particular financial instrument. Because no fair value exists for a significant portion of the financial instruments, fair value estimates are based on judgments regarding future expected loss experience, current economic conditions, risk characteristics of various financial instruments and other factors. These estimates are subjective in nature, involve uncertainties and matters of judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

The fair value estimates are based on existing on-and-off balance sheet financial instruments without attempting to value anticipated future business and the value of assets and liabilities that are not considered financial instruments. Other significant assets and liabilities that are not considered financial assets and liabilities include premises and equipment, and advances from borrowers for taxes and insurance. In addition, the ramifications related to the realization of the unrealized gains and losses can have a significant effect on fair value estimates and have not been considered in any of the estimates.

Finally, reasonable comparability between financial institutions may not be likely due to the wide range of permitted valuation techniques and numerous estimates which must be made given the absence of active secondary markets for many of the financial instruments. This lack of uniform valuation methodologies introduces a greater degree of subjectivity to these estimated fair values.

 

 

 

19.     COMPREHENSIVE (LOSS) INCOME

The components of accumulated other comprehensive (loss) income included in stockholders’ equity at March 31, 2020 and June 30, 2019 are as follows:

 

 

March 31,

 

 

June 30,

 

 

2020

 

 

2019

 

 

(In Thousands)

 

Net unrealized gain on securities available for sale

$

11,030

 

 

$

1,975

 

Tax effect

 

(3,234

)

 

 

(573

)

Net of tax amount

 

7,796

 

 

 

1,402

 

 

 

 

 

 

 

 

 

Net unrealized loss on securities available for sale

  transferred to held to maturity

 

-

 

 

 

(596

)

Tax effect

 

-

 

 

 

175

 

Net of tax amount

 

-

 

 

 

(421

)

 

 

 

 

 

 

 

 

Fair value adjustments on derivatives

 

(16,312

)

 

 

3,716

 

Tax effect

 

4,814

 

 

 

(1,094

)

Net of tax amount

 

(11,498

)

 

 

2,622

 

 

 

 

 

 

 

 

 

Benefit plan adjustments

 

(598

)

 

 

(1,083

)

Tax effect

 

175

 

 

 

319

 

Net of tax amount

 

(423

)

 

 

(764

)

 

 

 

 

 

 

 

 

Total accumulated other comprehensive (loss) income

$

(4,125

)

 

$

2,839

 

 

 

- 46 -

 

Other comprehensive loss and related tax effects for the three and nine months ended March 31, 2020 and March 31, 2019 are presented in the following table:

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

March 31,

 

 

March 31,

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

(In Thousands)

 

 

(In Thousands)

 

Net unrealized holding gain on securities

  available for sale

$

3,975

 

 

$

5,122

 

 

$

11,286

 

 

$

1,453

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization of net unrealized holding loss on

  securities available for sale transferred to held

  to maturity (1)

 

-

 

 

 

54

 

 

 

596

 

 

 

221

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net realized (gain) loss on sale and call of securities

  available for sale

 

(2,234

)

 

 

182

 

 

 

(2,231

)

 

 

182

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value adjustments on derivatives

 

(18,742

)

 

 

(7,139

)

 

 

(20,028

)

 

 

(16,913

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Benefit plans:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization of actuarial loss

 

4

 

 

 

11

 

 

 

14

 

 

 

33

 

Net actuarial loss (2)

 

-

 

 

 

-

 

 

 

471

 

 

 

(59

)

Net change in benefit plan accrued expense

 

4

 

 

 

11

 

 

 

485

 

 

 

(26

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive loss before taxes

 

(16,997

)

 

 

(1,770

)

 

 

(9,892

)

 

 

(15,083

)

Tax effect (3)

 

4,917

 

 

 

547

 

 

 

2,928

 

 

 

4,127

 

Total other comprehensive loss

$

(12,080

)

 

$

(1,223

)

 

$

(6,964

)

 

$

(10,956

)

 

(1)

Represents amounts reclassified out of accumulated other comprehensive income and included in interest income on taxable securities.

(2)

Represents amounts reclassified out of accumulated other comprehensive income and included in the computation of net periodic pension expense.  See Note 16 – Benefit Plans for additional information.

(3)

The amounts included in income taxes for items reclassified out of accumulated other comprehensive income totaled $(658) and $(515)for the three and nine months ended March 31, 2020, respectively, and $57 and $34 for the three and nine months ended March 31, 2019, respectively.

 

 

- 47 -

20.     REVENUE RECOGNITION

Effective July 1, 2018, the Company adopted ASU 2014-09 Revenue from Contracts with Customers and all subsequent amendments to the ASU (collectively, "ASC 606”), which (i) creates a single framework for recognizing revenue from contracts with customers that fall within its scope and (ii) revises when it is appropriate to recognize a gain (loss) from the transfer of nonfinancial assets, such as OREO. The majority of the Company’s revenues come from interest income and other sources, including loans, leases, securities, and derivatives that are outside the scope of ASC 606. The Company’s services that fall within the scope of ASC 606 are presented within non-interest income and are recognized as revenue as the Company satisfies its obligation to the customer. Services within the scope of ASC 606 include deposit service charges on deposits, interchange income, and the sale of OREO.

The Company, using a modified retrospective transition approach, determined that there was no cumulative effect adjustment to retained earnings as a result of adopting the new standard, nor did the standard have a material impact on our consolidated financial statements including the timing or amounts of revenue recognized.

All of the Company’s revenue from contracts with customers within the scope of ASC 606 is recognized within non-interest income. The following table presents the Company’s sources of non-interest income for the three and nine months ended March 31, 2020 and 2019.  Sources of revenue outside the scope of ASC 606 are noted as such.

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

March 31,

 

 

March 31,

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

(In Thousands)

 

 

(In Thousands)

 

Non-interest income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deposit-related fees and charges

$

423

 

 

$

376

 

 

$

1,362

 

 

$

1,126

 

Loan-related fees and charges (1)

 

915

 

 

 

1,298

 

 

 

3,589

 

 

 

2,979

 

Gain (loss) on sale and call of securities (1)

 

2,234

 

 

 

(182

)

 

 

2,231

 

 

 

(182

)

Gain on sale of loans (1)

 

565

 

 

 

151

 

 

 

1,838

 

 

 

384

 

Loss on sale and write down of other real estate owned

 

-

 

 

 

(6

)

 

 

(28

)

 

 

(20

)

Income from bank owned life insurance (1)

 

1,532

 

 

 

1,560

 

 

 

4,688

 

 

 

4,753

 

Electronic banking fees and charges (interchange income)

 

309

 

 

 

253

 

 

 

920

 

 

 

780

 

Miscellaneous (1)

 

223

 

 

 

226

 

 

 

117

 

 

 

347

 

Total non-interest income

$

6,201

 

 

$

3,676

 

 

$

14,717

 

 

$

10,167

 

 

(1)

Not within the scope of ASC 606.

A description of the Company’s revenue streams accounted for under ASC 606 is as follows:

Service Charges on Deposit Accounts

The Company earns fees from deposit customers for transaction-based, account maintenance, and overdraft services. Transaction-based fees, which include services such as ATM use fees, stop payment charges, statement rendering, and ACH fees, are recognized at the time the transaction is executed at the point in the time the Company fulfills the customer’s request. Account maintenance fees, which relate primarily to monthly maintenance, are earned over the course of a month, representing the period over which the Company satisfies the performance obligation. Overdraft fees are recognized at the point in time that the overdraft occurs. Service charges on deposits are withdrawn from the customer’s account balance.

- 48 -

Gains/Losses on Sales of OREO

The Company records a gain or loss from the sale of OREO when control of the property transfers to the buyer, which generally occurs at the time of an executed deed. Gain/Losses on the sales of OREO falls within the scope of ASC 606, if the Company finances the transaction.  Under ASC 606, if the Company finances the sale of OREO to the buyer, the Company is required to assess whether the buyer is committed to perform their obligations under the contract and whether the collectability of the transaction price is probable. Once these criteria are met, the OREO asset is derecognized and the gain or loss on sale is recorded upon the transfer of control of the property to the buyer. In determining the gain or loss on the sale, the Company adjusts the transaction price and related gain (loss) on sale if a significant financing component is present. Generally, the Company does not finance the sale of OREO properties.

Interchange Income

The Company earns interchange fees from debit and credit card holder transactions conducted through various payment networks. Interchange fees from cardholder transactions are recognized daily, concurrently with the transaction processing services provided by an outsourced technology solution.

 

 

- 49 -

 

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Forward-Looking Statements

This Quarterly Report on Form 10-Q may include certain forward-looking statements based on current management expectations. Such forward-looking statements may be identified by reference to a future period or periods or by the use of forward-looking terminology, such as “may”, “will”, “believe”, “expect”, “estimate”, “anticipate”, “continue”, or similar terms or variations on those terms, or the negative of those terms. The actual results of the Company could differ materially from those management expectations.  This includes statements regarding the planned merger of MSB Financial Corp. (“MSBF”) with and into the Company, with the Company surviving the merger as the surviving corporation (the “Merger”). Factors that could cause future results to vary from current management expectations include, but are not limited to, the inability to obtain approvals and/or meet the other closing conditions required to close the Merger in a timely manner, general economic conditions, public health crisis such as the governmental, social and economic effects of the novel coronavirus, legislative and regulatory changes, monetary and fiscal policies of the federal government, changes in tax policies, rates and regulations of federal, state and local tax authorities and failure to integrate or profitably operate acquired businesses. Additional potential factors include changes in interest rates, deposit flows, cost of funds, demand for loan products and financial services, competition and changes in the quality or composition of loan and investment portfolios of the Company. Other factors that could cause future results to vary from current management expectations include changes in accounting principles, policies or guidelines, and other economic, competitive, governmental and technological factors affecting the Company’s operations, markets, products, services and prices.  Further description of the risks and uncertainties to the business are included in the Company’s other filings with the Securities and Exchange Commission and under Item 1A. Risk Factors of the Quarterly Report on Form 10-Q.

Except as required by applicable law or regulation, the Company does not undertake, and specifically disclaims any obligation, to release publicly the result of any revisions that may be made to any forward-looking statements to reflect events or circumstances after the date of the statements or to reflect the occurrence of anticipated or unanticipated events.

Proposed Acquisition of MSBF

On December 18, 2019, the Company and MSBF, the holding company for Millington Bank, announced that the companies had entered into a definitive agreement pursuant to which the Company will acquire MSBF. Consideration will be paid to MSBF stockholders in a combination of stock and cash. Under the terms of merger agreement MSBF will merge with and into the Company and each outstanding share of MSBF common stock will be exchanged for 1.3 shares of the Company’s common stock or $18.00 in cash. MSBF stockholders may elect cash or stock, or a combination thereof, subject to proration to ensure that, in the aggregate, 10% of MSBF shares will be converted into cash and 90% of MSBF shares will be converted into the Company’s common stock. Upon closing, the Company’s stockholders holders will own approximately 94% of the combined company and MSBF stockholders will own approximately 6% of the combined company.

As of March 31, 2020, MSBF had approximately $600.4 million of assets, gross loans of $528.9 million and deposits of $447.4 million and operated four New Jersey branches located in Somerset and Morris counties. The Merger is expected to close late in the quarter ended June 30, 2020 or early in the quarter ended September 30, 2020, subject to MSBF receiving the requisite approval of its shareholders, receipt of all regulatory approvals and fulfillment of other customary closing conditions.

Impact of COVID-19

As the Company’s business is primarily conducted within the states of New Jersey and New York, and those states have been significantly impacted by COVID-19, the operations of the Company have been similarly impacted.

Employee Matters.  As the COVID-19 pandemic has unfolded, and stay-at-home orders have been mandated by government officials, the majority of our non-branch personnel have transitioned to working remotely. Our information technology infrastructure has afforded us the ability to work remotely with little interruption as we continue to service the needs of our clients. For those essential employees who are unable to work from home, we have provided personal protective equipment, established guidelines to maintain appropriate social distancing and have initiated enhanced cleaning of our facilities to ensure a safe working environment.

Retail Branches.  Across our branch network, branch hours and access have been modified to ensure the safety of our employees and clients.  Where possible, branch lobbies have been transitioned to appointment-only access, with the majority of branch operations being conducted via our drive-up windows.  As certain branches do not have drive-up capabilities, or suitable alternatives, we have temporarily closed six of our 48 branches.

- 50 -

 

Coronavirus Aid, Relief and Economic Security Act (“CARES Act”) and Paycheck Protection Program and Health Care Enhancement Act (“PPP Enhancement Act”).  On March 27, 2020 the CARES Act was signed into law.  Among the more significant components of the CARES Act, as it pertains to the Company, was the creation of the Paycheck Protection Program (“PPP”), the modification of rules and regulations surrounding Troubled Debt Restructured loans and modifications to the tax code to allow for the carryback of net operating losses.

The CARES Act authorized the SBA to temporarily guarantee loans under a new 7(a) loan program called the Paycheck Protection Program.  As part of this program the SBA will guarantee 100% of the PPP loans made to eligible borrowers. As a qualified SBA lender, the Bank is automatically authorized to originate PPP loans. On April 16, 2020, the original authorization of $349 billion in funding for the PPP program was exhausted. On April 23, 2020 the PPP Enhancement Act was signed into law and provided an additional $310 billion in funding for the PPP program. As of May 4, 2020 we had approved approximately 628 loans for $63.9 million under the PPP.

Under Section 4013 of the CARES Act, and based upon regulatory guidance promulgated by federal banking regulators, qualifying short-term loan modifications resulting in payment deferrals of up to six months, that are attributable to the adverse impact of COVID-19, are not considered to be troubled debt restructurings. As such, the applicable loans are reported a current with regard to payment status and continue to accrue interest during the payment deferral period. Additional information regarding loans modified in accordance with this guidance are provided in the tables below.

The CARES Act included multiple provisions which impacted the tax code. One such provision restored net operating loss (“NOL”) carrybacks that were eliminated by the 2017 Tax Cuts and Jobs Act. The new carryback provision allows for a five year carryback of NOLs incurred by corporations in the 2018, 2019 and 2020 tax years. As a result of this provision the Company was able to carry back NOLs, which had been recorded at the current statutory federal rate of 21%, at the prior statutory rate of 34%. The difference between these two rates, multiplied by the amount of the NOL, totaled $1.6 million and was recorded as a credit to income tax expense in the current period.

Loan Portfolio.  The government-mandated closure of certain businesses and the curtailment of non-essential travel has created an increased level of risk to certain segments of the loan portfolio. Additional disclosures surrounding portfolio-wide loan-to-value ratios for real estate secured loans, non-TDR loan modifications granted under section 4013 of the CARES Act and exposures to certain sectors are provided below.

The following table sets forth the composition of our real estate secured loans indicating the loan-to-value, by loan category, at March 31, 2020:

 

 

March 31, 2020

 

 

Balance

 

 

LTV

 

 

(In Thousands)

 

 

 

 

 

Residential mortgage loans:

 

 

 

 

 

 

 

One- to four-family residential mortgage

$

1,338,099

 

 

 

59

%

Home equity loans and lines of credit

 

87,909

 

 

 

42

%

Total residential mortgage loans

 

1,426,008

 

 

 

58

%

 

 

 

 

 

 

 

 

Commercial mortgage loans:

 

 

 

 

 

 

 

Multi-family commercial mortgage loans

 

1,879,907

 

 

 

64

%

Nonresidential commercial mortgage loans

 

1,202,652

 

 

 

55

%

Total commercial mortgage loans

 

3,082,559

 

 

 

60

%

 

 

 

 

 

 

 

 

Total mortgage loans

$

4,508,567

 

 

 

60

%

 

 

 

 

 

 

 

 

 

 

- 51 -

 

 

The following table identifies our exposure, at March 31, 2020, to various loan sectors:

 

 

March 31, 2020

 

 

Real-Estate Secured

 

 

Non-Real Estate Secured

 

 

Total

 

 

# of Loans

 

 

Balance

 

 

LTV

 

 

# of Loans

 

 

Balance

 

 

# of Loans

 

Balance

 

 

(Dollars In Thousands)

 

Hotel

 

4

 

 

$

4,494

 

 

 

51

%

 

 

6

 

 

$

1,537

 

 

 

10

 

$

6,031

 

Restaurant

 

15

 

 

 

9,671

 

 

 

52

%

 

 

38

 

 

 

3,849

 

 

 

53

 

 

13,520

 

Retail shopping center

 

116

 

 

 

304,929

 

 

 

54

%

 

 

2

 

 

 

60

 

 

 

118

 

 

304,989

 

Entertainment & recreation

 

4

 

 

 

5,318

 

 

 

44

%

 

 

14

 

 

 

1,207

 

 

 

18

 

 

6,525

 

Wholesale commercial business

 

-

 

 

 

-

 

 

 

 

 

 

 

15

 

 

 

21,306

 

 

 

15

 

 

21,306

 

Wholesale consumer unsecured

 

-

 

 

 

-

 

 

 

 

 

 

 

150

 

 

 

706

 

 

 

150

 

 

706

 

Total commercial loans

 

139

 

 

$

324,412

 

 

 

53

%

 

 

225

 

 

$

28,665

 

 

 

364

 

$

353,077

 

 

 

The following table identifies, at May 4, 2020, the number and balance of non-TDR loan modifications granted under section 4013 of the CARES Act:

 

 

May 4, 2020

 

 

# of Loans

 

 

Balance

 

 

 

 

 

 

(In Thousands)

 

Residential mortgage loans:

 

 

 

 

 

 

 

One- to four-family residential mortgage

 

305

 

 

$

126,647

 

Home equity loans and lines of credit

 

37

 

 

 

2,409

 

Total residential mortgage loans

 

342

 

 

 

129,056

 

 

 

 

 

 

 

 

 

Commercial loans:

 

 

 

 

 

 

 

Multi-family commercial mortgage loans

 

80

 

 

 

199,797

 

Nonresidential commercial mortgage loans

 

133

 

 

 

286,255

 

Commercial business

 

46

 

 

 

6,770

 

Construction

 

1

 

 

 

796

 

Total commercial loans

 

260

 

 

 

493,618

 

 

 

 

 

 

 

 

 

Total loans

 

602

 

 

$

622,674

 

 

 

Comparison of Financial Condition at March 31, 2020 and June 30, 2019

Executive Summary.  Total assets increased by $139.0 million to $6.77 billion at March 31, 2020 from $6.63 billion at June 30, 2019.  The net increase in total assets primarily reflected increases in cash and cash equivalents, investment securities and other assets partially offset by decreases in the balance of loans held-for-sale and loans receivable.

Wholesale Restructuring Transaction.  During the quarter ended March 31, 2020 the Company executed a wholesale restructuring transaction designed to enhance net interest income and reduce credit risk within the investment portfolio.  During the first phase of the transaction, $158.4 million of investment securities with a weighted average yield of 2.63% were sold and a portion of the proceeds utilized to extinguish $121.5 million of Federal Home Loan Bank (“FHLB”) advances with a weighted average cost of 2.84%.  Gains on sale of investment securities and debt extinguishment losses each totaled $2.2 million, resulting in a negligible impact on pre-tax net income.  During the second phase of the transaction, $248.7 million of US agency-backed mortgage-backed securities were purchased at a weighted average yield of 2.77% and were funded with a combination of FHLB advances, brokered time deposits and overnight borrowings at a weighted average cost of 1.65%.

- 52 -

 

Investment Securities.  Investment securities classified as available for sale increased by $762.1 million to $1.48 billion at March 31, 2020 from $714.3 million at June 30, 2019. The net increase in the portfolio partially reflected the adoption of ASU 2019-04 on July 1, 2019, upon which the Company reclassified $537.7 million of investment securities from held to maturity to available for sale.  In addition, the net increase in the portfolio during the nine months ended March 31, 2020 reflected security purchases totaling $487.9 million and a $9.1 million increase in the fair value of the portfolio to a net unrealized gain of $11.1 million.  The net increase in the portfolio was partially offset by security sales totaling $162.1 million and $110.5 million in principal repayment, net of premium amortization and discount accretion.

Investment securities classified as held to maturity decreased by $542.0 million to $34.6 million at March 31, 2020 from $576.7 million at June 30, 2019.  The decrease in held to maturity securities largely reflected the adoption of ASU 2019-04, as noted above. The decrease in the portfolio for the nine months ended March 31, 2020 also reflected principal repayment, net of discount accretion and premium amortization, totaling $4.3 million.

Based on its evaluation, management has concluded that no other-than-temporary impairment was present within the investment portfolio as of March 31, 2020 or June 30, 2019.  Additional information regarding investment securities as of those dates is presented in Note 7, Note 8 and Note 9 to the unaudited consolidated financial statements.

Loans Held-for-Sale. Loans held-for-sale totaled $11.2 million at March 31, 2020 as compared to $12.3 million at June 30, 2019 and are reported separately from the balance of net loans receivable as of those dates.  During the nine months ended March 31, 2020, $174.5 million of residential mortgage loans were sold, resulting in net gains on sale of $1.8 million.  

Net Loans Receivable.  Loans receivable, net of unamortized premiums, deferred costs and the allowance for loan losses, decreased by $120.3 million to $4.52 billion at March 31, 2020 from $4.65 billion at June 30, 2019.  The decrease in net loans receivable was primarily attributable to elevated levels of loan prepayment activity outpacing new loan origination and purchase volume during the nine months ended March 31, 2020.  The detail of the changes in loan portfolio is presented below:

 

 

March 31,

 

 

June 30,

 

 

Increase/

 

 

2020

 

 

2019

 

 

(Decrease)

 

 

(In Thousands)

 

Residential mortgage loans:

 

 

 

 

 

 

 

 

 

 

 

One- to four-family residential mortgage

$

1,338,099

 

 

$

1,344,044

 

 

$

(5,945

)

Home equity loans and lines of credit

 

87,909

 

 

 

96,165

 

 

 

(8,256

)

Total residential mortgage loans

 

1,426,008

 

 

 

1,440,209

 

 

 

(14,201

)

 

 

 

 

 

 

 

 

 

 

 

 

Commercial loans:

 

 

 

 

 

 

 

 

 

 

 

Multi-family commercial mortgage loans

 

1,879,907

 

 

 

1,946,391

 

 

 

(66,484

)

Nonresidential commercial mortgage loans

 

1,202,652

 

 

 

1,258,869

 

 

 

(56,217

)

Commercial business

 

73,922

 

 

 

65,763

 

 

 

8,159

 

Construction

 

17,880

 

 

 

13,907

 

 

 

3,973

 

Total commercial loans

 

3,174,361

 

 

 

3,284,930

 

 

 

(110,569

)

 

 

 

 

 

 

 

 

 

 

 

 

Other consumer loans

 

4,604

 

 

 

5,814

 

 

 

(1,210

)

 

 

 

 

 

 

 

 

 

 

 

 

Total loans

 

4,604,973

 

 

 

4,730,953

 

 

 

(125,980

)

 

 

 

 

 

 

 

 

 

 

 

 

Deferred fees, premiums and other, net

 

(42,461

)

 

 

(52,025

)

 

 

9,564

 

Allowance for loan losses

 

(37,191

)

 

 

(33,274

)

 

 

(3,917

)

 

 

 

 

 

 

 

 

 

 

 

 

Net loans receivable

$

4,525,321

 

 

$

4,645,654

 

 

$

(120,333

)

 

- 53 -

 

Residential mortgage loan origination volume for the nine months ended March 31, 2020, excluding loans held-for-sale, totaled $182.4 million, comprising $168.6 million of one- to four-family first mortgage loan originations and $13.8 million of home equity loan and line of credit originations.  Residential mortgage loan originations for the period were augmented with the purchase of one- to four-family first mortgage loans totaling $14.1 million.

Commercial loan origination volume for the nine months ended March 31, 2020 totaled $242.5 million, which comprised $203.3 million of commercial mortgage loan originations augmented by $35.1 million of commercial business loan originations and construction loan disbursements totaling $4.1 million.  Commercial loan originations were augmented with the funding of purchased loans totaling $57.4 million during the nine months ended March 31, 2020.

Additional information about the Company’s loans at March 31, 2020 and June 30, 2019 is presented in Note 10 to the unaudited consolidated financial statements.

Nonperforming Loans.  Nonperforming loans increased by $15.1 million to $35.4 million, or 0.78% of total loans at March 31, 2020, from $20.3 million, or 0.43% of total loans at June 30, 2019.  The increase in non-performing loans was primarily attributable to a single, $14.3 million, owner-occupied commercial real estate loan which was placed on non-accrual status during the quarter ended March 31, 2020.  This loan is secured by a grocery-anchored retail shopping center located in northern New Jersey and has an original loan-to-value of approximately 55%.  

Nonperforming loans generally include those loans reported as 90 days and over past due while still accruing and loans reported as nonaccrual with such balances totaling $12,000 and $35.4 million, respectively, at March 31, 2020.  

Additional information about the Company’s nonperforming loans at March 31, 2020 and June 30, 2019 is presented in Note 11 to the unaudited consolidated financial statements.

Allowance for Loan Losses.  During the nine months ended March 31, 2020, the balance of the allowance for loan losses (“ALLL”) increased by $3.9 million to $37.2 million at March 31, 2020 from $33.3 million, at June 30, 2019, resulting in an ALLL to total loans ratio of 0.81% and 0.70% as of those dates, respectively. The increase resulted from a loan loss provision of $4.0 million during the nine months ended March 31, 2020 coupled with charge-offs and net of recoveries totaling $106,000 during that same period.

The portion of the allowance for loan losses attributable to loans individually evaluated for impairment decreased by $15,000 to $16,000 at March 31, 2020 from $31,000 at June 30, 2019.  This balance reflected an allowance for impairment on $184,000 of impaired loans while an additional $43.7 million of impaired loans had no allowance.  By comparison, the balance at June 30, 2019 reflected an allowance for impairment on $363,000 of impaired loans while an additional $24.2 million of impaired loans had no allowance for impairment.

The portion of the allowance for loan losses attributable to loans collectively evaluated for impairment increased by $4.0 million to $37.2 million at March 31, 2020 from $33.2 million at June 30, 2019.  This increase was attributable to changes in a combination of historical and environmental loss factors.  With regard to historical loss factors, our loan portfolio experienced an annualized net charge-off rate of 0.00% for the nine months ended March 31, 2020, a decrease of two basis points from the 0.02% rate for the year ended June 30, 2019.  The annual average net charge off rate for June 30, 2019 had previously decreased by one basis point from   0.03% for the prior year ended June 30, 2018.  The effect of the net change in historical loss factors resulted in a decrease in the applicable portion of the allowance attributable to these factors of approximately $813,000 to $1.3 million at March 31, 2020 from $2.1 million at June 30, 2019.

- 54 -

 

With regard to environmental loss factors, the Company made adjustments to various factors during the nine months ended March 31, 2020.  Most notably, the environmental factors associated with national and regional economic conditions were increased substantially in response to the economic impact of COVID-19.  The net effect of these adjustments, partially offset by a decrease in the balance of the unimpaired portion of the loan portfolio, resulted in a $4.8 million increase in the portion of the allowance for loan losses attributable to environmental loss factors to $35.9 million at March 31, 2020 from $31.1 million at June 30, 2019.

The calculation of probable incurred losses within a loan portfolio and the resulting allowance for loan losses is subject to estimates and assumptions that are susceptible to significant revisions as more information becomes available and as events or conditions effecting individual borrowers and the marketplace as a whole change over time.  Future additions to the allowance for loan losses may be necessary if economic and market conditions deteriorate in the future from those currently prevalent in the marketplace.  In addition, our banking regulators, as an integral part of their examination process, periodically review our loan and foreclosed real estate portfolios and the related allowance for loan losses and valuation allowance for foreclosed real estate.  The regulators may require the allowance for loan losses to be increased based on their review of information available at the time of the examination, which may negatively affect our earnings.  Finally, changes in accounting standards promulgated by the Financial Accounting Standards Board, such as those discussed in Note 6 to the unaudited consolidated financial statements regarding the use of a current expected credit loss (“CECL”) model to calculate credit losses, may require increases in the allowance for loan losses upon adoption of the applicable accounting standard.

Additional information about the allowance for loan losses at March 31, 2020 and June 30, 2019 is presented in Note 11 to the unaudited consolidated financial statements.

Other Assets.  The aggregate balance of other assets, including premises and equipment, FHLB stock, interest receivable, goodwill, core deposit intangibles, bank owned life insurance, deferred income taxes, other real estate owned and other assets, increased by $19.8 million to $666.9 million at March 31, 2020 from $647.1 million at June 30, 2019.  

The increase in other assets primarily reflected the adoption of a new accounting standard that requires leases to be recognized on our Consolidated Statements of Condition as a right of use asset and lease liability. Our operating lease right of use asset totaled approximately $16.8 million as of March 31, 2020.  The remaining increases and decreases in other assets for the nine months ended March 31, 2020 generally reflected normal operating fluctuations in their respective balances.

Additional information about the Company’s operating lease right of use asset at March 31, 2020 is presented in Note 12 to the unaudited consolidated financial statements.

Deposits.  Total deposits increased by $105.6 million to $4.25 billion at March 31, 2020 from $4.15 billion at June 30, 2019.  The following table sets forth the distribution of total deposit accounts, by account type, at the dates indicated:

 

 

March 31,

 

 

June 30,

 

 

Increase/

 

 

2020

 

 

 

2019

 

 

(Decrease)

 

 

(In Thousands)

 

Deposits:

 

 

 

 

 

 

 

 

 

 

 

Non-interest-bearing deposits

$

321,824

 

 

$

309,063

 

 

 

12,761

 

Interest-bearing demand

 

1,134,420

 

 

 

843,432

 

 

 

290,988

 

Savings

 

848,950

 

 

 

790,658

 

 

 

58,292

 

Certificates of deposit

 

1,948,060

 

 

 

2,204,457

 

 

 

(256,397

)

Interest-bearing deposits

 

3,931,430

 

 

 

3,838,547

 

 

 

92,883

 

Total deposits

$

4,253,254

 

 

$

4,147,610

 

 

$

105,644

 

 

- 55 -

 

The net increase in deposit balances for the nine months ended March 31, 2020 was comprised of changes in the balances of retail deposits as well as non-retail deposits acquired through various wholesale channels.  The reallocation of deposits for the nine months ended March 31, 2020 reflected the Company’s continued success in realigning its funding mix in favor of core deposits. The following table sets forth the distribution of total deposit accounts, by retail and wholesale deposits, at the dates indicated:

 

 

March 31,

 

 

June 30,

 

 

Increase/

 

 

2020

 

 

 

2019

 

 

(Decrease)

 

 

(In Thousands)

 

Retail deposits:

 

 

 

 

 

 

 

 

 

 

 

Non-interest-bearing demand

$

321,824

 

 

$

309,063

 

 

$

12,761

 

Interest-bearing demand

 

1,134,420

 

 

 

843,432

 

 

 

290,988

 

Savings

 

848,950

 

 

 

790,658

 

 

 

58,292

 

Certificates of deposits

 

1,833,081

 

 

 

1,902,542

 

 

 

(69,461

)

Total retail deposits

 

4,138,275

 

 

 

3,845,695

 

 

 

292,580

 

 

 

 

 

 

 

 

 

 

 

 

 

Wholesale deposits:

 

 

 

 

 

 

 

 

 

 

 

Certificates of deposits  - listing service

 

33,608

 

 

 

66,110

 

 

 

(32,502

)

Certificates of deposits  - brokered

 

81,371

 

 

 

235,805

 

 

 

(154,434

)

Total wholesale deposits

 

114,979

 

 

 

301,915

 

 

 

(186,936

)

 

 

 

 

 

 

 

 

 

 

 

 

Total deposits

$

4,253,254

 

 

$

4,147,610

 

 

$

105,644

 

Additional information about the Company’s deposits at March 31, 2020 and June 30, 2019 is presented in Note 13 to the unaudited consolidated financial statements.

Borrowings.  The balance of borrowings increased by $62.0 million to $1.38 billion at March 31, 2020 from $1.32 billion at June 30, 2019.  The increase in borrowings primarily reflected increases in overnight borrowings of $170.0 million and new FHLB advances of $50.0 million, partially offset by the extinguishment and maturity of $121.5 million and $35.3 million of FHLB advances, respectively.

Additional information about the Company’s borrowings at March 31, 2020 and June 30, 2019 is presented in Note 14 to the unaudited consolidated financial statements.

Other Liabilities.  The balance of other liabilities increased by $28.8 million to $66.9 million at March 31, 2020 from $38.1 million at June 30, 2019. The increase in other liabilities primarily reflected the adoption of a new accounting standard related to leases and a decrease in the fair value of our interest rate derivatives. The new accounting standard requires leases to be recognized on our Consolidated Statements of Condition as a right of use asset and lease liability, as noted above.  Our operating lease liability totaled approximately $17.4 million as of March 31, 2020 and the decrease in the fair value of our interest rate derivatives portfolio in a liability position was approximately $15.2 at March 31, 2020.  The remaining variance generally represented normal operating fluctuations in the balances of other liabilities.

Additional information about the Company’s operating lease liability at March 31, 2020 is presented in Note 12 to the unaudited consolidated financial statements.  Additional information about the Company’s derivatives portfolio at March 31, 2020 is presented in Note 15 to the unaudited consolidated financial statements.

- 56 -

 

Stockholders’ Equity.  Stockholders’ equity decreased by $57.5 million to $1.07 billion at March 31, 2020 from $1.13 billion at June 30, 2019 largely reflecting the impact of our share repurchases during the first nine months of fiscal 2020.  In March 2019 we announced our fourth share repurchase program through which we authorized the repurchase of 9,218,324 shares, or 10%, of our outstanding shares as of that date.

During the nine months ended March 31, 2020, the Company repurchased 5,375,551 shares of common stock at a total cost of $69.8 million and an average cost of $12.98 per share. The shares of common stock repurchased during the period represented 58.3% of the total shares authorized to be repurchased under the current repurchase program. Cumulatively, the Company has repurchased a total of 8,457,294 shares or 91.7% of the shares to be repurchased under its current repurchase program at a total cost of $111.1 million and at an average cost of $13.14 per share.  On March 25, 2020 the Company temporarily suspended its stock repurchase program.

The net decrease in stockholders’ equity was partially offset by net income of $31.3 million, or $0.38 per share, for the nine months ended March 31, 2020 from which we declared and paid regular quarterly cash dividends totaling $0.21 per share. Cash dividends declared and paid during the nine months ended March 31, 2020 reduced stockholders’ equity by $17.3 million.

The change in stockholders’ equity also reflected a $7.0 million decrease in accumulated other comprehensive income during the nine months ended March 31, 2020.

- 57 -

 

Analysis of Net Interest Income

Net interest income represents the difference between income we earn on our interest-earning assets and the expense we pay on interest-bearing liabilities. Net interest income depends on the volume of interest-earning assets and interest-bearing liabilities and the interest rates earned on such assets and paid on such liabilities.

Average Balance Sheet and Yields. The following tables reflect the components of the average balance sheet and of net interest income for the periods indicated. We derived the average yields and costs by dividing income or expense by the average balance of assets or liabilities, respectively, for the periods presented with daily balances used to derive average balances.  No tax equivalent adjustments have been made to yield or costs.  Non-accrual loans were included in the calculation of average balances, however interest receivable on these loans has been fully reserved for and therefore not included in interest income. The yields and costs set forth below include the effect of deferred fees, discounts and premiums that are amortized or accreted to interest income or expense and exclude the impact of prepayment penalties, which are recorded to non-interest income.

 

 

For the Three Months Ended March 31,

 

2020

 

2019

 

Average

Balance

 

 

Interest

 

 

Average

Yield/

Cost

 

Average

Balance

 

 

Interest

 

 

Average

Yield/

Cost

 

(Dollars in Thousands)

Interest-earning assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loans receivable (1)

$

4,503,996

 

 

$

46,603

 

 

 

4.14

 

%

 

$

4,709,052

 

 

$

48,116

 

 

 

4.09

 

%

Taxable investment securities (2)

 

1,406,973

 

 

 

10,526

 

 

 

2.99

 

 

 

 

1,161,492

 

 

 

9,511

 

 

 

3.28

 

 

Tax-exempt securities (2)

 

101,771

 

 

 

547

 

 

 

2.15

 

 

 

 

134,309

 

 

 

710

 

 

 

2.12

 

 

Other interest-earning assets (3)

 

104,241

 

 

 

1,100

 

 

 

4.22

 

 

 

 

107,554

 

 

 

1,320

 

 

 

4.91

 

 

Total interest-earning assets

 

6,116,981

 

 

 

58,776

 

 

 

3.84

 

 

 

 

6,112,407

 

 

 

59,657

 

 

 

3.91

 

 

Non-interest-earning assets

 

598,335

 

 

 

 

 

 

 

 

 

 

 

 

574,921

 

 

 

 

 

 

 

 

 

 

Total assets

$

6,715,316

 

 

 

 

 

 

 

 

 

 

 

$

6,687,328

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest-bearing liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest-bearing demand

$

1,112,080

 

 

$

3,251

 

 

 

1.17

 

 

 

$

790,567

 

 

$

2,092

 

 

 

1.06

 

 

Savings

 

838,501

 

 

 

1,782

 

 

 

0.85

 

 

 

 

773,308

 

 

 

1,162

 

 

 

0.60

 

 

Certificates of deposit

 

2,004,785

 

 

 

9,735

 

 

 

1.94

 

 

 

 

2,288,836

 

 

 

10,860

 

 

 

1.90

 

 

Total interest-bearing deposits

 

3,955,366

 

 

 

14,768

 

 

 

1.49

 

 

 

 

3,852,711

 

 

 

14,114

 

 

 

1.47

 

 

Borrowings

 

1,295,699

 

 

 

6,398

 

 

 

1.98

 

 

 

 

1,318,205

 

 

 

6,905

 

 

 

2.10

 

 

Total interest-bearing liabilities

 

5,251,065

 

 

 

21,166

 

 

 

1.61

 

 

 

 

5,170,916

 

 

 

21,019

 

 

 

1.63

 

 

Non-interest-bearing liabilities (4)

 

372,986

 

 

 

 

 

 

 

 

 

 

 

 

343,575

 

 

 

 

 

 

 

 

 

 

Total liabilities

 

5,624,051

 

 

 

 

 

 

 

 

 

 

 

 

5,514,491

 

 

 

 

 

 

 

 

 

 

Stockholders' equity

 

1,091,265

 

 

 

 

 

 

 

 

 

 

 

 

1,172,837

 

 

 

 

 

 

 

 

 

 

Total liabilities and stockholders'

  equity

$

6,715,316

 

 

 

 

 

 

 

 

 

 

 

$

6,687,328

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net interest income

 

 

 

 

$

37,610

 

 

 

 

 

 

 

 

 

 

 

$

38,638

 

 

 

 

 

 

Interest rate spread (5)

 

 

 

 

 

 

 

 

 

2.23

 

%

 

 

 

 

 

 

 

 

 

 

2.28

 

%

Net interest margin (6)

 

 

 

 

 

 

 

 

 

2.46

 

%

 

 

 

 

 

 

 

 

 

 

2.53

 

%

Ratio of interest-earning assets

  to interest-bearing liabilities

 

1.16

 

X

 

 

 

 

 

 

 

 

 

 

1.18

 

X

 

 

 

 

 

 

 

 

 

(1)

Loans held-for-sale and non-accruing loans have been included in loans receivable and the effect of such inclusion was not material. Allowance for loan losses has been included in non-interest-earning assets.

(2)

Fair value adjustments have been excluded in the balances of interest-earning assets.

(3)

Includes interest-bearing deposits at other banks and FHLB of New York capital stock.

(4)

Includes average balances of non-interest-bearing deposits of $317,530,000 and $307,645,000, for the three months ended March 31, 2020, and 2019, respectively.

(5)

Interest rate spread represents the difference between the yield on interest-earning assets and the cost of interest-bearing liabilities.

(6)

Net interest margin represents net interest income as a percentage of average interest-earning assets.

- 58 -

 

 

For the Nine Months Ended March 31,

 

2020

 

2019

 

Average

Balance

 

 

Interest

 

 

Average

Yield/

Cost

 

Average

Balance

 

 

Interest

 

 

Average

Yield/

Cost

 

(Dollars in Thousands)

Interest-earning assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loans receivable (1)

$

4,569,341

 

 

$

140,811

 

 

 

4.11

 

%

 

$

4,676,435

 

 

$

144,568

 

 

 

4.12

 

%

Taxable investment securities (2)

 

1,265,871

 

 

 

29,552

 

 

 

3.11

 

 

 

 

1,166,995

 

 

 

27,441

 

 

 

3.14

 

 

Tax-exempt securities (2)

 

118,828

 

 

 

1,906

 

 

 

2.14

 

 

 

 

135,280

 

 

 

2,139

 

 

 

2.11

 

 

Other interest-earning assets (3)

 

115,764

 

 

 

3,588

 

 

 

4.13

 

 

 

 

102,664

 

 

 

3,737

 

 

 

4.85

 

 

Total interest-earning assets

 

6,069,804

 

 

 

175,857

 

 

 

3.86

 

 

 

 

6,081,374

 

 

 

177,885

 

 

 

3.90

 

 

Non-interest-earning assets

 

691,611

 

 

 

 

 

 

 

 

 

 

 

 

586,366

 

 

 

 

 

 

 

 

 

 

Total assets

$

6,761,415

 

 

 

 

 

 

 

 

 

 

 

$

6,667,740

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest-bearing liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest-bearing demand

$

992,261

 

 

$

9,304

 

 

 

1.25

 

 

 

$

790,568

 

 

$

5,707

 

 

 

0.96

 

 

Savings

 

817,025

 

 

 

4,964

 

 

 

0.81

 

 

 

 

754,775

 

 

 

2,849

 

 

 

0.50

 

 

Certificates of deposit

 

2,082,677

 

 

 

32,145

 

 

 

2.06

 

 

 

 

2,182,820

 

 

 

28,824

 

 

 

1.76

 

 

Total interest-bearing deposits

 

3,891,963

 

 

 

46,413

 

 

 

1.59

 

 

 

 

3,728,163

 

 

 

37,380

 

 

 

1.34

 

 

Borrowings

 

1,291,045

 

 

 

20,540

 

 

 

2.12

 

 

 

 

1,374,421

 

 

 

22,338

 

 

 

2.17

 

 

Total interest-bearing liabilities

 

5,183,008

 

 

 

66,953

 

 

 

1.72

 

 

 

 

5,102,584

 

 

 

59,718

 

 

 

1.56

 

 

Non-interest-bearing liabilities (4)

 

375,792

 

 

 

 

 

 

 

 

 

 

 

 

351,307

 

 

 

 

 

 

 

 

 

 

Total liabilities

 

5,558,800

 

 

 

 

 

 

 

 

 

 

 

 

5,453,891

 

 

 

 

 

 

 

 

 

 

Stockholders' equity

 

1,102,615

 

 

 

 

 

 

 

 

 

 

 

 

1,213,849

 

 

 

 

 

 

 

 

 

 

Total liabilities and stockholders'

  equity

$

6,661,415

 

 

 

 

 

 

 

 

 

 

 

$

6,667,740

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net interest income

 

 

 

 

$

108,904

 

 

 

 

 

 

 

 

 

 

 

$

118,167

 

 

 

 

 

 

Interest rate spread (5)

 

 

 

 

 

 

 

 

 

2.14

 

%

 

 

 

 

 

 

 

 

 

 

2.34

 

%

Net interest margin (6)

 

 

 

 

 

 

 

 

 

2.39

 

%

 

 

 

 

 

 

 

 

 

 

2.59

 

%

Ratio of interest-earning assets

  to interest-bearing liabilities

 

1.17

 

X

 

 

 

 

 

 

 

 

 

 

1.19

 

X

 

 

 

 

 

 

 

 

 

(1)

Loans held-for-sale and non-accruing loans have been included in loans receivable and the effect of such inclusion was not material. Allowance for loan losses has been included in non-interest-earning assets.

(2)

Fair value adjustments have been excluded in the balances of interest-earning assets.

(3)

Includes interest-bearing deposits at other banks and FHLB of New York capital stock.

(4)

Includes average balances of non-interest-bearing deposits of $319,451,000 and $312,342,000, for the nine months ended March 31, 2020, and 2019, respectively.

(5)

Interest rate spread represents the difference between the yield on interest-earning assets and the cost of interest-bearing liabilities.

(6)

Net interest margin represents net interest income as a percentage of average interest-earning assets.

- 59 -

 

 

Comparison of Operating Results for the Three Months Ended March 31, 2020 and March 31, 2019

Net Income.  Net income for the three months ended March 31, 2020 was $9.3 million, or $0.11 per basic and diluted share, compared to $11.4 million, or $0.13 per basic and diluted share, for the three months ended March 31, 2019. The decrease in net income reflected a decrease in net interest income, as detailed above, an increase to the provision for loan losses and an increase to non-interest expense that was partially offset by an increase in non-interest income and a decrease in income tax expense.

  Net income for the three months ended March 31, 2020 reflected the Company’s recognition of certain merger-related expenses totaling $285,000 related to its proposed acquisition of MSBF.

Net Interest Income.  Net interest income decreased by $1.0 million to $37.6 million for the three months ended March 31, 2020. The decrease between the comparative periods resulted from a decrease of $881,000 in interest income coupled with an increase of $147,000 in interest expense.

For the three months ended March 31, 2020, net interest spread declined by five basis points to 2.23% while net interest margin declined seven basis points to 2.46%. The decrease in net interest spread and margin reflected a decrease in the average yield on interest-earning assets partially offset by a decrease in the average cost of interest-bearing liabilities.

Interest Income.  Interest income decreased by $881,000 to $58.8 million for the three months ended March 31, 2020, reflecting a $4.6 million decrease in the average balance of interest-earning assets and a seven basis point decrease in their yield to 3.84%.  Interest income on loans decreased by $1.5 million to $46.6 million for the three months ended March 31, 2020.  The decrease in interest income on loans was primarily attributable to a $205.1 million decrease in the average balance of loans to $4.50 billion during the three months ended March 31, 2020. The average yield on loans increased five basis points to 4.14%.

The increase in interest income on interest-earning assets, excluding loans, was due to the increase in interest income on taxable investment securities, partially offset by a decrease in interest income on other interest-earning assets.

Interest Expense.  Total interest expense increased by $147,000 to $21.2 million for the three months ended March 31, 2020.  The increase in interest expense reflected an increase of $80.1 million in the average balance of interest-bearing liabilities to $5.25 billion partially offset by a two basis point decrease in the average cost of interest-bearing liabilities to 1.61% for the three months ended March 31, 2020.

Interest expense on deposits increased $654,000 to $14.8 million for the three months ended March 31, 2020 and was attributable to an increase of $102.7 million in the average balance of interest-bearing deposits coupled with a two basis point increase in their cost.

Interest expense on borrowings decreased by $507,000 to $6.4 million for the three months ended March 31, 2020 and was attributable to a decrease of $22.5 million in the average balance of borrowings coupled with a 12 basis point decrease in their cost.

Provision for Loan Losses.  The provision for loan losses increased by $6.5 million to provision expense of $6.3 million for the three months ended March 31, 2020 compared to a provision reversal of $179,000 for the three months ended March 31, 2019.  The increase in provision was largely attributable to increases in qualitative factors associated with the impact of COVID-19 on national and regional economic conditions. The increase also reflected the effects of an increase in the outstanding balance of the loan portfolio that was collectively evaluated for impairment during the three months ended March 31, 2020, compared to a net decrease in that portion of the portfolio for the three months ended March 31, 2019.

Additional information regarding the allowance for loan losses and the associated provisions recognized during the three months ended March 31, 2020 and 2019 is presented in Note 11 to the unaudited consolidated financial statements as well as the Comparison of Financial Condition at March 31, 2020 and June 30, 2019.  

Non-Interest Income.  Non-interest income increased by $2.5 million to $6.2 million for the three months ended March 31, 2020, reflecting the effects of several offsetting factors.

Fees and service charges decreased by $336,000 to $1.3 million for the three months ended March 31, 2020.  The decrease primarily reflected a decrease in loan-related fees attributable to a decrease in commercial loan prepayment activity.

- 60 -

 

We recognized a net gain of $2.2 million on the sale and call of securities during the three months ended March 31, 2020 compared to a net loss of $182,000 during the earlier comparative period.  The increase was attributable to the execution of a wholesale restructuring transaction, as noted above.  

Gain on sale of loans increased by $414,000 to $565,000 for the three months ended March 31, 2020. The increase in loan sale gains reflected an increase of $426,000 in gains on sale of residential mortgage loans, partially offset by a decrease of $11,000 in gains on sale of SBA loans.  Both the increase in residential mortgage gains on sale and the decrease in SBA gains on sale primarily reflected changes in the volume of loans originated and sold between comparative periods.

We recognized a net loss of $6,000 related to the write down and sale of other real estate owned (“OREO”) during the three months ended March 31, 2019 while there were no such losses during the current period.

The remaining changes in the other components of non-interest income between comparative periods generally reflected normal operating fluctuations within those line items.

Non-Interest Expenses.  Total non-interest expense increased by $1.3 million to $28.1 million for the three months ended March 31, 2020.

Salaries and employee benefits expense increased by $187,000 to $15.5 million for the three months ended March 31, 2020.  The net increase in salaries and employee benefits was largely attributable to a non-recurring increase of $250,000 associated with discretionary bonuses granted to certain essential front-line branch employees.  Also contributing to the net increase were decreases in employee severance, employee benefits expense and employee stock-based compensation that were partially offset by increases in ESOP expense and payroll tax expense.

Net occupancy expense of premises decreased by $294,000 to $2.7 million for the three months ended March 31, 2020.  This decrease was largely attributable to $226,000 of snow removal expense recognized in the prior comparative period.

Equipment and systems expense decreased by $381,000 to $2.7 million for the three months ended March 31, 2020.  This decrease was largely attributable to non-recurring core processing expense reductions totaling $500,000 which were associated with the re-negotiation of the Company’s core processing contract, partially offset by increases in other equipment and technology infrastructure costs.

Advertising and marketing expense decreased by $127,000 to $612,000 for the three months ended March 31, 2020.  This decrease largely reflected changes in advertising expense across a variety of advertising formats reflecting normal fluctuations in the timing of certain campaigns supporting our loan and deposit growth initiatives.

For the three months ended March 31, 2020, the Company recorded no expense associated with FDIC insurance premiums compared to $455,000 for the three months ended March 31, 2019.  No expense was recorded in the current period as a result of the FDIC’s Deposit Insurance Fund Reserve Ratio having reached a pre-established threshold defined by federal regulation.  Upon reaching this threshold qualifying banks with total consolidated assets of less than $10 billion were awarded assessment credits to be utilized towards their FDIC insurance premiums.

Debt extinguishment expenses increased by $2.2 million and were related to the Company’s execution of a wholesale restructuring transaction, as noted above, for which no comparable expense was recorded during the earlier comparative period.

Merger-related expenses increased by $285,000 and were related to the Company’s pending acquisition of MSBF, as noted above, for which no comparable expense was recorded during the earlier comparative period.

Miscellaneous expense decreased by $81,000 to $3.3 million for the three months ended March 31, 2020.  The decrease in expense was mainly attributable to decreases in professional and consulting fees and subscription expense.  These decreases in expense were partially offset by increases to regulatory filing fees, loan expense, bad debt expense and ATM & Debit card supplies.

- 61 -

 

Provision for Income Taxes.  The provision for income taxes decreased by $4.1 million to $225,000 for the three months ended March 31, 2020.  The decrease in income tax expense partly reflected a $1.6 million reduction in income tax expense attributable to the carryback of net operating losses into prior periods at a higher statutory federal tax rate than is currently in effect for the Company.  This carryback was permitted by tax law changes enacted by the CARES Act, which was signed into law on March 27, 2020.  In addition, the Company reversed valuation allowances totaling $591,000 which were associated with capital loss carryforwards and were determined to be realizable due to the sale of investment securities at the Bank’s New Jersey investment company subsidiary.  Finally, a lower level of pre-tax net income, as compared to the prior period, resulted in a lower provision for income tax expense.  

Our effective tax rates for the three month periods ended March 31, 2020 and March 31, 2019 were 2.4% and 27.4% which, in relation to statutory income tax rates, reflected the effects of recurring sources of tax-favored income included in pre-tax income. However, the effective tax rate for the three months ended March 31, 2020 further reflected the effects of the CARES Act and the reversal of valuation allowances recognized during the period, as discussed above.

Comparison of Operating Results for the Nine Months Ended March 31, 2020 and March 31, 2019

Net Income.  Net income for the nine months ended March 31, 2020 was $31.3 million, or $0.38 per basic and diluted share, compared to $33.3 million, or $0.36 per basic and diluted share, for the nine months ended March 31, 2019. The decrease in net income reflected a decrease in net-interest income, as detailed above, an increase to the provision for loan losses and an increase to non-interest expense that was partially offset by an increase in non-interest income and a decrease in income tax expense.

Net income for the nine months ended March 31, 2020 was impacted by a non-recurring increase of $720,000 in non-interest expense and a non-recurring decrease of $342,000 in non-interest income which were recognized in conjunction with the Company’s previously completed branch consolidations.  In addition, net income reflected the Company’s recognition of certain merger-related expenses totaling $504,000 related to its proposed acquisition of MSBF, as noted above.

Net Interest Income.  Net interest income decreased by $9.3 million to $108.9 million for the nine months ended March 31, 2020. The decrease between the comparative periods resulted from a decrease of $2.0 million in interest income and an increase of $7.2 million in interest expense.

For the nine months ended March 31, 2020, net interest spread declined by 20 basis points to 2.14% while net interest margin declined 20 basis points to 2.39%. The decrease in the net interest rate spread reflected a decrease in the average yield on interest-earning assets and an increase in the average cost of interest-bearing liabilities.

Interest Income.  Interest income decreased by $2.0 million to $175.9 million for the nine months ended March 31, 2020.  The decrease in interest income partly reflected an $11.6 million decrease in the average balance of interest-earning assets and a four basis points decrease in their yield to 3.86%.  Interest income on loans decreased by $3.8 million to $140.8 million for the nine months ended March 31, 2020. The decrease in interest income on loans was primarily attributable to a $107.1 million decrease in the average balance of loans to $4.57 billion during the nine months ended March 31, 2020. The average yield on loans decreased one basis point to 4.11%.

The decrease in interest income on interest-earning assets, excluding loans, was due to decreases in interest income on tax-exempt securities and other interest-earning assets partially offset by an increase in interest income on taxable investment securities.

Interest Expense.  Total interest expense increased by $7.2 million to $67.0 million for the nine months ended March 31, 2020.  The increase in interest expense partly reflected an $80.4 million increase in the average balance of interest-bearing liabilities to $5.18 billion for the nine months ended March 31, 2020, while also reflecting a 16 basis point increase in the average cost of interest-bearing liabilities to 1.72%.

Interest expense on deposits increased $9.0 million to $46.4 million for the nine months ended March 31, 2020 and was attributable to an increase of $163.8 million in the average balance of interest-bearing deposits coupled with a 25 basis point increase in their cost.

Interest expense on borrowings decreased by $1.8 million to $20.5 million for the nine months ended March 31, 2020 and was attributable to a decrease of $83.4 million in the average balance of borrowings coupled with a five basis point decrease in their cost.

- 62 -

 

Provision for Loan Losses.  The provision for loan losses increased by $1.1 million to $4.0 million for the nine months ended March 31, 2020 compared to $2.9 million for the nine months ended March 31, 2019.  The increase in provision at March 31, 2020, was attributable to increases in qualitative factors associated with the economic impact of COVID-19 on national and regional economic conditions.  This increase was partially offset by the effects of a decrease in the outstanding balance of the loan portfolio that was collectively evaluated for impairment during the nine months ended March 31, 2020, compared to a net increase in that portion of the portfolio for the nine months ended March 31, 2019.  

Additional information regarding the allowance for loan losses and the associated provisions recognized during the nine months ended March 31, 2020 and 2019 is presented in Note 11 to the unaudited consolidated financial statements as well as the Comparison of Financial Condition at March 31, 2020 and June 30, 2019.  

Non-Interest Income.  Non-interest income increased by $4.5 million to $14.7 million for the nine months ended March 31, 2020, reflecting the effects of several offsetting factors.

Fees and service charges increased by $846,000 to $5.0 million for the nine months ended March 31, 2020.  The increase primarily reflected an increase in loan-related fees attributable to an increase in commercial loan prepayment activity.

We recognized a net gain of $2.2 million on the sale and call of securities during the nine months ended March 31, 2020 compared to a net loss of $182,000 during the earlier comparative period.  The increase was primarily attributable to the execution of a wholesale restructuring transaction, as noted above.  

Gain on sale of loans increased by $1.5 million to $1.8 million for the nine months ended March 31, 2020. The increase in loan sale gains reflected an increase of $1.5 million in gains on sale of residential mortgage loans.  The increase in residential mortgage gains on sale primarily reflected changes in the volume of loans originated and sold between comparative periods.

The Company incurred a net loss of $28,000 related to the write down and sale of OREO during the nine months ended March 31, 2020 compared to a net loss of $20,000 during the earlier comparative period.

Miscellaneous non-interest income decreased by $230,000 to $117,000 for the nine months ended March 31, 2020.  The decrease primarily reflected $342,000 of non-recurring asset disposal losses recognized in conjunction with the Company’s previously completed branch consolidations.

The remaining changes in the other components of non-interest income between comparative periods generally reflected normal operating fluctuations within those line items.

Non-Interest Expenses.  Total non-interest expense increased by $235,000 to $80.7 million for the nine months ended March 31, 2020.

Salaries and employee benefits expense decreased by $203,000 to $46.5 million for the nine months ended March 31, 2020.  The net decrease in salaries and employee benefits expense reflected decreases in incentive compensation, bonus, benefits expense and employee stock-based compensation expenses. These decreases were partially offset by increases in wages and salaries, employee severance, ESOP expense and payroll taxes.

Net occupancy expense of premises increased by $260,000 to $8.7 million for the nine months ended March 31, 2020.  This increase was largely attributable to $517,000 of non-recurring lease termination costs recognized in conjunction with the previously noted branch consolidations coupled with an increase in facility lease expenses arising from costs associated with forthcoming branch additions and relocations.  Partially offsetting these increases were decreases in ongoing facility repairs and maintenance expenses.

Equipment and systems expense decreased by $549,000 to $8.8 million for the nine months ended March 31, 2020.  This decrease in expense was largely attributable to a decrease of $729,000 in core processing expense and $347,000 in telecommunication delivery channel expense, partially offset by increases in other technology infrastructure costs.  The reduction in core processing expense was primarily attributable to non-recurring expense reductions of $500,000, recognized in the current period, attributable the re-negotiation of the Company’s core processing contract.  The remaining reduction in core processing expense and the reduction in telecommunication channel expense was largely the result of expenses recognized by the Company, in the earlier comparative period, related to an acquired institution.

Advertising and marketing expense decreased by $66,000 to $2.0 million for the nine months ended March 31, 2020.  This decrease largely reflected changes in advertising expenses across a variety of advertising formats reflecting normal fluctuations in the timing of certain campaigns supporting our loan and deposit growth initiatives.

- 63 -

 

For the nine months ended March 31, 2020, the Company recorded no expense associated with FDIC insurance premiums compared to $1.3 million for the nine months ended March 31, 2019.  No expense was recorded in the current period as a result of the FDIC’s Deposit Insurance Fund Reserve Ratio having reached a pre-established threshold defined by federal regulation.  Upon reaching this threshold qualifying banks with total consolidated assets of less than $10 billion were awarded assessment credits to be utilized towards their FDIC insurance premiums.

Directors’ compensation expense increased by $36,000 to $2.3 million for the nine months ended March 31, 2020.  The increase in expense primarily reflected an increase in director-related stock based compensation.  

Merger-related expenses increased by $504,000 and were related to the Company’s pending acquisition of MSBF, as noted above, for which no such expenses were recorded during the earlier comparative period.

Debt extinguishment expenses increased by $2.2 million and were related to the Company’s execution of a wholesale restructuring transaction designed to enhance net interest income and reduce credit risk within the investment portfolio, as noted above, for which no such expenses were recorded during the earlier comparative period.

Miscellaneous expense decreased by $562,000 to $9.7 million for the nine months ended March 31, 2020. The decrease in expense was largely attributable to the recovery of asset write-down costs totaling $288,000 which were recognized in conjunction with branch consolidations.  The decrease in expense also reflected decreases in education expenses, consulting expense and audit and accounting fees that were partially offset by increases in loan expense and legal expense.

Provision for Income Taxes.  The provision for income taxes decreased by $4.0 million to $7.6 million for the nine months ended March 31, 2020.  The decrease in income tax expense reflected a $1.6 million reduction in income tax expense attributable to the carryback of net operating losses into prior periods at a higher statutory federal tax rate than is currently in effect for the Company.  This carryback was permitted by tax law changes enacted by the CARES Act, which was signed into law on March 27, 2020.  In addition, the Company reversed valuation allowances totaling $591,000 which were associated with capital loss carryforwards and were determined to be realizable due to the sale of investment securities at the Bank’s New Jersey investment company subsidiary.  Finally, a lower level of pre-tax net income, as compared to the prior period, resulted in a lower provision for income tax expense.  

Our effective tax rates for the nine month periods ended March 31, 2020 and March 31, 2019 were 19.5% and 25.8% which, in relation to statutory income tax rates, reflected the effects of recurring sources of tax-favored income included in pre-tax income. However, the effective tax rate for the nine months ended March 31, 2020 further reflected the effects of the CARES Act and the reversal of valuation allowances recognized during the period, as discussed above.

 

 

 

- 64 -

 

Liquidity and Capital Resources

Liquidity, represented by cash and cash equivalents, is a product of operating, investing and financing activities. The Company’s primary sources of funds are deposits, borrowings, cash flows from investment securities and loans receivable and funds provided from operations. While scheduled payments from the amortization and maturity of loans and investment securities are relatively predictable sources of funds, general interest rates, economic conditions and competition greatly influence deposit flows and prepayments on loans and securities.

Liquidity, at March 31, 2020, included $59.5 million of short-term cash and equivalents supplemented by $1.48 billion of investment securities classified as available for sale which can readily be sold or pledged as collateral, if necessary.  In addition, the Company has the capacity to borrow additional funds from the FHLB, Federal Reserve Bank or via unsecured lines of credit.  As of March 31, 2020, the Company had the capacity to borrow additional funds totaling $1.62 billion and $323.5 million, without pledging additional collateral, from the FHLB of New York and FRB, respectively.  The Company also had the capacity to borrow additional funds, on an unsecured basis, via lines of credit established with other financial institutions.  As of March 31, 2020, the available borrowing capacity under those lines of credit totaled $415.0 million.

At March 31, 2020, the Company had outstanding commitments to originate and purchase loans totaling approximately $94.2 million while such commitments totaled $27.7 million at June 30, 2019.  As of those same dates, the Company’s pipeline of loans held for sale included $114.5 million and $46.2 million of loans in process whose terms included interest rate locks to borrowers that were paired with a non-binding, best-efforts, commitment to sell the loan to a buyer at a fixed price and within a predetermined timeframe after the sale commitment is established.

Construction loans in process and unused lines of credit were $8.3 million and $79.1 million, respectively, at March 31, 2020 compared to $3.9 million and $78.5 million, respectively, at June 30, 2019. The Company is also subject to the contingent liabilities resulting from letters of credit whose outstanding balances totaled $217,000 and $612,000 at March 31, 2020 and June 30, 2019, respectively.

Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require payment of a fee by the customer. Our exposure to credit loss in the event of nonperformance by the other party to the financial instrument for commitments to extend credit is represented by the contractual notional amount of those instruments. We use the same credit policies in making commitments and conditional obligations as we do for on-balance-sheet instruments. Since many of the commitments are expected to expire without being drawn upon, the total commitment amounts do not necessarily represent future cash requirements.

Deposits increased $105.6 million to $4.25 billion at March 31, 2020 from $4.15 billion at June 30, 2019.  The increase in deposit balances reflected a $92.9 million increase in interest-bearing deposits coupled with a $12.8 million increase in non-interest-bearing deposits.  Borrowings from the FHLB of New York and other sources are generally available to supplement the Bank’s liquidity position or to replace maturing deposits.  As of March 31, 2020, the Bank’s outstanding balance of FHLB advances, excluding fair value adjustments, totaled $1.18 billion.  In addition to FHLB advances we have $200.0 million in overnight borrowings and other borrowings totaling $6.7 million which represent collateralized overnight sweep account balances linked to customer demand deposits.

Consistent with its goals to operate a sound and profitable financial organization, the Bank actively seeks to maintain its status as a well-capitalized institution in accordance with regulatory standards. As of March 31, 2020, the Company and the Bank exceeded all capital requirements of federal banking regulators.

- 65 -

 

The following table sets forth the Bank’s capital position at March 31, 2020 and June 30, 2019, as compared to the minimum regulatory capital requirements that were in effect as of those dates:

 

 

At March 31, 2020

 

Actual

 

 

For Capital

Adequacy Purposes

 

 

To Be Well Capitalized

Under Prompt

Corrective Action

Provisions

 

Amount

 

 

Ratio

 

 

Amount

 

 

Ratio

 

 

Amount

 

 

Ratio

 

(Dollars in Thousands)

Total capital (to risk-weighted assets)

$

807,569

 

 

 

20.66

 

%

$

312,691

 

 

 

8.00

 

%

$

390,864

 

 

 

10.00

 

%

Tier 1 capital (to risk-weighted assets)

 

770,378

 

 

 

19.71

 

%

 

234,519

 

 

 

6.00

 

%

 

312,691

 

 

 

8.00

 

%

Common equity tier 1 capital (to risk-weighted assets)

 

770,378

 

 

 

19.71

 

%

 

175,889

 

 

 

4.50

 

%

 

254,062

 

 

 

6.50

 

%

Tier 1 capital (to adjusted total assets)

 

770,378

 

 

 

11.92

 

%

 

258,527

 

 

 

4.00

 

%

 

323,159

 

 

 

5.00

 

%

  

 

At June 30, 2019

 

Actual

 

 

For Capital

Adequacy Purposes

 

 

To Be Well Capitalized

Under Prompt

Corrective Action

Provisions

 

Amount

 

 

Ratio

 

 

Amount

 

 

Ratio

 

 

Amount

 

 

Ratio

 

(Dollars in Thousands)

Total capital (to risk-weighted assets)

$

787,219

 

 

 

19.50

 

%

$

322,974

 

 

 

8.00

 

%

$

403,718

 

 

 

10.00

 

%

Tier 1 capital (to risk-weighted assets)

 

753,945

 

 

 

18.68

 

%

 

242,231

 

 

 

6.00

 

%

 

322,974

 

 

 

8.00

 

%

Common equity tier 1 capital (to risk-weighted assets)

 

753,945

 

 

 

18.68

 

%

 

181,673

 

 

 

4.50

 

%

 

262,417

 

 

 

6.50

 

%

Tier 1 capital (to adjusted total assets)

 

753,945

 

 

 

11.78

 

%

 

256,116

 

 

 

4.00

 

%

 

320,145

 

 

 

5.00

 

%

 

 

The following table sets forth the Company’s capital position at March 31, 2020 and June 30, 2019, as compared to the minimum regulatory capital requirements that were in effect as of those dates:

 

 

 

At March 31, 2020

 

Actual

 

 

For Capital

Adequacy Purposes

 

Amount

 

 

Ratio

 

 

Amount

 

 

Ratio

 

(Dollars in Thousands)

Total capital (to risk-weighted assets)

$

896,622

 

 

 

22.84

 

%

$

314,076

 

 

 

8.00

 

%

Tier 1 capital (to risk-weighted assets)

 

859,431

 

 

 

21.89

 

%

 

235,557

 

 

 

6.00

 

%

Common equity tier 1 capital (to risk-weighted assets)

 

859,431

 

 

 

21.89

 

%

 

176,668

 

 

 

4.50

 

%

Tier 1 capital (to adjusted total assets)

 

859,431

 

 

 

13.25

 

%

 

259,385

 

 

 

4.00

 

%

 

 

 

At June 30, 2019

 

Actual

 

 

For Capital

Adequacy Purposes

 

Amount

 

 

Ratio

 

 

Amount

 

 

Ratio

 

(Dollars in Thousands)

Total capital (to risk-weighted assets)

$

941,319

 

 

 

23.22

 

%

$

324,246

 

 

 

8.00

 

%

Tier 1 capital (to risk-weighted assets)

 

908,045

 

 

 

22.40

 

%

 

243,184

 

 

 

6.00

 

%

Common equity tier 1 capital (to risk-weighted assets)

 

908,045

 

 

 

22.40

 

%

 

182,388

 

 

 

4.50

 

%

Tier 1 capital (to adjusted total assets)

 

908,045

 

 

 

14.14

 

%

 

256,856

 

 

 

4.00

 

%

- 66 -

 

 

As a result of the Economic Growth, Regulatory Relief, and Consumer Protection Act, the federal banking agencies have adopted a rule to establish for institutions with assets of less than $10 billion that meet other specified criteria a community bank leverage ratio (“CBLR”) that such institutions may elect to utilize in lieu of the generally applicable leverage and risk-based capital requirements noted above.   The federal banking agencies have adopted 9% as the applicable ratio, effective March 31, 2020, and as a result of the Coronavirus Aid, Relief and Economic Security (“CARES”) Act, temporarily reduced the ratio to 8% in response to COVID-19. Institutions with capital meeting the specified requirements and electing to follow the alternative framework will be considered compliant with all applicable regulatory capital and leverage requirements, including the requirement to be “well capitalized.”  The Company has elected not to utilize the CBLR framework at this time.

Off-Balance Sheet Arrangements

In the normal course of our business of investing in loans and securities we are a party to financial instruments with off-balance-sheet risk.  These financial instruments include significant purchase commitments, such as commitments related to capital expenditure plans and commitments to extend credit to meet the financing needs of our customers. We had no significant off-balance sheet commitments for capital expenditures as of March 31, 2020.

Recent Accounting Pronouncements

For a discussion of the expected impact of recently issued accounting pronouncements that have yet to be adopted by the Company, please refer to Note 6 to the unaudited consolidated financial statements.

 

 

 

- 67 -

 

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK

The majority of our assets and liabilities are sensitive to changes in interest rates. Consequently, interest rate risk is a significant form of business risk that we must manage.  Interest rate risk is generally defined in regulatory nomenclature as the risk to earnings or capital arising from the movement of interest rates and arises from several risk factors including re-pricing risk, basis risk, yield curve risk and option risk.

We maintain an Asset/Liability Management (“ALM”) program in order manage our interest rate risk. The program is overseen by the Board of Directors through its Interest Rate Risk Management Committee.  The Board of Directors has assigned the responsibility for the operational aspects of the ALM program to our Asset/Liability Management Committee (“ALCO”).  The ALCO is a management committee comprising the Chief Executive Officer, Chief Operating Officer, Chief Financial Officer, Chief Lending Officer, Chief Credit Officer, Chief Banking Officer, Chief Risk Officer and Treasurer/Chief Investment Officer. Additional members of our management team may be asked to participate on the ALCO, as appropriate.

The quantitative analysis that we conduct measures interest rate risk from both a capital and earnings perspective. With regard to earnings, movements in interest rates and the shape of the yield curve significantly influence the amount of net interest income (“NII”) that we recognize.  Movements in market interest rates, and the effect of such movements on the risk factors noted above, significantly influence the spread between the interest earned on our interest-earning assets and the interest paid on our interest-bearing liabilities.  Our internal interest rate risk analysis calculates the sensitivity of our projected NII over a one year period utilizing a static balance sheet assumption through which incoming and outgoing asset and liability cash flows are reinvested into similar instruments. Product pricing and earning asset prepayment speeds are appropriately adjusted for each rate scenario.

With regard to capital, our internal interest rate risk analysis calculates the sensitivity of our Economic Value of Equity (“EVE”) ratio to movements in interest rates. EVE represents the present value of the expected cash flows from our assets less the present value of the expected cash flows arising from our liabilities adjusted for the value of off-balance sheet instruments.  EVE attempts to quantify our economic value using a discounted cash flow methodology while the EVE ratio reflects that value as a form of capital ratio.  The degree to which the EVE ratio changes for any hypothetical interest rate scenario from its base case measurement is a reflection of an institution’s sensitivity to interest rate risk.

For both earnings and capital at risk our interest rate risk analysis calculates a base case scenario that assumes no change in interest rates. The model then measures changes throughout a series of interest rate scenarios representing immediate and permanent, parallel shifts in the yield curve up and down 100, 200 and 300 basis points with additional scenarios modeled where appropriate. The model requires that interest rates remain positive for all points along the yield curve for each rate scenario which may preclude the modeling of certain falling rate scenarios during periods of lower market interest rates. The relatively low level of interest rates prevalent at March 31, 2020 and June 30, 2019 precluded the modeling of certain falling rate scenarios.

 

- 68 -

 

The following tables present the results of our internal EVE analysis as of March 31, 2020 and June 30, 2019, respectively:

 

 

 

March 31, 2020

 

 

Economic Value of

Equity ("EVE")

 

EVE as a % of

Present Value of Assets

Change in

Interest Rates

 

$ Amount

of EVE

 

 

$ Change

in EVE

 

 

% Change

in EVE

 

EVE Ratio

 

Change in

EVE Ratio

 

 

(Dollars in Thousands)

 

 

 

 

 

 

 

 

 

 

+300 bps

 

 

676,674

 

 

 

(63,757

)

 

 

(9

)

%

 

 

11.05

 

%

 

 

(20

)

bps

+200 bps

 

 

728,344

 

 

 

(12,087

)

 

 

(2

)

%

 

 

11.57

 

%

 

 

32

 

bps

+100 bps

 

 

755,022

 

 

 

14,591

 

 

 

2

 

%

 

 

11.70

 

%

 

 

44

 

bps

0 bps

 

 

740,431

 

 

-

 

 

-

 

 

 

 

11.25

 

%

 

-

 

 

-100 bps

 

 

629,791

 

 

 

(110,640

)

 

 

(15

)

%

 

 

9.54

 

%

 

 

(172

)

bps

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

June 30, 2019

 

 

Economic Value of

Equity ("EVE")

 

EVE as a % of

Present Value of Assets

Change in

Interest Rates

 

$ Amount

of EVE

 

 

$ Change

in EVE

 

 

% Change

in EVE

 

EVE Ratio

 

Change in

EVE Ratio

 

 

(Dollars in Thousands)

 

 

 

 

 

 

 

 

 

 

+300 bps

 

 

733,887

 

 

 

(172,135

)

 

 

(19

)

%

 

 

12.44

 

%

 

 

(168

)

bps

+200 bps

 

 

795,855

 

 

 

(110,167

)

 

 

(12

)

%

 

 

13.12

 

%

 

 

(100

)

bps

+100 bps

 

 

859,686

 

 

 

(46,336

)

 

 

(5

)

%

 

 

13.77

 

%

 

 

(35

)

bps

0 bps

 

 

906,022

 

 

-

 

 

-

 

 

 

 

14.12

 

%

 

-

 

 

-100 bps

 

 

892,775

 

 

 

(13,247

)

 

 

(1

)

%

 

 

13.63

 

%

 

 

(49

)

bps

-200 bps

 

 

800,049

 

 

 

(105,973

)

 

 

(12

)

%

 

12.11

 

%

 

 

(201

)

bps

There are numerous internal and external factors that may contribute to changes in our EVE ratio and its sensitivity.  Changes in the composition and allocation of our balance sheet, or utilization of off balance sheet instruments such as derivatives, can significantly alter the exposure to interest rate risk as quantified by the changes in the EVE sensitivity measures.  Changes to certain external factors, most notably changes in the level of market interest rates and overall shape of the yield curve, can also alter the projected cash flows of our interest-earning assets and interest-costing liabilities and the associated present values thereof.

- 69 -

 

The following tables present the results of our internal NII analysis as of March 31, 2020 and June 30, 2019, respectively:

 

 

 

 

 

 

 

March 31, 2020

 

 

 

 

 

 

Net Interest

Income ("NII")

Change in

Interest Rates

 

Balance Sheet

Composition

 

Measurement

Period

 

$ Amount

of NII

 

 

$ Change

in NII

 

 

% Change

in NII

 

 

 

 

 

 

(Dollars In Thousands)

 

 

 

 

 

 

+300 bps

 

Static

 

One Year

 

$

141,872

 

 

$

(14,918

)

 

 

(9.51

)

%

+200 bps

 

Static

 

One Year

 

 

148,495

 

 

 

(8,295

)

 

 

(5.29

)

 

+100 bps

 

Static

 

One Year

 

 

154,698

 

 

 

(2,092

)

 

 

(1.33

)

 

0 bps

 

Static

 

One Year

 

 

156,790

 

 

 

-

 

 

 

-

 

 

-100 bps

 

Static

 

One Year

 

 

155,173

 

 

 

(1,617

)

 

 

(1.03

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

June 30, 2019

 

 

 

 

 

 

Net Interest

Income ("NII")

Change in

Interest Rates

 

Balance Sheet

Composition

 

Measurement

Period

 

$ Amount

of NII

 

 

$ Change

in NII

 

 

% Change

in NII

 

 

 

 

 

 

(Dollars In Thousands)

 

 

 

 

 

 

+300 bps

 

Static

 

One Year

 

$

131,190

 

 

$

(16,118

)

 

 

(10.94

)

%

+200 bps

 

Static

 

One Year

 

 

136,883

 

 

 

(10,425

)

 

 

(7.08

)

 

+100 bps

 

Static

 

One Year

 

 

143,007

 

 

 

(4,301

)

 

 

(2.92

)

 

0 bps

 

Static

 

One Year

 

 

147,308

 

 

 

-

 

 

 

-

 

 

-100 bps

 

Static

 

One Year

 

 

148,011

 

 

 

703

 

 

 

0.48

 

 

-200 bps

 

Static

 

One Year

 

 

146,927

 

 

 

(381

)

 

 

(0.26

)

 

 

Notwithstanding the rate change scenarios presented in the EVE and NII-based analyses above, future interest rates and their effect on net interest income are not predictable.  Computations of prospective effects of hypothetical interest rate changes are based on numerous assumptions, including relative levels of market interest rates, prepayments and deposit run-offs and should not be relied upon as indicative of actual results.  Certain shortcomings are inherent in this type of computation.  Although certain assets and liabilities may have similar maturities or periods of re-pricing, they may react at different times and in different degrees to changes in market interest rates.  The interest rate on certain types of assets and liabilities, such as demand deposits and savings accounts, may fluctuate in advance of changes in market interest rates, while rates on other types of assets and liabilities may lag behind changes in market interest rates.  Certain assets, such as adjustable-rate mortgages, generally have features which restrict changes in interest rates on a short-term basis and over the life of the asset. In the event of a change in interest rates, prepayments and early withdrawal levels could deviate significantly from those assumed in the analyses set forth above.  Additionally, an increase in credit risk may result as the ability of borrowers to service their debt may decrease in the event of an interest rate increase.

 

 

- 70 -

 

ITEM 4.

CONTROLS AND PROCEDURES

As of the end of the period covered by this Report, an evaluation was performed under the supervision and with the participation of the Company’s management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended). Based on that evaluation, the Company’s management, including the Chief Executive Officer and the Chief Financial Officer, concluded that the Company’s disclosure controls and procedures were effective.

During the quarter ended March 31, 2020, there were no changes in the Company’s internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934) that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

 

 

- 71 -

 

PART II

ITEM 1.

At March 31, 2020, neither the Company nor the Bank were involved in any pending legal proceedings other than routine legal proceedings occurring in the ordinary course of business, which involve amounts in the aggregate believed by management to be immaterial to the financial condition of the Company and the Bank.

ITEM 1A.

Risk Factors

The Risk Factors noted below are in addition to the Risk Factors previously disclosed under Item 1A of the Company’s Form 10-Q for the quarter ended December 31, 2019 and Item 1A of the Company’s Annual Report on Form 10-K for the year ended June 30, 2019, previously filed with the Securities and Exchange Commission. The Risk Factors below relate to the planned Merger of MSBF and the Company and the recent global outbreak of the coronavirus.

The recent global coronavirus outbreak has and will continue to pose risks and could harm business and results of operations for each of the Company, and MSBF and the combined company following the completion of the merger.

The COVID-19 pandemic is having an adverse impact on the Company, its customers and the communities it serves. Given its ongoing and dynamic nature, it is difficult to predict the full impact of the COVID-19 outbreak on the business of the Company and MSBF and the combined company following the completion of the merger. The extent of such impact will depend on future developments, which are highly uncertain, including when the coronavirus can be controlled and abated and when and how the economy may be reopened.

As the result of the COVID-19 pandemic and the related adverse local and national economic consequences, both the Company and MSBF, and the combined company following the completion of the merger, are subject to the following risks, any of which could have a material, adverse effect on the business, financial condition, liquidity, and results of operations of the Company, MSBF and, following the merger, the combined company:

 

 

•

risks to the capital markets that may impact the performance of the investment securities portfolios of the Company and MSBF;

 

 

•

effects on key employees, including operational management personnel and those charged with preparing, monitoring and evaluating the companies’ financial reporting and internal controls;

 

 

•

declines in demand for loans and other banking services and products, as well as a decline in the credit quality of our loan portfolio, owing to the effects of COVID-19 in the markets served by the Company and MSBF;

 

 

•

if the economy is unable to substantially reopen, and high levels of unemployment continue for an extended period of time, loan delinquencies, problem assets, and foreclosures may increase, resulting in increased charges and reduced income;

 

 

•

collateral for loans, especially real estate, may decline in value, which could cause loan losses to increase;

 

 

•

allowance for loan losses may increase if borrowers experience financial difficulties, which will adversely affect net income;

 

 

•

the net worth and liquidity of loan guarantors may decline, impairing their ability to honor commitments;

 

 

•

as the result of the decline in the Federal Reserve Board’s target federal funds rate to near 0%, the yield on assets may decline to a greater extent than the decline in cost of interest-bearing liabilities, reducing net interest margin and spread and reducing net income;

 

- 72 -

 

 

•

cyber security risks are increased as the result of an increase in the number of employees working remotely;

 

 

•

declines in demand resulting from adverse impacts of the disease on businesses deemed to be “non-essential” by governments in the markets served by the Company and MSBF; and

 

 

•

increasing or protracted volatility in the price of the Company’s common stock.

 

These factors, together or in combination with other events or occurrences not yet known or anticipated, could adversely affect the value of the merger consideration or could delay or prevent the consummation of the merger and the related transactions. If the Company or MSBF is unable to recover from a business disruption on a timely basis, the merger and the combined company’s business and financial conditions and results of operations following the completion of the merger could be adversely affected. The merger and efforts to integrate the businesses of the Company and MSBF may also be delayed and adversely affected by the coronavirus outbreak, and become more costly. Each of the Company, MSBF and the combined company may also incur additional costs to remedy damages caused by such disruptions, which could adversely affect its financial condition and results of operations.

ITEM 2.

Unregistered Sales of Equity Securities and Use of Proceeds

ISSUER PURCHASES OF EQUITY SECURITIES

The following table reports information regarding repurchases of the Company’s common stock during the quarter ended March 31, 2020:

 

Period

 

Total Number

of Shares

Purchased

 

 

Average Price

Paid per Share

 

 

Total Number

of Shares

Purchased as

Part of Publicly

Announced Plans

or Programs (1)

 

 

Maximum

Number of Shares

that May Yet Be

Purchased Under

the  Plans or

Programs

 

January 1-31, 2020

 

 

525,000

 

 

$

13.39

 

 

 

525,000

 

 

 

1,711,030

 

February 1-29, 2020

 

 

475,000

 

 

$

12.13

 

 

 

475,000

 

 

 

1,236,030

 

March 1-31, 2020

 

 

475,000

 

 

$

9.96

 

 

 

475,000

 

 

 

761,030

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

1,475,000

 

 

$

11.88

 

 

 

1,475,000

 

 

 

761,030

 

 

 

(1)

On March 13, 2019, the Company announced the authorization of a fourth repurchase plan for up to 9,218,324 shares or 10% of shares then outstanding.  This plan has no expiration date.  The plan commenced upon the completion of the third stock repurchase plan, which was announced on April 27, 2018, and authorized the purchase of up to 10,238,557 shares or 10% of shares then outstanding. On March 25, 2020, the Company temporarily suspended its stock repurchase program.

ITEM 3.

Defaults Upon Senior Securities

Not applicable.

ITEM 4.

Mine Safety Disclosures

Not applicable.

ITEM 5.

Other Information

None.

- 73 -

 

 ITEM 6.

Exhibits

The following Exhibits are filed as part of this report:

 

3.1

 

Articles of Incorporation of Kearny Financial Corp. (Incorporated by reference to the Registrant’s Registration Statement on Form S-1 (File No. 333-198602), originally filed on September 5, 2014)

3.2

 

Bylaws of Kearny Financial Corp. (Incorporated by reference to the Registrant’s Registration Statement on Form S-1 (File No. 333-198602), originally filed on September 5, 2014)

4

 

Form of Common Stock Certificate of Kearny Financial Corp. (Incorporated by reference to the Registrant’s Registration Statement on Form S-1 (File No. 333-198602), originally filed on September 5, 2014)

31.1

 

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

 

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1

 

Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2

 

Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101

 

The following materials from the Company’s Form 10-Q for the quarter ended March 31, 2020, formatted in Inline XBRL (Extensible Business Reporting Language): (i) the Consolidated Statements of Financial Condition, (ii) the Consolidated Statements of Income; (iii) the Consolidated Statements of Comprehensive Income, (iv) the Consolidated Statements of Changes in Stockholder’s Equity, (v) the Consolidated Statements of Cash Flows and (vi) the Notes to Consolidated Financial Statements.

101.INS

 

Inline XBRL Instance Document (The instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document)

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

 

Inline XBRL Taxonomy Extension Labels Linkbase Document

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104

 

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

 

 

- 74 -

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

KEARNY FINANCIAL CORP.

 

 

 

Date: May 8, 2020

By:

  /s/ Craig L. Montanaro

 

 

  Craig L. Montanaro

 

 

  President and Chief Executive Officer

 

 

  (Principal Executive Officer)

 

 

 

Date: May 8, 2020

By:

  /s/ Keith Suchodolski

 

 

  Keith Suchodolski

 

 

  Executive Vice President and Chief Financial Officer

 

 

  (Principal Financial and Accounting Officer)

 

 

- 75 -